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Abstract 
It is known that the functionality of the vascular network is affected by 
closed soft tissue trauma (CSTT) resulting from high-energy impact. 
Furthermore, it has been shown that the revascularisation after muscle injuries 
is necessary for tissue healing. Currently, the objective and scientific evaluation 
of the efficacy of clinical therapeutic methods for the treatment of CSTT is 
hampered by a lack of quantitative diagnostic tools to monitor the 
revascularisation of the injured tissue. Even the most common treatments such 
as cryotherapy (icing) are based on anecdotal evidence rather than scientific 
studies. While revascularisation after muscle injuries is necessary for tissue 
healing, knowledge regarding the vascular morphology changes following CSTT 
during the natural healing process and during cryotherapy is missing.  
Therefore, this research aimed to investigate the effects of CSTT and 
cryotherapy on the vascular morphology in 3D in a well-characterised rat model 
using contrast-enhanced micro-computed tomography (micro-CT) imaging and 
histological analysis.  
In the injury group, an impact device was used to apply a reproducible 
CSTT to the left thigh of anaesthetised rats. This group was divided into two 
untreated (sham) and treated groups (icing) where the icing group received 
cryotherapy on the injured region. The injured animals were also compared 
with non-injured and non-treated group (control).  
To visualise the vasculature, the blood vessels of euthanised rats were 
perfused with a contrast agent using an infusion pump. The hindlimbs were 
then imaged using a micro-CT scanner to characterise the 3D vascular 
morphology using the parameters such as vessel diameter, volume, and density. 
The results derived from micro-CT imaging were then interpreted and validated 
by histomorphometry.  
Through the CSTT model, it was found that there are measureable changes 
to the vascular morphology after traumatic injuries and during the natural 
healing period.  
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Also, it was confirmed that the recovery of the injured vasculature is 
affected by therapeutic modalities such as icing. The perfused vessel volume, 
diameter and number increased from the first day after trauma in non-treated 
injuries, while the increase of these parameters is reduced in the early time 
points as a result of icing. Therefore, while cryotherapy reduces the 
inflammation and pain in the early days following CSTT, the results obtained 
from this research suggest that this may delay the restoration of the vasculature 
and consequently the healing of the injured tissue. Although the exact 
mechanisms responsible for these changes need to be evaluated further, these 
findings will be useful for the development of future clinical monitoring, 
diagnosis and treatment of CSTT. In addition, characterisation of the vascular 
morphology allows for assessment of the severity of CSTT and for monitoring 
the effect of treatment modalities on healing progression.  
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Chapter 1: Introduction 
1.1 PROBLEM STATEMENT AND RESEARCH MOTIVATION 
Closed soft tissue trauma (CSTT) may result from slow crushing or high-
energy impact, causing vascular and muscle injuries. These contusion injuries 
commonly occur during high intensity sports, traffic accidents, or workplace 
accidents. The damage to the vascular network and tissue leads to bleeding 
along with a series of inflammatory reactions triggering early acute symptoms. 
The acute symptoms appear as inflammation, haematoma and swelling, which 
in severe cases may lead to compartment syndrome, necrosis (tissue loss) and 
even amputation of the limb (Blaisdell 2002).  
While acute CSTT injuries generally heal over time, chronic symptoms 
such as swelling and pain may take time to heal, which may delay the patient’s 
return to normal life. Despite the problems created by CSTT for individuals, the 
musculoskeletal complications cause a substantial socio-economic burden due 
to their cost of treatment (Australian Institute of Health and Welfare 2012). This 
indicates the importance of musculoskeletal injuries, as well as their diagnosis 
and monitoring based on a systematic classification. However, an objective 
classification for closed soft tissue trauma is currently lacking. Available clinical 
classifications of soft tissue injuries by Tscherne (Tscherne et al. 1984, Moore 
2011) and also the AO foundation (Arbeitsgemeinschaft für 
Osteosynthesefragen; Association for the Study of Internal Fixation) (Rüedi et al. 
2007) categorise only macroscopic symptoms qualitatively which makes the 
diagnosis and also the monitoring of treatment efficacy subjective and 
extremely challenging in regard to its accuracy.  
From research reported in the literature, where animal models were used 
to assess CSTT, there has been some evidence indicating that there is a 
disruption of microvascular circulation following CSTT (Schaser et al. 1999) 
causing hypoxia and necrosis in the injured soft tissue. Also, a reduction in 
blood flow has been reported one day following CSTT (Claes et al. 2006).  
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Furthermore, the necessity of blood vessel formation for the regeneration 
of injured muscle tissue has been emphasised in the literature (Bauer et al. 
2005, Järvinen et al. 2005).  
In ischemia research models of rat hindlimbs, the vital role of mechanisms 
such as angiogenesis (sprouting new capillaries from pre-existing vessels) and 
arteriogenesis (widening the pre-existing arteries) during the healing process 
has been highlighted by characterising the vascular morphology (Tonnesen et 
al. 2000, Scholz et al. 2002, Duvall et al. 2004). Collectively, these studies show 
that during the natural healing process following an ischemic muscle injury, 
changes to vascular morphology are necessary for adequate perfusion, in order 
to provide sufficient oxygen and nutrients for successful tissue regeneration. 
However, most methods that have been previously used in research 
studying the effect of CSTT on the vascular network are either evaluated based 
on two-dimensional (2D) imaging modalities, or focused on the changes to 
vascular functionality (e.g. blood flow). These do not provide comprehensive 
information on the detailed morphological changes to the vascular morphology 
following CSTT in three dimensions (3D) (Schaser et al. 1999, Claes et al. 2006). 
Also, while there is more detailed information available regarding vascular 
morphology, this originates from ischemia research models where the injury is 
created by arterial ligation (Duvall et al. 2004), which is fundamentally different 
from a CSTT resulting from a high energy impact. To date, detailed knowledge 
regarding vascular morphology changes following CSTT is lacking. 
Current clinical treatments for CSTT include immobilisation, elevation, 
compression and icing (cryotherapy) for reducing the haematoma, 
inflammation and swelling (Järvinen et al. 2007). It has been emphasised that 
the application of appropriate treatments to restore the vascular network can 
potentially accelerate muscle tissue healing (Järvinen et al. 2005). In this regard, 
oxygen therapy has also been suggested as a remedy for reduction of hypoxia 
post injury (Gottrup 2004). 
To date, the research on the application of these methods remains mostly 
qualitative without sufficient scientific evidence to demonstrate its efficacy.  
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One traditional non-invasive treatment that has been extensively used in 
sport and discussed in literature is the immediate application of ice to the 
injured region to reduce pain (Hubbard et al. 2004) and the development of a 
haematoma (Schaser et al. 2007) following trauma. Despite a few studies that 
have recommended cryotherapy as a possible method for the treatment of 
closed soft tissue injuries (Schaser et al. 2006, Schaser et al. 2007), this method 
still remains controversial with regard to its efficacy for treating the injured 
muscle per se (Collins 2008, Takagi et al. 2011, Tseng et al. 2013). 
Overall, a scientific research model that could be applied for the 
quantitative and objective study of the changes to the vascular structure 
following CSTT during the natural healing process and also after icing is not 
currently available. While methods for the assessment of CSTT healing are 
mostly qualitative and in 2D, a 3D quantitative characterisation of the vascular 
injury following CSTT may provide more comprehensive information that can 
be used for the assessment and monitoring of the muscle injury and its healing. 
This experimental framework may also facilitate the development of an efficient 
CSTT treatment by assessing the effect of therapeutic modalities (e.g. icing) on 
the vascular injuries following CSTT.  
Therefore, the goal of this research is to develop and characterise an 
experimental rat injury model to investigate the effects of CSTT and cryotherapy 
on the vascular morphology (3D) at various time points. 
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Chapter 2:  Literature Review 
2.1 OVERVIEW 
This chapter provides an overview of the pathophysiological pathways 
involved with vascular damage following soft tissue injuries. The discussion is 
continued by evaluating CSTT and vascular injury from two perspectives; 
clinical and experimental. This is then followed by an introduction to injury 
models and advanced imaging techniques available for the assessment of 
vascular injuries. Current clinical treatments are also outlined and the 
subsequent discussion is focused on cryotherapy, the method applied in this 
research. Current gaps found in the literature regarding vascular injury 
following CSTT are also summarised. In the light of the literature review, the 
hypothesis, aims and finally the research questions are stated at the end of this 
chapter. 
 
2.2  CSTT, VASCULATURE DAMAGE AND HEALING MECHANISMS 
Prior to explaining the CSTT pathophysiology, it is important to know the 
structure of the healthy muscle tissue. Muscle fibres as functional units are long 
cylindrical cells surrounded by a connective tissue called an endomysium. Each 
muscle fibre includes many nuclei that are peripherally attached to the muscle 
fibre beneath the covering membrane called a sarcolemma. Parallel muscle 
fibres are surrounded by another connective tissue layer called the perimysium 
that together form a fascicle. A group of fascicles are encapsulated by a thick 
connective tissue layer called an epimysium (Gillies et al. 2011)(Figure 2-1).  
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Figure 2-1: A schematic of the muscle structure.  
A cross section of the muscle tissue including several fascicles and blood vessels located 
inside and outside the fascicles. Each fascicle is surrounded by a layer called perimysium 
and contains several muscle fibres. Each muscle fibre is also covered by a layer of 
connective tissue called an endomysium and includes many peripherally located nuclei. 
The original image illustrated here has been kindly provided by Relaix and Zammit 
(Relaix et al. 2012) and modified for this thesis. 
 
Wound healing mechanisms can be classified into three main phases as 
suggested by Järvinen and colleagues (Järvinen et al. 2005). Many of these 
mechanisms overlap and the classification discussed here is only to provide a 
simple explanation of these terms. 
The wound healing phases are described as the:  
 
 Destruction phase 
 Repair phase 
 Remodelling phase 
 
2.2.1 Destruction phase 
 Depending on the severity of the injury, the damage to the soft tissues 
including muscles and blood vessels leads to the formation of a haematoma as 
well as a vascular and cellular inflammatory response (Hunt 1988, Nauta et al. 
2011). 
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CSTT is often the result of an external compressive force such as a blunt 
impact (Gierer et al. 2010), or a prolonged crush (Akimau et al. 2005). Such 
forces increase the internal mechanical stresses (pressure) in the affected tissue 
causing deformation (strain) and damage to the skin, muscle and the 
neurovascular system. In the case of CSTT, even though the skin is not 
perforated, rupturing of the muscle fibres along with vasculature walls usually 
leads to internal bleeding and the formation of a haematoma under the skin 
(Lovering 2008).  
Meanwhile, the processes of haemostasis begins to control and reduce the 
internal bleeding through three mechanisms (Linares 1996). The first 
mechanism is vasoconstriction which is the contraction of blood vessels to 
reduce blood flow to the affected region (Casey et al. 2012). The second 
mechanism is the formation of platelet plugs, which is the accumulation and 
adherence of platelets within the injured vasculature to seal the ruptured 
regions (Nauta et al. 2011). The last mechanism is blood clot development 
through initiation of the coagulation cascade and production of a fibrin mesh 
around the platelet plug to seal the ruptured microvasculature preventing 
further haemorrhage (Norris 2003). Blaisdell (2002) has reported that a 
secondary effect of the haemostasis is hypoxia that is caused by a reduction of 
blood flow, and consequently oxygen perfusion to the injured site. He has 
explained that this is accompanied by a blockage of the microvasculature due to 
swollen endothelial cells of capillaries, blood clot formation and finally adhesion 
of other blood cells (leukocytes, lymphocytes and monocytes) in the 
microvasculature lumen. He has also suggested that this effect may be followed 
by depletion of adenosine triphosphate (ATP) following ischemia leading to 
necrosis of muscle cells (Blaisdell 2002). Soon after the haemostasis phase, a 
series of inflammatory reactions begin to deliver biochemical mediators such as 
histamine, heparin and prostaglandins from ruptured mast cells located in the 
injury site (Metcalfe et al. 1997). Both haemostasis and inflammatory phases are 
associated with early microcirculation changes after CSTT (Schaser et al. 1999, 
Blaisdell 2002). 
The vascular response starts soon after the haemostasis phase through the 
following processes. 
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 Vasoconstriction refers to the narrowing (contraction) of blood vessels 
and vasodilation is the enlargement of blood vessels through relaxation of the 
vascular smooth muscles. While vasoconstriction narrows the surviving blood 
vessels to reduce the blood flow, the vasodilation mechanism widens the vessels 
to increase the blood flow following the injury (Dodd et al. 1993, Williamson et 
al. 2004, Casey et al. 2012). Another mechanism is increasing vaso-permeability 
which results in an increased plasma passage across blood vessel walls. These 
early changes in the microvasculature such as vasodilation and increasing vaso-
permeability trigger plasma leakage into the surrounding connective tissue and 
the accumulation of fluid in the extracellular matrix (ECM) which eventually 
results in swelling of the tissue (Williamson et al. 2004).  
Usually, symptoms of the inflammatory phase are identified as pain, 
inflammation, swelling (oedema), redness, and local temperature elevation 
(Goodman et al. 2014). Compartment syndrome is a serious and painful 
complication that occurs when the intramuscular pressure is increased. Severe 
injuries may lead to compartment syndrome due to excessive swelling 
(Gourgiotis et al. 2007).  
 
2.2.2 Repair phase 
Following the destruction phase, the repair phase begins where the 
damaged tissue is repaired through two mechanisms; regeneration of the 
disrupted tissue (muscles and vasculature), and the establishment of the scar 
(connective tissue) providing the muscle strength to tolerate contractions. 
These two mechanisms independently commence at the same time and a 
successful repair depends upon a balance between these two mechanisms 
(Clark 1996, Baoge et al. 2012). Damage to the integrity of the tissue activates a 
number of  growth factors such as the fibroblast growth factor (FGF) and the 
vascular endothelial growth factor (VEGF) which are already stored in the ECM 
of myocites in an inactive form (Hodde et al. 2007). Growth factors are natural 
regulators in the form of proteins that participate in cell proliferation, growth, 
and differentiation.  
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For example, FGF is involved in myogenesis by promoting the proliferation 
and differentiation of myofibres and VEGF stimulates angiogenesis by initiating 
the formation of new blood vessels and capillaries (Enoch et al. 2008).  
During the repair phase, proliferation and differentiation of new 
myoblasts begin from satellite cells which are mono-nucleated myogenic cells 
located on the surface of the myofibre (Anderson et al. 2004, Schmalbruch H. 
2006, Relaix et al. 2012). After myoblasts are regenerated, several new 
myoblasts join together to form the multinucleated myotubes. The newly 
shaped myotubes eventually attach to the pre-existing myofibres to mend the 
broken muscle fibres (Gilbert 2006, Turner et al. 2012). 
In parallel with muscle regeneration, the repair of the damaged 
vasculature begins with regenerating endothelial cells that form a loose 
granular tissue enriched with capillaries. Gradually the new capillaries begin to 
grow from pre-existing vessels towards the injured area to provide the 
necessary nutrition and oxygen for the aerobic metabolism required for the 
development of myofibres and capillaries. Finding evidence of wound re-
vascularisation after trauma is a sign of successful regeneration within the 
tissue (Enoch et al. 2008, Tu et al. 2008, Wullschleger 2010).  
Besides the regeneration of the muscle fibres and vasculature during the 
repair phase, the connective tissue and other elements of the ECM are produced 
to provide an early frame for embedding the myofibres and capillaries 
(Stroncek et al. 2007). In this phase, fibroblasts are responsible for synthesizing 
the ECM, collagen and connective tissue scar. As the repair procedure 
progresses, collagen fibres begin to cross-link to form a stronger structure for 
the tissue scar (Veikkola et al. 1999).  
 
2.2.3 Remodelling Phase 
The remodelling phase is the final stage of wound healing. The scar 
formation including cross-linking and orientation of collagen fibres transforms 
the granulation tissue which has been developed in the regeneration phase 
within the skin and muscles into a strong fibrous frame (Driessen et al. 2003). 
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The remodelling stage is also identified by the maturation of the newly 
produced muscle fibres and arteries to restore muscle functionality  (Smith et al. 
2008). It should be pointed out that although the mechanisms involved with the 
repair and remodelling phases (e.g. muscle and scar formation) are independent 
processes, they are significantly associated and may overlap (Stroncek et al. 
2007, Smith et al. 2008). Usually, the remodelling phase is a long process and it 
may take weeks or months for soft tissue to heal and return to its original 
functional and morphological condition prior to injury (Kannus 2000, Stroncek 
et al. 2007). The CSTT healing phases and the approximate time points are 
summarised in Figure 2-2 based on the finding from literature (Li et al. 2007, 
Smith et al. 2008). 
 
 
 
 
Figure 2-2: The CSTT healing phases and the time points. 
 
2.2.4 The necessity of vasculature for the healing of the injured muscles 
The vital role of vascularisation for the healing of damaged tissue and 
muscle fibre regeneration has been highlighted previously (Bauer et al. 2005, 
Nauta et al. 2011, Turner et al. 2012). The first sign of regeneration is the 
restoration of the vascular supply, which is essential for the morphological and 
functional recovery of the injured muscles (Longo et al. 2012).  
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The growth of new capillaries in the injury site is necessary to restore the 
blood perfusion and supply sufficient oxygen facilitating aerobic metabolism 
and consequently the energy required for regeneration of muscle fibres 
(Järvinen et al. 2005, Järvinen et al. 2007, van Wessel et al. 2010). Research has 
shown that vascular functionality and morphology changes following injury 
(Duvall et al. 2004, Claes et al. 2006). In animal CSTT models, early changes of 
vascular functionality following CSTT have been demonstrated through 
disruption of the microvascular circulation causing hypoxia and necrosis in the 
injured soft tissue (Schaser et al. 1999). This is aligned with other findings 
which have shown a reduction of blood flow following trauma (Claes et al. 
2006). 
Changes to vascular morphology have been reported in animal models of 
ischemia, where ischemia is established by ligation of the collateral hindlimb 
artery. There was a demonstrated increase in the number, diameter and volume 
of blood vessels during the natural wound healing process in the hindlimb of the 
ligated artery compared to the control hindlimb (Tonnesen et al. 2000, Scholz et 
al. 2002, Duvall et al. 2004, Lu et al. 2010). These results indicate that in the 
natural healing process, these changes to the vascular morphology are 
necessary for adequate perfusion providing enough oxygen and nutritional 
supply for successful tissue regeneration.  
 
2.2.5 Vascular regeneration mechanisms  
Following injury, the vasculature within the impaired tissue is regenerated 
through three mechanisms. The first mechanism is ‘angiogenesis’ or 
neovascularisation which is initiated after injury (e.g. ischemic condition). 
Angiogenesis is the sprouting of new capillaries derived from endothelial cells 
of pre-existing vessels towards the ECM (within the first 5 days) in response to 
the reduction of the tissue oxygen level and the presence of angiogenesis 
stimulators such as VEGF (Greenhalgh 1998, Hershey et al. 2001, van Oostrom 
et al. 2008). In animal models, several authors have shown evidence that the 
application of an angiogenesis inhibitor can suppress revascularization 
(Couffinhal et al. 1998, Murohara et al. 1998, Hausman et al. 2001).  
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Therefore, since a direct correlation between vascular growth and tissue 
repair has been demonstrated, the supressed angiogenesis and subsequent 
revascularisation may cause the impairment of muscle regeneration following 
injury (Zhu et al. 2011). 
The second mechanism for revascularisation is ‘arteriogenesis’ which is 
the growth of new arteries through two mechanisms; arterial branching and the 
formation of pre-existing collateral arterioles (Zhuang et al. 2006). In this 
process, the pre-existing arterioles which are naturally bridging the larger 
arteries (bypasses) remodel and grow to form functional arteries (Heil et al. 
2006). This mechanism involves the enlargement of the lumen diameter, wall 
thickness and the length of the collateral arterioles through endothelial cell 
growth and proliferation (Herzog et al. 2002, Heil et al. 2004). Arteriogenesis is 
stimulated to recover blood flow at the injury site in response to the changes in 
shear stresses due to an artery ligation or blockage (Heil et al. 2004, van 
Oostrom et al. 2008). It has been shown that after ischemia due to ligation of the 
femoral artery, the diameter of the collateral artery is increased (Scholz 2002). 
It should be pointed out that although both angiogenesis and arteriogenesis 
facilitate restoration of blood flow following injury, these mechanisms act 
independently (Herzog et al. 2002).  
The third mechanism is ‘vasculogenesis’ which is the migration and 
differentiation of endothelial precursor cells (angioblasts) to the injured area to  
produce and form new blood vessels (de novo) in response to the growth factors 
including VEGF and FGF (Bauer et al. 2005, Schmidt et al. 2007). The newly 
formed blood vessels are initially immature and after lumen formation 
eventually turn into capillaries and then subsequently into matured arterioles, 
venules, arteries, and veins (Bauer et al. 2005).  
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2.3 CLINICAL CHARACTERISATION OF VASCULAR DAMAGE AND 
CSTT  
2.3.1 Definition of CSTT characterisation  
In this research, the term “CSTT characterisation” is generally used to 
describe both clinical (in vivo) and experimental (in vivo and ex vivo) approaches 
for monitoring, assessing and diagnosing CSTT. This represents both the 
qualitative and quantitative evaluation of CSTT using criteria that together form 
the characterisation package. These criteria can be identified as morphological 
(structural), biochemical, functional, physiological or biomechanical in nature.  
 
2.3.2 Current clinical CSTT classifications and limitations 
For better clinical management of injuries, several CSTT classifications   
have been developed. The most commonly used clinical classification systems 
for CSTT are the Tscherne and AO classifications. The Tscherne classification 
(Tscherne et al. 1984) divides closed fractures accompanied with CSTT into four 
categories that range from minimal injuries (grade 0) to extensive damage 
(grade 3). While the Tscherne classification system scores a variety of 
symptoms within the same category, the AO grading system provides more 
detailed information regarding the CSTT in combination with closed fractures 
(Südkamp 2004). This method classifies CSTT into the various anatomical 
structures including skin, muscles, neurovascular and then based on the 
severity of the injury assigns them into five categories. The muscle-tendon (MT) 
injuries range from mild (MT1) to severe (MT5) and neurovascular (NV) 
injuries range from mild (NV1) to severe (NV5) (Rüedi et al. 2007) (Table 2-1). 
However, these classification systems are based on a qualitative assessment of 
macroscopic symptoms and palpation, which makes the characterisation 
subjective. They can be applied for the qualitative characterisation of CSTT 
whereas quantitative classification will allow for a more accurate initial 
diagnosis, thereby leading to a better treatment. 
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Table 2-1: The Tscherne  (Tscherne et al. 1984) and AO (Rüedi et al. 2007) CSTT 
Classification with the injury descriptions.  
 
Tscherne classification 
 
Grade Description 
0 Minimal soft tissue damage, simple pattern 
 
1 
Superficial abrasion with local contusion damage to skin or muscle 
caused by pressure from within, mild to moderate pattern 
 
2 
Deep contaminated abrasion with local contusion damage to skin and 
muscle, impending compartment syndrome, severe pattern 
 
3 
Extensive contusion or crushing of skin or destruction of muscle, 
underlying severe muscle, decompensate compartment syndrome, 
associated with a major vascular injury, severe pattern 
 
AO classification 
 
Muscle/tendon injury (MT)  
  
 
  
 
  
 
  
 
  
 
  
Neurovascular injury (NV) 
Grade Description Grade Description 
 
MT 1 No muscle injury NV 1 No neurovascular injury 
MT 2 Circumscribed muscle injury, 
one compartment only 
NV 2 Isolated nerve injury 
MT 3 Considerable muscle injury, two 
compartments 
NV 3 Localized vascular injury 
MT 4 Muscle defect, tendon 
laceration, extensive muscle 
contusion 
NV 4 Extensive segmental 
vascular injury 
MT 5 Compartment syndrome/crush,  
syndrome with wide injury 
zone 
NV 5 Combined neurovascular 
injury including partial or 
total amputation 
 
In general, it was found that the most common clinical classifications for 
CSTT diagnosis are non-specific, qualitative and subjective, failing to provide 
enough information regarding the injury status of the microvasculature after 
the CSTT.  
Another clinical avenue to characterise the injured tissue following a CSTT 
is by monitoring levels of systemic markers such as Creatine Kinase (CK) and 
Lactate Dehydrogenase (LDH). The elevation of these biochemical markers in 
the blood serum indirectly indicates damage to skeletal muscle and tissue 
(Brancaccio et al. 2006, Sudhakar et al. 2012). However, any muscle breakdown 
releases CK into the blood serum and any general tissue damage elevates the 
LDH (Wullschleger 2010).  
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Therefore, these systemic markers are non-specific for the accurate 
characterisation of soft tissue injury, and these non-specific systemic markers 
cannot monitor individual injuries in multi-trauma patients. 
In general, inaccessibility of the subcutaneous microvasculature restricts 
the detailed assessment of the microvascular network following trauma during 
clinical monitoring and treatment administration (Levin et al. 1996). Most 
clinical imaging modalities are hampered by limitations that restrict the 
comprehensive visualisation of changes to the microvasculature anatomy and 
detailed microvascular quantification considerably. 
While conventional X-ray (radiography) is useful for assessing hard 
tissues such as bone, it may not be able to visualise soft tissue accurately (Li et 
al. 2004, Zhang et al. 2011). Contrast-enhanced angiography for vascular 
imaging using fluoroscopy is limited by an inadequate number of fixed viewing 
angles as well as difficulties to differentiate the overlap between pre-existing 
and regenerated vessels (Zhuang et al. 2006).  
Ultrasound may be used to measure general blood perfusion within a 
defined area, but its use is highly dependent on the radiologist’s expertise 
(Canadian Society of Diagnostic Medical Sonography 2008). The visualisation or 
quantification of individual blood vessels or the vascular morphology using 
ultrasound is currently not possible in a clinical setting. 
Magnetic resonance imaging (MRI) and computed tomography (CT) are 
currently available as advanced clinical imaging tools for visualisation of 
changes to the soft tissue. These systems are being used for vascular imaging 
such as MR-angiography and CT-angiography. The highest resolution range that 
these systems are able to visualise the vascular network is within a resolution 
range of 80-100μm for MR-angiography (Qian et al. 2012) and 75-100μm for 
CT-angiography (Gakhal et al. 2009, Funama et al. 2012). This means that the 
small blood vessels and capillaries less than 75μm cannot be observed using 
these systems.  
Therefore, these systems may not be suitable for evaluating capillaries 
which are mainly less than 10μm (Tata et al. 2002) and also the events that 
occur at the capillary level such as angiogenesis (Hershey et al. 2001).  
 16  
2.4 EXPERIMENTAL MODELS OF CSTT AND VASCULAR INJURY 
2.4.1 Rat models 
Animal models are important for pre-clinical investigation, simulation of 
traumatic injuries, assessment of healing processes, and testing the efficiency of 
therapeutic modalities. Rat models have been used for research on CSTT 
(Kälicke et al. 2003) to show vascular perfusion disruption following traumatic 
injuries (Schaser et al. 1999, Claes et al. 2006) and for testing the efficacy of 
treatment modalities such as cryotherapy (Smith et al. 1994, Dolan et al. 1997). 
In order to simulate clinical cases of musculoskeletal damage including CSTT 
and ischemia models, many authors have used rat models for their experiments 
(Kälicke et al. 2003, Lomas-Niera et al. 2005, Khattak et al. 2010, Frink et al. 
2011). Furthermore, rat models have been applied for investigation of vascular 
growth and tissue healing (Ishii et al. 2002, Boerckel et al. 2011) as well as the 
effect of cold therapy on swelling following a blunt injury (Dolan et al. 1997).  
Rats are favoured for studies of CSTT because they are quickly acclimatised to 
their environment as well as being easy to handle, easy to maintain and house 
due to their small size. Also, their lower cost compared with larger animals is 
another advantage especially when research requires a large number of 
animals. Based on these reasons, rats are good candidates to be used for the 
investigation of the CSTT and therefore, it is essential to be familiar with their 
basic anatomy including muscles and hindlimb vessels (Figures 2-3, 2-4 and 2-
5).  
While rat models in musculoskeletal research are well documented, there 
are only limited studies reported on quantification of the CSTT healing process, 
particularly with respect to the characterisation of the vascular injury. 
Experimentally, few models are available in which detailed characterisation in 
vivo and ex vivo of the vascular and muscle injuries have been conducted. Some 
of these models including trauma-induced models (i.e. impact and crush) as well 
as ischemic models (based on arterial ligation) are explained here. 
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Figure 2-3: The rat’s muscle anatomy. 
The rat’s muscle anatomy is shown in particular the medial (A) and lateral (B) views of 
the hindlimbs. Adapted from (Bismarck Public School 2014) and (Creative Commons 
2007, Fastol 2012) respectively.  
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Figure 2-4: The deep muscles of the lateral surface of the rat’s hindlimb.  
1. Deep Gluteus superficialis, (reflected), 2. Gluteus medius, 3. Piriformis, 4. 
Semitendinosus, 5. Biceps femoris (reflected), 6. Semimembranosus, 7. Vastus lateralis, 8. 
Gastrocnemius. This image has been kindly permitted to use in this thesis by Deborah 
Sillman, Penn State University, USA (Sillman 2007). 
 
 
 
Figure 2-5: CT angiograms of rat hindlimb vessels with reference to vessel name.  
L_left leg, R_right leg, 1_arteria circumflexa femoris caudalis, 2_arteria iliaca interna, 
3_arteria epigastrica caudalis, 4_circumflexa femoris lateralis, 5_arteria femoralis, 
6_arteria genus descendens, 7_arteria saphena, 8_arteria poplitea, 9_arteria caudalis 
femoris distalis; 10_arteria profunda femoris; 11_arteria ductus deferentis, 12_arteria 
caudalis dorsolateralis. This image has been kindly provided to use in this thesis by the 
Radiological Society of North America (RSNA)  (Zhuang et al. 2006). 
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2.4.2 Impact Models 
Several animal impact models using an impact device have been 
developed to study closed soft tissue trauma. One of the first impact trauma 
devices reported in the literature was developed by Francis (Francis 1985). This 
impact device was based on a drop weight mechanism and utilised an impactor 
to produce a uniform CSTT on the lateral thighs of rats. Later, similar impact 
devices have been developed by other authors, while only a few reported impact 
characteristics such as impact height, impactor weight and the velocity of the 
impactor (Claes et al. 2006) (Figure 2-6). 
 
 
 
Figure 2-6: The impact device developed by Claes and his group (Claes et al. 2006).  
These images have been kindly provided by Lutz Claes and his group and are reproduced 
here with his permission. 
 
Schaser and colleagues produced a standardised CSTT using a computer-
assisted impact device on rat hindlimbs to simulate the clinical condition of 
impact to the inferior extremities (Schaser et al. 1999, Schaser et al. 2003). 
Their device included a compressed nitrogen gas supply, a plastic container for 
locating the hindlimb, an adjustable impactor, a displacement transducer, and a 
computer for time and displacement data examination. Their impact device 
provided sufficient information regarding the measurement of the depth of the 
injury due to the impact and other mechanical parameters such as impact speed.  
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2.4.3 Crush models 
 A rat crush injury model was developed by Akimau and colleagues to 
evaluate local and systemic responses (crush syndrome) using systemic 
markers (CK and LDH) under a mechanical compression load for three hours. 
They found that there is a correlation between the severity of the crush injury 
shown by elevated CK and LDH and the volume of the injured muscle (Akimau et 
al. 2005). Through the measurement of the capillary pressure, Korthuis and 
colleagues have also demonstrated in a canine model that microvasculature 
permeability is increased in a crush skeletal muscle injury after 4 hours.  They 
have indicated that this may be due to oxygen free radicals and histamine 
produced by mast cells causing oedema and compartment syndrome (Korthius 
et al. 1985).  
 
2.4.4 Ischemia models 
Many ischemia models have studied the vascular morphology and 
functionality changes following injury induced by the ligation of arteries in 
collateral hindlimbs (Couffinhal et al. 1998, Scholz et al. 2002, Zhuang et al. 
2006, Oses et al. 2009, Lu et al. 2010, Orbay et al. 2013, Nebuloni et al. 2014). 
Some authors have conducted comprehensive assessments of the changes to the 
vascular morphology resulting from an ischemia model by quantifying vascular 
morphometric parameters such as vessel volume and density after ligating the 
femoral artery in mice using micro-CT and a silicon rubber contrast agent 
(Microfil: MV-122 Microfil, Flow Tech, Carver, MA) (Duvall et al. 2004, Bolland 
et al. 2008). The authors confirmed that high resolution micro-CT scanning 
along with an appropriate contrast agent provides an accurate visualisation of 
the 3D microvascular architecture and is capable of sophisticated quantitative 
evaluation (Duvall et al. 2004). This was a significant advancement towards the 
characterisation of vascular morphology. 
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2.4.5 Characterisation of vascular injury following CSTT  
Currently, there are only a few reported CSTT models and they are 
mostly focused on changes to the vascular functionality (e.g. blood flow) 
following trauma (Schaser et al. 1999, Claes et al. 2006). Claes and colleagues 
have applied a CSTT (grade 2 according to Tscherne) to the thighs (biceps 
femoris muscle) of 38 rats. Laser Doppler flowmetry (LDF) was utilised to 
document blood flow of the injured muscles before and after trauma. The rats 
were then sacrificed at days 1, 3, 7, 14 (n=3) and on day 28 (n=7). The authors 
found that moderate CSTT reduced blood flow in the injured muscle for the first 
24 hours after trauma (Claes et al. 2006). They also demonstrated that the blood 
flow could recover during healing after 3 days. Despite the fact that LDF can 
provide information regarding the blood flow changes of the superficial injured 
tissue, it may not be suitable for deeper tissue injury evaluation as this method 
cannot detect the blood flow at a depth of more than 2mm.  
Regarding the vascular functionality after CSTT, other studies were carried 
out by Schaser and colleagues (Schaser et al. 1999, Schaser et al. 2003), who 
analysed the microcirculation versus capillary size using in vivo fluorescence 
microscopy at various time points (1.5, 24, 72 and 120 hours after injury). They 
found that perfusion of the skeletal muscle microvasculature was significantly 
reduced whereas the capillary diameter and microvasculature permeability 
were increased. This was accompanied by a loss of endothelial integrity, 
macromolecule leakage through microvasculature causing intramuscular 
pressure and swelling. They concluded that the initial changes in 
microvasculature following CSTT ultimately cause tissue death.  
Their findings draw attention to the importance of early detection of 
functionality changes to the vasculature due to trauma (Schaser et al. 1999, 
Schaser et al. 2003). Although the changes to individual blood vessels in vivo 
investigated by Schaser and colleagues have delivered important information, 
they have used fluorescent microscopy, which restricts the study to highly 
localised and superficial regions.  
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Through reviewing the literature, the importance of capillaries and 
skeletal muscle perfusion to supply nutrients and oxygen for cellular 
metabolism during the wound healing process was found (Landry et al. 2000, 
Wolfard et al. 2002, Schaser et al. 2003, Zhang et al. 2003, Järvinen et al. 2005, 
Claes et al. 2006, Duda et al. 2008).  
On the other hand, using ischemia animal models, vascular morphological 
changes have been shown to include an increase in the number, diameter and 
volume of blood vessels during the wound healing process (Oses et al. 2009). 
They have confirmed that during the natural wound healing process, changes to 
vascular morphology are necessary for adequate perfusion, providing sufficient 
oxygen and nutritional supply for successful tissue regeneration (Tonnesen et 
al. 2000, Scholz et al. 2002, Duvall et al. 2004, Lu et al. 2010).  
While the necessity of revascularisation (Hershey et al. 2001) and changes 
to the vascular morphometric parameters (Duvall et al. 2004) is clear for wound 
healing in ischemia models, an adequate investigation into the morphological 
changes to the vasculature following CSTT is lacking. Current vascular 
morphometric information is mostly derived from ischemia models where the 
injury is invasively created by ligation of the main artery (e.g. arterial femoralis) 
and disconnecting it completely from the vascular network. These injuries are 
fundamentally different from a CSTT resulting from a high-energy impact where 
the skin and the connections between the main arteries and the vascular 
network remain intact.  
An additional drawback is that current CSTT models are limited to 
localised and superficial assessments, which may not provide comprehensive 
information regarding the anatomical changes of blood vessels in 3D.  
This emphasises the necessity for the development of a 3D vascular 
assessment model to facilitate a detailed exploration of the morphometric 
changes following CSTT, during the natural healing process and in response to 
treatment.  
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2.5 EXPERIMENTAL ASSESSMENT OF CSTT AND VASCULAR 
INJURY 
 
2.5.1 Advanced imaging methods in vascular injury models 
Contrast-enhanced MR-angiography and CT-angiography have been used 
for 3D vascular assessment using small animals (Zhuang et al. 2006, Ungersma 
et al. 2010). However, the low special resolution of these clinical imaging 
modalities does not make them suitable for a detailed morphological evaluation 
of the vascular network. X-ray micro computed tomography (micro-CT) has 
been acknowledged by a variety of authors (Duvall et al. 2004, Bolland et al. 
2008, Nebuloni et al. 2013) as the most suitable imaging modality with a high 
resolution and reliability for the experimental assessment of vascular injuries.  
Micro-CT is an advanced imaging modality that has been applied for high 
resolution visualisation between 1 and 100 μm (Guldberg et al. 2004, Zagorchev 
et al. 2010). The high resolution characteristics makes the micro-CT an accurate 
imaging modality, providing anatomical information in great detail particularly 
for hard tissue such as bone and its microstructure (Müller 2009). For instance, 
micro-CT is being used for 3D imaging and quantification of complex structures 
such as trabecular bone (Bouxsein et al. 2010), contrast-enhanced tissues and 
vasculature in animal models (Schambach et al. 2010).  
Investigating the rat microvasculature injury following CSTT demands an 
accurate analysis of the vasculature network architecture during formation and 
remodelling. As the inner diameter of capillaries in rats’ hindlimbs suggested to 
be less than 10μm (Kindig et al. 1999), therefore, micro-CT with its high 
resolution can be more suitable for accurate visualisation of small capillaries in 
comparison with conventional imaging modalities. Furthermore, the accuracy of 
contrast enhanced micro-CT imaging for visualising and quantifying vascular 
structural parameters in 3D has been confirmed by other authors (Marxen et al. 
2004, Jackowski et al. 2005, Bolland et al. 2008, Zagorchev et al. 2010). 
In an X-ray image, the contrast and visibility of various tissue structures 
depends on their physical characteristics such as density and thickness.  
 24  
This results in an attenuation spectrum of the X-ray image that allows for 
visualising structures of different contrast (Sprawls 1995, Bushberg et al. 2011). 
Since the density of soft tissue and blood vessels have small differences in 
contrast and also is much lower than bone, conventional X-ray imaging may not 
distinguish between the vasculature and tissues satisfactorily compared to the 
high contrasting bone. To increase the vascular contrast in the image, radio-
opaque contrast agents are required to improve the visibility of the vascular 
network. Knowledge of contrast media and injection techniques becomes 
important for filling the microvasculature adequately in order to produce a high 
quality image. For example, a contrast agent with a high viscosity demands a 
higher pressure for infusion, which may cause the microvasculature to rupture. 
Depending on the contrast agent type, there are different methods to reduce the 
viscosity such as increasing the temperature or adding diluents (Voeltz et al. 
2007). Available contrast agents for in vivo vascular imaging are divided into 
two categories. These are water-soluble media, which are used clinically, and 
blood-pool media that are currently only utilised for pre-clinical visualisations 
(Nebuloni et al. 2013).  
Water-soluble media such as iohexol (Omnipaque, GE Healthcare) and 
iomeprol (Iomeron, Bracco) are iodine based with low toxicity but exhibit a high 
extracellular diffusion due to the small size of the iodine element leading to a 
lower resolution over prolonged imaging (Morcos et al. 1998, Hussain et al. 
2012). To overcome this limitation, blood-pool contrast agents such as AuroVist 
15 nm (Nanoprobes, Yaphank, NY) and ExiTron nano 12000 (Miltenyi Biotec, 
Berlin, Germany) were developed with a larger molecule size to remain within 
the blood at a higher concentration over a longer period (Hallouard et al. 2010, 
Annapragada et al. 2012 ). In a recent study, AuroVist 15 nm was identified as a 
suitable blood-pool media for in vivo visualisation of the vascular anatomical 
network because of its high X-ray attenuation and maximum concentration after 
prolonged imaging  (Nebuloni et al. 2013). By using micro-CT and small animals 
for investigating the vascular network, there is a trade-off between in vivo and 
ex vivo imaging. In vivo imaging permits monitoring of the dynamics of the 
biological processes in real time. However, in vivo micro-CT can be challenging 
when it comes to the resolution and imaging time.  
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While high resolution imaging of up to 9 µm has been successfully used 
(Perilli et al. 2010), typically a lower resolution is chosen (e.g. 60-70 µm) to 
reduce imaging time and radiation exposure to the animal (Nebuloni et al. 
2014). Hence, for detailed anatomical exploration of the vascular network, ex 
vivo imaging is preferred as it allows for a longer scanning duration and 
provides a higher resolution (e.g. up to 1 µm).  
For ex vivo vascular imaging in rats, different contrast agents have been 
suggested to facilitate visualisation of the microvasculature using micro CT. 
These include water-soluble (Omnipaque/Iohexol) (Lu et al. 2010), insoluble in 
water (barium-sulphate) (Zagorchev et al. 2010) and blood pool (silicon rubber 
based microfil) contrast agents (Duvall et al. 2004). It is essential to evaluate the 
capability of each contrast agent for a stable and reproducible perfusion. A 
contrast agent should allow for the homogeneous X-ray attenuation to facilitate 
a better segmentation of the vascular network from surrounding tissues 
(Bouxsein et al. 2010). Therefore, contrast agents such as barium-sulphate 
which settles rapidly and affects the contrast homogeneity is not suitable for 
vascular perfusion (Marxen et al. 2004, Zagorchev et al. 2010).  
The silicone rubber contrast agent (Microfil: MV-122 Microfil, Flow Tech, 
Carver, MA) has been used by several authors (Duvall et al. 2004, Bolland et al. 
2008) due to its low viscosity (20 to 30 centipoises) and a satisfactory filling of 
the microvasculature (Duvall et al. 2004). This material is from the category of 
radio-opaque silicone rubbers, which are well known for their easy 
manipulation with limited variation of their physical properties. This makes 
microfil a good candidate for microvasculature visualisation. This material is 
also safe and simply polymerizes at room temperature after 90 minutes (Flow 
Tech Inc 1999). Consequently, microfil has been used in several studies as 
radio-opaque contrast agent for improving the visibility of the 3D vascular 
network in ex vivo research (Cheung et al. , Savai et al. 2009, Jia et al. 2010, 
Yeung 2011) as it fills both the arteries and veins completely (Zagorchev et al. 
2010). These studies have confirmed that the methodologies using microfil 
allow for an accurate and reproducible characterisation of the vascular network.  
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It should be pointed out that other techniques for visualising the 3D 
architecture of vascular networks have been described in the literature, such as 
vascular corrosion casting. In this method, after replacing the vascular network 
with a polyurethane-based casting resin (e.g. PU4ii), the surrounding tissue is 
removed to reconstruct the vascular morphology (Krucker et al. 2006). 
However, since one of the goals of this project was to investigate the muscle 
injury, this technique was not deemed to be suitable for this research, as the 
muscle tissue was required to remain intact for the histological analysis. 
In general, vascular imaging and analysis using micro-CT can be 
challenging requiring many choices such as determining a suitable voxel size, 
segmentation values (e.g. threshold) and  volume of interest (Qin et al. 2007). 
Also, factors including animal preparation, quantification software and the 
property of the contrast agent (e.g. viscosity) may affect the image quality and 
the quantitative results obtained from micro-CT (Zagorchev et al. 2010). 
Micro-CTs and their software packages were originally developed for the 
morphometric analysis of hard tissue such as trabecular bone structure. Due to 
the high resolution and accuracy, many authors have favoured micro-CT for the 
quantification of the vascular anatomical structure using contrast-enhanced 
techniques (Oses et al. 2009, Zagorchev et al. 2010, Nyangoga et al. 2011, 
Nebuloni et al. 2014). The morphometric parameters of the trabecular bone 
provided by micro-CT software such as Scanco (Scanco Medical, Switzerland) 
has been suggested to be interpretable for the vascular network (Bouxsein et al. 
2010, Scanco Medical SCANCO Medical microCT systems: 3D analysis). For 
example, trabecular bone volume, number, and thickness have been translated 
as vascular volume, number and diameter (Duvall et al. 2004, Bouxsein et al. 
2010, Zagorchev et al. 2010). However, a parameter such as the structural 
model index (SMI) has been developed specifically for trabecular bone 
characteristics of a plate or rod-like geometry of trabecular structures, which 
may not be directly used for the morphology vascular network (Birkenhäger-
Frenkel et al. 1988). Furthermore, there are other geometrical properties within 
the vascular network that current micro-CT tools are not able to measure such 
as the length of blood vessels.  
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Due to this limitation, many authors have preferred using other software 
packages specifically developed for vascular geometrical exploration including; 
AngioTool (Zudaire et al. 2011), Rapid Analysis of Vessel Elements (RAVE) 
(Marc et al. 2011), AngioQuant (Niemistö et al. 2005), ImageJ (Fischer et al. 
2010), AMIRA (Sider et al. 2010), and Winfiber3D (Edgara et al. 2012). 
However, many of these tools such as Angiotools, RAVE and AngioQuant have 
been developed for the characterisation of microvascular networks in tissue 
culture plates in 2D and are therefore not suitable for the evaluation of a 3D 
vascular network. In addition, each of these software packages only quantifies a 
limited number of morphometric parameters, and so far, none of them provides 
a complete set of anatomical parameters for characterising the vasculature 
completely. Therefore, combining the vascular parameters derived from a 
robust modality such as micro-CT with parameters provided by other 3D tools 
(i.e. AMIRA) may establish the most comprehensive assessment of the geometry 
for the vascular network.  
 
2.5.2 Histological evaluation  
Histology is the evaluation of tissue morphology at a microscopic level. 
Histological techniques have been used for the evaluation of muscle crush injury 
(Stratos et al. 2010), muscle contusion in a rat model (Khattak et al. 2010), the 
assessment of vascular density (Thompson et al. 2002) and also as an 
independent modality for the evaluation and validation of vascular 
morphometric parameters (e.g. vessel number) derived from other modalities 
such as micro-CT (Raines et al. 2011). Among several available histological 
procedures, the paraffin embedding method has been commonly used. The 
processing steps for this method include formalin fixation, dehydration, 
clearing, embedding, sectioning with a microtome, rehydration, staining, 
mounting on microscope slides, and finally visualising the specimen using a 
microscope. A variety of staining methods have been developed for the 
visualisation of various tissue components within histological sections. The 
most commonly used method of staining is haematoxylin (H) and eosin (E) 
staining (H&E staining technique).  
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Haematoxylin stains cell nuclei blue while eosin stains cytoplasmic 
components with a pink colour. Although histological visualisations provide 
high resolution insights into the microvasculature, they are limited to small 2D 
fields of view and are therefore not able to characterise the full three-
dimensional structure of the vascular network. 
Histological evaluation (e.g. histomorphometry) has been applied and 
acknowledged in the literature as a precise independent modality for validating 
micro-CT based characterisations of the vasculature including quantified 
vascular morphometric parameters (Boerckel et al. 2011, Tomlinson et al. 2013, 
Ehling et al. 2014). For example, in 2D validations of the vasculature, it has been 
shown that the vessel number obtained from microfil enhanced micro-CT 
images, is an accurate representation of the corresponding 2D histological 
sections (Bolland et al. 2008, Oses et al. 2009). Although micro-CT imaging can 
evaluate vascular morphometric parameters in 3D, the validation using 2D 
histomorphometrical analysis is limited to a few vascular morphometric 
parameters such as vessel number and diameter (Ehling et al. 2014, Nebuloni et 
al. 2014). Therefore, parameters such as vessel connectivity that can only be 
evaluated in 3D may not be validated using 2D histomorphometrical analysis.  
ImageJ software is an image-processing tool, which has been successfully 
used by other authors for quantifying morphological parameters of the vascular 
network (Zhuang et al. 2006, Tomlinson et al. 2013). Using correlated 2D 
sections obtained from microfil-enhanced micro-CT and histology and with the 
aid of ImageJ, authors have provided a way for an acceptable unbiased 
correlation between these two independent modalities particularly for the 
vessel number parameter (Bolland et al. 2008, Raines et al. 2011).  
 
2.6 CURRENT CLINICAL TREATMENT OF CSTT 
Closed soft tissue injuries are clinically important, yet knowledge of an 
appropriate treatment is restricted and most current clinical treatments of CSTT 
are based on qualitative assessments. For example, immobilisation (Woodard 
1954, Järvinen 1977, Khattak et al. 2010) and RICE principles (rest, ice, 
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compression and elevation) (Järvinen et al. 1993, Bleakley et al. 2004, Järvinen 
et al. 2005, Matharu et al. 2010, Takagi et al. 2011) are common approaches that 
are currently being used clinically as an immediate treatment for CSTT and 
haematoma.  
Surgical interventions, such as fasciotomy, may be necessary for treatment 
of extensive CSTTs for relieving the muscle tissue pressure in compartment 
syndrome (Altizer 2004). The use of analgesic and anti-inflammatory 
medications represents another option, which requires more investigation 
regarding their side effects after long-term usage (Gierer et al. 2005, Schaser et 
al. 2005, Ochman et al. 2011).  
Icing (cryotherapy) is commonly used for the treatment of CSTT, such as 
those resulting from sport injuries because it is assumed that this technique 
reduces inflammation through vasoconstriction (Smith et al. 1994, Deal et al. 
2002, Bleakley et al. 2004, Bleakley et al. 2006). However, the effect of this 
technique on the healing of injured vasculature and muscle injuries following 
trauma has not been well investigated. Recent evidence suggests that muscle 
regeneration is delayed after cryotherapy (Takagi et al. 2011, Tseng et al. 2013).  
 
2.6.1 Icing (cryotherapy) 
Icing (cryotherapy) is defined as the use of cold modalities including ice 
packs, ice massages, cold baths, cold spray and cold compression for therapeutic 
purposes after trauma (Michlovitz et al. 2011). The immediate application of ice 
to the injured region has been adopted as a common practice for the general 
treatment of CSTT. While cryotherapy is being widely used in clinical 
applications, this method is mostly based on qualitative studies and the 
mechanism by which it is presumed to contribute to tissue healing is poorly 
understood. It is thought that cryotherapy induces vasoconstriction around the 
site of injury and through this mechanism restricts inflammation and 
microvascular permeability. Therefore, this leads to the reduction of 
inflammatory cell influx such as neutrophils and macrophages, which ultimately 
limits progressive swelling and pain (Smith et al. 1993, Smith et al. 1994, Deal et 
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al. 2002, Merrick 2002, Hubbard et al. 2004). Also it is assumed that this 
approach accelerates muscle regeneration (Merrick 2002) and tissue 
restoration resulting in faster functional recovery, shorter hospitalization and 
rehabilitation (Cohn et al. 1989). This implies that a reduction in local 
temperature, as it occurs in cryotherapy, decreases the oxygen demand and 
metabolic rate of hypoxic tissues (Merrick 2002) suggesting a reduction in 
repair responses to injury. Furthermore, it has been previously suggested that 
icing may reduce the amount of muscle degeneration following injury leading to 
a faster muscle repair (Merrick 2002). Overall, the benefits of local cooling for 
reducing the swelling and inflammation have mostly been attributed to 
vasoconstriction and suppression of immune reactions in the injured tissues. 
However, it is not well understood as to whether this treatment impacts the 
proliferative capacity of cells responsible for tissue revascularisation during the 
wound healing period (Bleakley et al. 2004, Collins 2008). 
 
2.6.2 Adverse effects of cryotherapy and controversies  
Contrary to studies which have claimed cryotherapy as an effective 
remedy for musculoskeletal injuries, clinical (Tseng et al. 2013) and 
experimental (Takagi et al. 2011) studies exist, suggesting that cryotherapy may 
slow down muscle recovery and tissue regeneration by inhibiting the local 
inflammatory response.  
Tseng et al. explored the effect of clinical cryotherapy (using ice packs for 
15 minutes at 0, 3, 24, 48, and 72 hours after exercise) for the recovery of 
muscle injuries due to the effect of elbow extensions as well as hemodynamic 
changes in eleven male subjects (aged 20-60 years). They have demonstrated 
that cryotherapy surprisingly elevated the creatine kinase-MB isoform (CK-MB) 
and myoglobin levels compared to the control group suggesting muscle damage. 
The subjective feeling of fatigue also increased 48–72 hours post injury, 
suggesting a delayed recovery (Tseng et al. 2013). Clinical problems resulting 
from exposure to very low temperatures may raise the complexity of the injury 
such as higher systemic blood pressure, an anaesthetic effect as well as ischemic 
necrosis leading to extensive skin loss or amputation (McMaster 1977).  
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Yet, the information obtained from the limited number of available clinical 
trials is not convincing enough to confirm that cryotherapy is necessarily 
beneficial for the improvement of acute tissue injuries or detrimental. Further 
clinical studies would be required to show evidence-based cryotherapy 
treatment was effective. 
Takagi et al. experimentally investigated the effect of cryotherapy on 
muscle regeneration following a crush injury (Takagi et al. 2011). Crush injuries 
were induced by compressing the extensor digitorum longus (EDL) in rats’ 
hindlimbs using forceps for 30 seconds. An ice pack (0.3-1.3°C at the surface) 
was applied for 20 minutes and then the results were evaluated at 6, 12 hours 
and 1, 2, 3, 4, 5, 6, 7 (n=3), 14 and 28 (n=6) days following the injury using 
histological analysis. The authors concluded that early cooling of the tissue 
delayed the macrophage influx into the skeletal muscles, causing the 
impairment of both muscle degeneration and regeneration. This means that the 
inflammatory response plays an important role during the early healing stages 
following injury. Evaluating the effect of cooling on the muscle injury at 11 time 
points has made this research one of the most detailed studies available in the 
field of cryotherapy. The necessity of macrophage activation after injury has 
been reported as key factors affecting the regulation of muscle regeneration 
(Honda et al. 1990, Takagi et al. 2011).  
Takagi and Honda’s findings disagree with earlier research which assumed 
that cryotherapy helps repair muscle faster through the reduction of 
inflammation and thus suppressing muscle degeneration following cryotherapy 
(Merrick 2002).  
In other research, evidence was found that reducing the tissue 
temperature leads to blood flow reduction (Alexander et al. 1973, Smith et al. 
1993, Dolan et al. 1997). However, the blood circulation may return after 
cessation of the therapy causing a local fluctuation in blood perfusion. It is still 
not well understood whether the disturbance in blood flow following the 
cryotherapy may aggravate muscle damage and influence the healing rate.  
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2.6.3 Cryotherapy application following CSTT 
The goal of cryotherapy is to reduce the surface and core temperature of 
the injured region in order to decrease the inflammation, swelling and pain 
(Smith et al. 1993, Smith et al. 1994, Deal et al. 2002, Merrick 2002, Hubbard et 
al. 2004).  
There are many external cryotherapy techniques described in the 
literature that use ice or iced-water and are typically referred to as “ice-
therapy” which usually involves a low temperature near zero degrees Celsius 
(e.g. ice block, ice pack) (Bleakley et al. 2004, Algafly et al. 2007, Herrera et al. 
2011). Also those at higher temperatures between 8oC - 22oC are referred to as 
“cold therapy” (e.g. the immersion in cold water or cold saline) (Schaser et al. 
2006, White et al. 2013). It is shown that ice therapy is more effective regarding 
cooling the tissue faster (Mcmaster et al. 1978, Zemke et al. 1998, 
Kanlayanaphotporn et al. 2005) and to a lower temperature (Mcmaster et al. 
1978, Swenson et al. 2007), when compared to cold therapy. 
Following cryotherapy, the level of cooling is directly related to the cooling 
techniques, the temperature of the cooling component, the thickness of the fat 
under the skin and also the duration of the treatment (Bleakley et al. 2004).  
Mars and colleagues have shown that during cryotherapy, tissue cooling is 
not uniform and different temperatures can be measured from the skin and 
muscles (Mars et al. 2006). They have studied the effect of cryotherapy on the 
skin surface (SK), subcutaneous fat (SC) and muscle (Ms) (rectus femoris to a 
depth of 1cm) in humans using an icepack, hypodermic needle-tip thermistors 
and a temperature probe (Mars et al. 2006). An icepack was placed on the skin 
for 15 minutes while the temperature was measured before, during, and for up 
to 45 minutes after cryotherapy. They found that after 5 minutes of cooling, the 
temperature of the skin, subcutaneous fat and muscle reduced from 370C to 28.8 
± 1.40C, 33.1 ± 1.10C and 34.9 ± 1.20C respectively. By continuing the icing 
therapy for 20 minutes, the temperature reached a minimum temperature of 8.1 
± 2.70C (SK), 21.7 ± 2.20C (SC) and 26.2 ± 3.50C (Ms).  
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Although the temperature then increased 45 minutes after cryotherapy 
ceased, the temperature in different tissue layers still remained lower than the 
initial temperature prior to cryotherapy by approximately 5°C. Finally, the 
authors have suggested that the degree of inhomogeneity of the temperature at 
different tissue layers may be associated with a sympathetic response adjusting 
the local blood flow following cryotherapy (Mars et al. 2006, White et al. 2013). 
For an optimum cryotherapy including an efficient reduction in pain, cell 
metabolism and swelling, it has been suggested that the tissue temperature 
should be decreased within a range of 10-15oC (Rivenburgh 1992, Mac Auley 
2001). However, prolonged cryotherapy is not recommended due to tissue 
damage and the impairment of the microcirculation caused by very low 
temperatures (Schaser et al. 2007, Collins 2008, Baoge et al. 2012). Also, it was 
indicated that a dramatic reduction of the tissue temperature to below 6o to 8°C 
causes serious damage to the microcirculation of the capillaries (Schaser et al. 
2007).  
In humans, a continuous and prolonged cryotherapy, even as short as 20-
30 minutes, is not recommended to be a safe technique due to the risk of skin 
burns known as frostbite (Bleakley et al. 2004, Lee et al. 2007). For this reason, 
intermittent cryotherapy over short durations (e.g. 10 minutes) has been 
acknowledged for clinical applications (Bleakley et al. 2006, Knobloch et al. 
2007).  
Intermittent cryotherapy for 3×10 minutes has been shown to reduce the 
microcirculation of capillaries locally in Achilles tendon disorders by 71% 
measured by a laser Doppler spectrophotometry system while the oxygenation 
of the tendon has been facilitated by 2 minutes of rewarming within the 
cryotherapy sessions (Knobloch et al. 2007). Also, this technique has been 
suggested to diminish the pain and swelling caused by moderate ankle sprains 
in humans (Bleakley et al. 2006). However, the differences in skin structure 
between humans and rats should be taken into consideration. Human skin is 
attached to the tissue (Dorsett-Martin 2004) and a cooling temperature can 
quickly penetrate to the tissue beneath the skin (Knobloch et al. 2007).  
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However, rats are loose-skinned animals and their skin contains several 
thick cellular layers with a nonvascular structure on the surface and is not 
attached to the underlying tissue (Sanders et al. 1995, Dorsett-Martin 2004, 
Dorsett-Martin et al. 2008). This suggests that to transfer the cooling 
temperature of ice to the underlying tissue where the injury is located, more 
time may be required. Also, the severity of the CSTT models may not be 
comparable with mild or moderate injuries such as an Achilles tendon disorder 
(Knobloch et al. 2007) or ankle sprains (Bleakley et al. 2006). 
In rats, one session of cryotherapy for a duration of 20 minutes appears to 
cool the muscle effectively (16oC) (Takagi et al. 2011) with no reported skin 
complications  (Smith et al. 1994, Deal et al. 2002). In this regard, Takagi and 
colleagues examined the effect of cryotherapy on muscle regeneration following 
a crush injury induced by forceps for 30 seconds on the extensor digitorum 
longus (EDL) of rat’s hindlimbs (Takagi et al. 2011). The authors applied an ice 
pack (0.3-1.3°C at the surface) onto the injured region for 20 minutes. The 
temperature of the muscle surface and the rectum (as a core temperature) were 
monitored using a thermometer during and after icing. The results were 
evaluated at 6, 12 hours and 1, 2, 3, 4, 5, 6, 7 (n=3), 14 and 28 (n=6) days 
following injury using histological analysis. The authors observed a linear 
reduction of temperature from 30°C (5 minutes before test) to 13.3±1.2 °C (20 
minutes after icing) and indicated that the temperature raised to around 25°C, 
20 minutes after cryotherapy ceased which was still 5°C lower than the initial 
temperature prior to cryotherapy (30°C). Investigating the effect of icing on the 
muscle injury at 11 time points has made their research one of the most detailed 
studies available in the field of cryotherapy.  
 
2.7 STATISTICAL APPROACHES FOR VASCULAR 
MORPHOMETRIC ANALYSIS 
The linear relationship between two vascular morphometric parameters 
within one modality (e.g. histology) is usually tested through a correlation 
coefficient (R) ranging between +1 (positive correlation) and −1 (negative 
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correlation) where 0 means no correlation. In addition, within one modality, the 
coefficient of determination (R2) shows how well data fitted into the model. The 
quantitative validation between two modalities is commonly assessed using 
standard statistical criteria including an intra-class correlation coefficient (ICC) 
with a 95% confidence interval (CI) (Lee et al. 1989) and also with an 
agreement analysis (Bland-Altman plot) for measuring one particular 
morphometric parameter. The ICC is a reliability assessment indicating the 
degree of association between two or more quantitative measurements (Müller 
et al. 1994) and ranges between 0 and 1. Lee and colleagues have defined the 
principles of correlation and agreement between two independent methods 
measuring one parameter by demonstrating these criteria; no systemic bias, no 
statistically significant difference between the mean values obtained from the 
two techniques and also the ICC being greater than 0.75 for a 95% CI (Lee et al. 
1989).  
The Lee principles were completed by Bland-Altman suggesting the 
agreement assessment between two techniques based on the estimation of the 
mean and standard deviation (SD) of differences between measurements. In the 
Bland-Altman diagram where the scattered data of differences between two 
measurements are plotted versus the mean of differences, the agreement level 
between two independent methods lies between these two limits of agreement 
and given as mean ± 1.96 SD.  
The confidence interval (CI) is a range of defined values in which a 
specified probability is that the value of a parameter lies within it. A 95% 
confidence interval interprets that a range of values with a 95% certainty 
includes the true mean of the population (Webber 2013). It has been shown that 
for a CI of 95%, the ICC should be greater than 0.75  (Lee et al. 1989) which 
indicates good reliability.  
 
2.8 GAPS IN KNOWLEDGE  
Through this literature review, the following gaps in knowledge of 
vascular injury following CSTT were identified: 
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 Available experimental investigations regarding vascular injuries 
following CSTT have been mostly focused on the functionality 
changes of blood vessels (e.g. blood flow) and not morphology. 
 Evaluation of current CSTT models is restricted to a highly localised 
and superficial regions and this may not provide comprehensive 
information regarding the morphology of the entire vascular 
network in 3D.  
 Currently, there is no adequate experimental model that allows the 
study of morphological changes to the vasculature following 
trauma in 3D. Developing a 3D characterisation model using a 
reliable imaging modality with higher resolution and accuracy 
(Guldberg et al. 2004) is needed to quantify changes to the  
vascular morphometric parameters such as vessel volume, number 
and diameter following CSTT. 
    Changes to the vascular morphology and the revascularisation 
mechanisms, including degradation of the injured capillaries, 
propagation of surviving endothelial cells and development of the 
new vasculature network remain only partially understood 
(Zhuang et al. 2006). This is due to the complexity of the processes 
requiring fundamental experimental research.  
 More investigation is required regarding the influence of 
microvasculature damage due to CSTT on the mechanisms such as 
vasodilation, angiogenesis and arteriogenesis during the healing 
process. 
 Systematic research into cryotherapy and its influence on muscle 
regeneration and revascularisation is currently lacking due to a 
limited knowledge of the processes involved of the structural 
changes caused by injuries to the vascular network.  
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2.9 FINDINGS AND SUMMARY 
The findings from the reviewing of the literature are discussed from two 
perspectives; experimental and clinical. In general, clinical evaluations are 
limited regarding a precise characterisation and quantification of vascular 
injury after the CSTT. Clinical investigations of musculoskeletal trauma are 
restricted by several factors; lack of knowledge regarding vascular injury 
following CSTT, and limited non-invasive analytical tools for monitoring and 
assessing these complications.  
Available clinical CSTT classifications are qualitative, based only on 
macroscopic observation leading to a challenging and subjective diagnosis. For 
example, CSTT monitoring with only systemic markers makes a definite 
diagnosis of vascular impairment non-specific and potentially inaccurate. 
Despite the existence of advanced imaging techniques such as MR and CT 
angiography, their resolutions are not high enough to be suitable for the 
detailed analysis of microvasculature changes following CSTT.  
From an experimental view, evidence was found regarding changes to the 
vascular functionality (Schaser et al. 1999, Schaser et al. 2003, Claes et al. 2006) 
and morphology (Duvall et al. 2004) following injuries indicating the necessity 
of vascularisation for the healing of injured tissue and muscle fibre regeneration 
(Järvinen 1976, Bauer et al. 2005, Järvinen et al. 2005, Nauta et al. 2011).  
It was shown that only a few experimental methods are available that 
allow for a sufficiently detailed characterisation of CSTT in vivo and ex vivo. The 
importance of capillaries and skeletal muscle perfusion to supply nutrients and 
oxygen for the cellular metabolism during tissue repair has been emphasised in 
the literature (Landry et al. 2000, Wolfard et al. 2002, Schaser et al. 2003, Zhang 
et al. 2003, Järvinen et al. 2005, Claes et al. 2006, Duda et al. 2008). In ischemia 
models, the vital role of changes to the vascular morphology such as vessel 
volume, number and diameter following injury and during the natural wound 
healing process has been highlighted through angiogenesis and arteriogenesis 
(Tonnesen et al. 2000, Scholz et al. 2002, Duvall et al. 2004, Lu et al. 2010).  
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This indicates that during the natural healing period, these changes to 
vascular morphology are necessary for adequate perfusion, providing sufficient 
oxygen and nutritional supply for successful tissue regeneration.  
Regarding CSTT treatments, while cryotherapy is widely used, 
disagreements were identified with respect to the effectiveness of this 
therapeutic method on the damaged tissue following injuries. Several authors 
have recommended cryotherapy as a beneficial method for reducing 
inflammation and vascular permeability following CSTT thereby reducing the 
swelling (Smith et al. 1993, Smith et al. 1994, Deal et al. 2002, Merrick 2002, 
Hubbard et al. 2004). However, this was not supported by other studies which 
have shown clinically (Bleakley et al. 2004, Collins 2008, Tseng et al. 2013) and 
experimentally (Takagi et al. 2011) that there was not enough evidence to 
confirm that cryotherapy can be an effective remedy for soft tissue injuries. 
Evidence has shown that decreasing the early inflammatory reaction delays the 
muscle regeneration and consequently reduces the speed and efficiency of the 
repair outcome during the healing period (Takagi et al. 2011).  
The limitation of current CSTT evaluations emphasises the necessity for 
the development of a quantitative 3D method to show a detailed exploration of 
the morphometric changes of the vasculature such as vessel volume, number 
and diameter following CSTT.  
The shortcomings of localised and superficial methods can be overcome by 
using appropriate techniques that are available for vascular assessment and 
better suited for deeper injury investigation (e.g. micro-CT imaging system). 
 
2.10 RESEARCH SIGNIFICANCE 
This research is expected to bring a significant contribution to the field of 
orthopaedics and traumatology by improving our understanding of the impact 
of CSTT’s on changes to the microvascular network, and furthermore, on the 
influence of these changes on tissue healing.  
 
 Literature Review 39 
Since most previous experimental studies regarding CSTT have been using 
localised and superficial (i.e. two-dimensional) methods to characterise vascular 
injury following CSTT, it is anticipated that the standardised, quantitative 
characterisation of the vascular injury in 3D may increase the accuracy and 
reproducibility of experimental CSTT models that are currently being used.  
Previously, in the absence of objective and quantitative methods for the 
characterisation of closed soft tissue injuries, the efficacy of many clinical 
treatment modalities, such as cryotherapy or hyperbaric oxygen therapy, has 
remained controversial. As a result of the improved accuracy in detecting 
changes to microvascular architecture caused by CSTT and during the healing, it 
will be possible to better evaluate the efficacy of treatment modalities on the 
healing of closed soft tissue injuries, which will enable the objective comparison 
of therapeutic measures and also drive the development of new treatment 
modalities.  
Ultimately, if the methods developed in this research lead to new insights 
on the relationships between changes to microvascular architecture, CSTT 
severity and healing, it will be possible to develop objective, quantitative clinical 
CSTT classifications that are superior to the currently used qualitative and 
subjective classification methods (e.g. Tscherne and AO). This is important, as 
better classification systems allow for more accurate diagnosis and monitoring 
of CSTT, resulting in better-informed decision-making during the treatment of 
these injuries. As such, the invasive, experimental methods developed in this 
project to characterise changes to the microvascular architecture may aid in the 
validation of future non-invasive clinical assessment modalities for CSTT.  
 
2.11 RESEARCH QUESTIONS 
From the review of the literature, the following key questions were raised.  
1. Does vascular morphology change following CSTT and during the 
healing period?  
2. What is the effect of cryotherapy on CSTT and the injured 
vasculature?  
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2.12 RESEARCH HYPOTHESIS 
In this research, it was hypothesised that CSTT and cryotherapy change 
the vascular morphology during the healing period. 
 
2.13 KEY GOAL AND RESEARCH AIMS 
To answer the research questions and address the hypothesis, the main 
goal of this research was to investigate the effects of both CSTT and cryotherapy 
on the vascular morphology in 3D as well as the effect of cryotherapy on the 
CSTT. This was achieved through the development of a characterised CSTT 
model in rats, using contrast-enhanced micro-CT imaging and also histological 
analysis.  
To achieve the main goal, the specific aims of this research were: 
 To develop and characterise a CSTT model.  
 To characterise vascular morphological changes following CSTT by 
developing perfusion and micro-CT evaluation protocols 
 To investigate the effect of cryotherapy on the injured vasculature 
following CSTT 
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Chapter 3: Development and 
characterisation of the CSTT model 
3.1 INTRODUCTION 
In order to study CSTT and to see whether there are any changes in 
vascular morphology following trauma, the development of a well-defined CSTT 
animal model was required. CSTT animal models using an impact device have 
been established previously and reported in the literature (Schaser et al. 1999, 
Claes et al. 2006) as an efficient way to create a defined and reproducible injury. 
In this research, this same method was applied to create a standardised and 
reproducible CSTT with a defined vascular injury. To confirm that the impact 
device creates a consistent injury, it was essential to characterise the device at 
first. The CSTT was also characterised through qualitative observations and 
quantitative evaluations. This was carried out by monitoring the symptoms and 
the size of the muscle injury at different time points. The changes to the muscle 
injury were also verified using histological assessments. The developed and 
characterised experimental model was then used to study the effect of 
cryotherapy on the healing process after CSTT as well as the injured 
vasculature. 
 
3.2 METHODOLOGY 
3.2.1 Structural design and the functionality of the impact device  
The following figures illustrate the components of the impact device 
(Figures 3-1). 
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Figure 3-1: A schematic of the impact device’s structure.  
This schematic shows two views of the impact device’s structure including the internal (A) 
and external (B) components. A: The top part of the impact device consists of a guiding 
rod, along which the drop weight slides down. The lower part of the device is comprised of 
a base plate, a support frame, an impact cylinder, and force distributers to transfer the 
force from the drop weight to the impact cylinder and a height-adjustable support anvil. 
Two safety pins were also used in the upper and lower parts of the device to secure the 
drop weight in its location. Since the height of the guiding rod was 1.66 m, here only the 
lower part of the device is shown. The positioning of the specimen (rat leg) between the 
impact cylinder and the support anvil is schematically exhibited. To reduce the risk of any 
injury to the researchers using this device, the entire impact device was encased by a 
frame made from Perspex panels, with lateral holes for locating the safety pins (B). 
 
3.2.2 Characterising the impact device  
To create a standardised and reproducible CSTT combined with a vascular 
injury, a previously manufactured impact device with a blunt impactor was used 
(Figures 3-1 and 3-2). The device was based on similar models reported in the 
literature where the authors had used a drop weight of 170g which fell freely 
from 1.8 m to create a CSTT of Grade 2, based on the Tscherne classification, on 
a rat’s hindlimb (Claes et al. 2006). These authors presented the velocity of their 
drop weight as 6m/s at the impact surface producing an impact energy equal to 
3.06 kg m2/s2.  
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As indicated in Table 2-1, a Grade 2 injury according to the Tscherne 
classification is approximately equivalent to a Grade 4 in the AO classification, 
whereby both classifications describe a severe muscle and skin contusion. 
 
 
Figure 3-2: The structure and functionality of the imapct device. 
This image shows the imapct device functionality in order to create an impact injury to a 
rat’s hindlimb. The drop weight is positioned at its highest point (1.66m) where it is 
secured by the upper safety pin (for illustrative purposes only the lower safety pin is 
displayed here, as the upper safety pin at a height of 1.66m is outside the image area). The 
hindlimb of the rat is positioned between the impact cylinder and the support anvil. To 
begin the test, the lower and upper safety pins are removed to allow the drop weight to 
fall down along the guiding rod onto the impact surface, and onto the top part of the force 
distributor. The energy of this impact is thereby transferred to the impact cylinder and 
then onto the soft tissue of the hindlimb thereby creating the injury.  
 
For this research, a suitable impact energy was desired to create a severe 
injury with no broken bone or skin perforation (equivalent to Grade 4 based on 
the AO classification). The impact energy is a function of the impact velocity and 
the mass of the drop weight.  Therefore, to ensure that the impact device 
produced a consistent injury, it was characterised based on these two 
parameters; the weight and the velocity of the drop weight at the impact 
surface.   
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Determination of the impact velocity 
Theoretical calculation of the impact velocity 
Figure 3-3 shows the drop weight with mass m, at height h holding zero 
kinetic energy while it is resting in the starting position. By releasing the safety 
pins, the drop weight falls freely from its resting position in a vertical 
downward direction. This occurs under the influence of the force of gravity. The 
drop weight continues downward and after travelling the height h, it hits the 
impact surface where its kinetic energy is transferred to the impact cylinder and 
then absorbed by the muscle tissue. 
 
 
Figure 3-3: A schematic of the mechanical functionality of the impact device.  
This schematic shows the penetrated distance of the impact cylinder through the tissue 
after a drop weight falls from a starting point towards the impact surface. 
 
According to the conservation of energy, the initial potential energy of the 
drop weight is equal to its final kinetic energy assuming an ideal system where 
the wasted thermal energy such as air resistance and the friction between the 
drop weight and guiding rod is zero. This is shown as: 
 
 mgh=1/2mv2f (3-1) 
 
The total height between the starting drop point and the impact surface 
was measured and then the final analytical velocity of the drop weight at the 
impact surface was calculated accordingly given as:  
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  Vf=√2gh   (3-2) 
 
The final impulse (I) of the drop weight at the impact surface was defined 
as: 
 I=mvf  (3-3) 
 
The information related to the starting point and the impact surface are 
summarised in Table 3-1. 
 
Table 3-1: The initial and final conditions of the drop weight. 
The information related to the initial condition of the drop weight at starting point as 
well as at the impact surface (end point) is summarised in this table.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Velocity assessment using a high-speed camera (HSC) 
The theoretical final impact velocity of the drop weight (vf) (equation 3-2) 
was verified by applying a frame-by-frame analysis of the drop weight velocity 
measured with a high-speed camera (HSC: X-Stream XS4, Version 2.10.01) at the 
impact surface (Figures 3-4 and 3-5). The HSC was utilised as another 
independent method to visualise and analyse the drop weight’s motion.  
Initial condition at starting point  
Parameters Descriptions and units 
hi=h Initial height at starting point (m) 
PEi=mgh Initial potential energy (J) 
m Mass of drop weight (kg) 
KEi=0 Initial kinetic energy (J) 
Conditions at impact surface 
g=9.8 Gravitational acceleration (m/s2) 
PEf=0 Potential energy at impact surface (J) 
KEf=1/2mv2f Kinetic energy at impact surface (J) 
I=mvf Impulse (kgm/s)  
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The drop weight velocity was recorded by tracking its motion using a HSC 
and an image acquisition processing software (IDT Motion Studio, DEL Imaging 
Systems, LLC. 1781 Highland Avenue, Cheshire, CT 06410). The camera was set 
up on a tripod and then connected to a laptop (Intel Core (TM) 2 Duo CPU, 
Windows 7). A 50 mm lens was calibrated at a distance of 1.36 m. The field of 
view was illuminated by using portable 1000 W LED lights (Figure 3-4).  
 
 
Figure 3-4: A set up for characterising the impact speed with a high-speed camera. 
The set up for characterising the impact speed using a high-speed camera, a laptop, the 
impact device and LED lights is shown. High-speed movies were captured from the impact 
area, where a frame-by-frame analysis of the drop weight position allowed for the 
calculation of the impact speed using a regression analysis performed in Microsoft Excel 
software. 
 
 
An experimental study was conducted by releasing the drop weight to fall 
freely from the highest point (1.66 m) along the guiding rod. The frame rate for 
imaging (frequency) was adjusted to 1500 Hz. As the parameter ‘time’ is the 
inverse of the frequency, the time between two frames is 667µs. By using the 
camera’s frame rate, the time trace of the drop weight position was collected. 
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Figure 3-5: A representation of the captured images by the high-speed camera.  
The images exhibit the last sequences of a dropped weight while it is travelling from 
location A and approaching the impact surface (location B). The drop weight bounced 
back approximately 4 mm at its first impact, which is not shown here.  The ruler shows the 
position of the drop weight from the starting point and the ending point at the impact 
surface. The positions of the drop weight between locations A and B (where visible) were 
recorded as well as the time between frames for measuring the velocity of the drop weight 
at different points and finally at the impact surface. 
 
The velocity of the drop weight was measured at the impact surface using 
the HSC by applying a frame-by-frame analysis and by finding the position of the 
drop weight on each frame of the high-speed movie (Figure 3-5). By applying a 
regression analysis, the position of the drop weight as a function of time was 
determined and plotted.  
The final drop weight velocity at the impact surface was derived by 
computing the derivative of the position-time function with respect to time. The 
impact experiments were repeated five times. 
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Determination of the appropriate impact weight  
In Claes’s research, the travelled distance by the drop weight (170g) was 
1.8 m creating a velocity of 6 m/s (equation 3-2) and an impact energy of 3.06 
kg m2/s2 (equation 3-3) (Claes et al. 2006). In the impact device used for this 
research, the travelled distance by the drop weight was 1.66m; therefore, to 
achieve an equivalent impact energy as Claes et al, the weight of the drop weight 
had to be increased. The first tested weight (n=5) was 180g which was obtained 
from equation 3-3, given the theoretical velocity of 5.7 m/s and the impact 
energy of 1.02 kg.m/s from the Claes study. However, by using this weight a 
severe injury was not achieved. Therefore, a variety of weights including 230g 
(n=7), 300g (n=4) and 400g (n=8) were tested for the drop weight in which the 
weight was increased sequentially by adding additional scaled plasticine on the 
drop weight until the desirable CSTT was achieved.  
 
3.2.3 Development of a standardised CSTT model using the impact device 
 
Animal ethics  
All animal procedures were performed in accordance with the Australian 
National Health and Medical Research Council guidelines for laboratory animal 
use and were approved (approval number: 1100000318) by the ‘University 
Animal Ethics Committee’ at Queensland University of Technology (QUT), 
Brisbane, Australia.  
 
Defining the region of interest 
To create a standardised and reproducible injury using the impact device, 
a region of interest (ROI) was defined on the left hindlimbs of anaesthetised rats 
between the tibia-notch (TN) of the knee joint and tibia-fibula conjunction 
(TFC). This region contains the biceps femoris and gracillis muscles in the 
lateral and medial sides respectively (Figure 3-6).  
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The area of the ROI was measured for non-injured hindlimbs of all animals 
using ImageJ software (ImageJ 1.47v: Wayne Rasband, National Institute of 
Health, USA). This ROI was used for all experiments throughout this research. 
 
   
Figure 3-6: Defining a region of interest (ROI). 
The ROI was defined between two anatomical markers; the tibia’s notch of the knee joint 
(TN) and the TFC (tibia-fibula conjunction) (left images) and also on the biceps femoris 
and the gracillis muscles (right images). 
 
Animal preparation 
For this study, male Wistar rats (12 weeks) were provided from the 
Animal Resources Centre, Canning Vale, WA, Australia. The animal housing and 
welfare were based on the Australian code for the care and use of animals for 
scientific purposes (National Health and Medical Research Council 2013).  
Animals were accommodated in enclosed, safe and clean cages where they could 
freely have access to water and nutritious pellets as well as social and physical 
activity. Rats were anaesthetised prior to impact by inhaling isoflurane (2.5%) 
at a rate of 5 L/minutes mixed with oxygen at 4 L/minutes for induction and 
this was maintained with 2 L/minutes mixed with oxygen at 2 L/minutes. Prior 
to the initiation of the CSTT, the anaesthetised animals were injected with 
analgesic subcutaneously (Buprenorphine: 0.2 mg/ml, 0.05 mg/kg) and then 
transferred to the impact device. The left hindlimb was secured between the 
impact cylinder and support anvil. Care was taken to exclude the bone from the 
impact zone to prevent any bone fracture. Once the positioning of the animal 
was completed, the drop weight was released and it dropped along the guiding 
rod to create the desired CSTT.  
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After impact, animals were kept warm during recovery while their vital 
signs were monitored. The post-operative pain was managed by injecting one 
dose of Buprenorphine 12 hours after impact. The rats were euthanized 24 
hours after impact according to the standard operating protocol (SOP) #261 of 
the Medical Engineering Research Facility (MERF) at QUT. Briefly, the rats were 
placed in a plastic container under a laboratory hood. The container was 
connected to CO2 and had a sealed lid to prevent the gas leaking outside. A filling 
rate of 20% of the chamber volume per minute with 100% carbon dioxide was 
added to the existing air in the chamber to achieve a balanced gas mixture to 
fulfil the objective of rapid unconsciousness with minimal distress to the 
animals. After euthanasia, to ensure that the bone has not broken due to the 
impact, animals were placed inside a portable X-ray cabinet (Faxitron MX-20, 
Faxitron Bioptics LLC, USA) and imaged with an energy of 31 kVp for 83 seconds 
(Fouletier-Dilling et al. 2005). 
 
3.2.4 CSTT and muscle injury characterisation using ImageJ software 
To confirm the reproducibility of the model for creating a CSTT with a 
consistent injury grade, the severity of the created CSTT was determined 
qualitatively and quantitatively.  
For qualitative assessments, one day after impact, animals were 
euthanised and then both lateral and medial views of the rat’s hindlimb were 
visually observed. The CSTT was qualitatively evaluated based on macroscopic 
symptoms of the skin surface (tissue of epidermis side) and under the skin after 
dissection (subcutaneous tissue) and muscles (surfaces of the biceps femoris 
and gracillis). In addition, observations were made of the CSTT location and its 
symptoms such as bleeding (haematoma) and inflammation (redness, stiffness, 
and swelling). Finally, the CSTT observations were compared with the AO 
classification (Table 2-1) and then graded based on the muscle defect, contusion 
and segmental vascular injury. 
For quantitative analysis, the inflamed areas of CSTT (haematoma) where 
the impact was induced were measured using ImageJ software.  
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The quantification of the CSTT (muscle injury) was carried out by 
measuring the total area of the inflamed region using the ‘freehand selection’ 
tool within ImageJ for each case (Figure 3-7).  
 
 
Figure 3-7: A configuration of the CSTT showing the inflamed area.  
This area of haematoma was used for the quantification of the size of the haematoma and 
the severity of the muscle injury.  
 
3.2.5 Histology analysis 
Biopsy samples 
Corresponding biopsy samples were taken from both injured and non-
injured contralateral hindlimbs using a biopsy punch for two reasons (Figure 3-
8). One reason was for a detailed quantification of vascular morphology utilising 
contrast-enhanced micro-CT imaging, as described in Chapter 4.  
The other reason was for evaluating the muscle injury and inflammation 
using histological techniques. Figure 3-8 shows a schematic diagram illustrating 
the geometrical technique that was designed to enable the collection of defined 
and reproducible biopsy samples from the same regions of rat’s hindlimbs.  
 
 52 
 
  
Figure 3-8: The geometrical technique for taking corresponding biopsy specimens.  
A schematic representing the geometrical design for taking two corresponding biopsy 
specimens from the CSTT location within the ROIs of injured and non-injured hindlimbs is 
shown. This method has been designed and applied to evaluate correlated areas in a 
consistent and standard manner for all samples throughout this research. After placing 
the paired hindlimbs side by side showing their lateral view where the injury was 
observed on the biceps femoris (BF). The knee joints (tibia notch) of both hindlimbs were 
used as anatomical markers and a straight line was drawn to connect them together. A 
circle was marked using the same diameter as a biopsy punch (8mm) on the tissue surface 
where the central region of the contusion was located. Straight parallel lines were then 
utilised to outline the circle to obtain the distance measurements required to reproduce 
the same region on the contra-lateral non-injured hindlimb. The blue cross within each 
circle, which is facing the corresponding knee joint, was utilised as an indicator for the 
biopsy sample’s alignment. 
 
Histological section preparation 
The general section preparation for the histological analysis is based on 
the techniques previously reported in the literature (Tsivitse et al. 2003, 
Shireman et al. 2006). Briefly, the biopsy specimens were fixed in 10% neutral 
buffered formalin (NBF) for 24 hours to prevent tissue degradation.  
The samples were treated using several different solutions using an 
automated tissue processor machine (Thermo Excelsior Tissue Processor and 
paraffin embedding station, Thermo Fisher Scientific, USA). The samples were 
dehydrated by increasing the ethanol concentration from 70% (30 minutes) to 
90%, 95% and 100% for one hour respectively. 
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 This was followed by incubation in a hydrophobic clearing agent (xylene 
for 2 hours) to remove the alcohol. Finally, the sample was embedded for 2 
hours and 45 minutes into melted paraffin wax (the infiltration agent). After 
tissue embedding, the samples were placed on a freeze plate to allow the wax to 
harden into a block. Serial sections with a thickness of 5-um were then 
transversely sliced using a microtome (Leica Biosystems RM2235, Sydney, 
Australia) and mounted on Poly-L-lysine adhesion glass sections (Thermo 
Fisher Scientific, Brisbane, Australia). As tissue staining requires water and wax 
is hydrophobic, therefore, the wax needs to be removed from the tissue before 
staining. To achieve this, after the sectioning procedure, the wax was removed 
from the tissue samples using xylene for 12 minutes. This process was then 
followed by a rehydration procedure utilising serial ethanol with decreasing 
concentrations (100%, 90% and 70%, 3 minutes at each stage) and finally 
rinsing the sample in water for 3 minutes.  
 
Haematoxylin and eosin (H&E) staining 
The prepared tissue sections were stained using haematoxylin and eosin 
staining (H&E) (H&E, Sigma-Aldrich, NSW, Australia) in order to identify tissue 
components and to evaluate the degree of muscle injury and regeneration, as 
well as the level of the inflammatory cell influx and its location. The rehydrated 
tissue sections were rinsed with distilled water and then stained with Mayers 
haematoxylin for 5 minutes in order to stain the nuclei of the cells blue. The 
samples were then rinsed using running tap water for 10 minutes and stained 
with eosin for 10 seconds to colour the cellular cytoplasm and connective tissue 
pink.  
Subsequently sections were then dehydrated again as explained 
previously and were mounted with menzel coverslips (Lomb Scientific, 
Australia) using a xylene based mounting medium (Eukitt: Kindler, Germany) 
and then dried overnight.  
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Imaging, analysis and quantifications of histological sections  
The histology sections were scanned using a Leica SCN400 histology 
section scanner (Leica Microsystems Pty Ltd, NSW, AU) and visualised using a 
light microscope, Zeiss Axio Imager M.2 (Carl Zeiss, Gottingen, Germany). The 
histological images were captured using the Zeiss Axio Zen 2011 image analysis 
software and subsequently analysed qualitatively for evaluation of tissue 
morphology relating to the muscle injury, inflammation and muscle 
regeneration. Selecting random histological views and the quantitative analysis 
of the vascular morphometric parameters using histology and ImageJ software 
are explained in Chapter 4.   
 
3.2.6 General statistics 
The quantitative data obtained from experimental examinations is 
presented as a Mean ± SD (standard deviation). Further calculations were 
performed using statistical tools available in SPSS (SPSS: IBM SPSS Statistics, 
Version 21), MedCalc software (MedCalc: Version 13.1.2.0, Microsoft Partner, 
Belgium) as well as Microsoft Excel (Microsoft Excel: Microsoft office 
professional 2010, Microsoft Corporation). For all statistical analysis, p < 0.05 
was considered significant while comparing the differences between the mean 
values. The differences between two independent groups were analysed using a 
two-tailed Student t-test assuming equal variance. The reproducibility of the 
impact device was determined by finding the coefficient of variation (CV: 
SD/mean ×100 %) for the velocity parameter. In this research, a CV less than or 
equal to 10% was determined to be an acceptable level of variability indicating 
the reproducibility of the described method (Jensen et al. 1994, Mitzner et al. 
2001).  
The criteria for detection and exclusion of an outlier value was defined 
based on determining a qualifying band for the measured values given in 
following formula (Thompson 2013): 
 
 Mean – (1.5 ⨯ SD) < Measured value < Mean + (1.5⨯ SD)  (3-4) 
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The SD is the standard deviation from the mean. The measured values 
outside the defined band were identified as outlier values and excluded. 
 
3.3 RESULTS  
3.3.1 Impact velocity characterisation 
The theoretical results of the calculated velocities of the drop weight 
obtained from equation 3-2 are given as a function of different heights between 
the starting point at the top, where the drop weight is released, and the bottom 
point where the drop weight hits the impact surface (Figure 3-9 and Table A-1).  
 
 
 
Figure 3-9: Calculated velocities of the drop weight versus various distances.  
The calculated velocities of the drop weight versus the distance travelled by the drop 
weight (drop height) between the starting point and the impact surface (ending point) is 
shown.  
 
The final impact velocity vfc at the impact surface was also calculated from 
this equation and presented below where the total travelled distance (drop 
height) by the drop weight was 1.66 m.  
The data (Figure 3-9) showed that the velocity of the drop weight 
increased as it was approaching the impact surface. 
 
 vfc=√(2ghi) =√(2⨯9.8⨯1.66)=5.7 m/s (3-4) 
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The calculated velocity validation using a high-speed camera (HSC) 
As mentioned, to confirm that the theoretically calculated final velocity 
(vfc) of the drop weight can accurately predict the actual velocity of the drop 
weight measured experimentally, vfc was validated at the impact surface by a 
high-speed camera (HSC). The final drop weight velocity at the impact surface 
was obtained from the derivative of the position-time function with respect to 
time (Figure 3-10). 
 
 
Figure 3-10: Measured velocities obtained from a high-speed camera (HSC).  
One series of measurements observed for the distance travelled by the drop weight (drop 
heights) versus corresponding times captured by the HSC is shown. At the beginning of the 
test, the drop weight falls from the original starting point of 1.66m, which is the distance 
between the original point and the end point (impact surface). After travelling 1.56 m, the 
drop weight reaches the HSC field of view (FOV) where it begins to capture the images for 
the remaining distance (0.1m). This FOV distance (0.1m) was determined with a starting 
point of 0.1m (where the drop weight reaches the FOV and its position starts to be 
captured) and the ending point of 0.02m at the impact surface. The polynomial trend line 
(curve fitting) was set for the quadratic free fall equation where the R2 (coefficient of 
determination) was computed as 0.99 indicating that the data fits well with the 
regression line. 
 
The Mean ± SD derived from the HSC was determined to be vfm=5.46 
(≈5.5)±0.15m/s. This value was compared with the final theoretical velocity 
(5.7m/s). Comparisons between the final drop weight velocity derived from 
calculations using the formula (vfc) (a single absolute value) and experimental 
measurements (vfm) (mean value) utilising the HSC indicated no significant 
difference between these two methods (single Student t-test) for measuring the 
velocity at the impact surface (Figure 3-11). 
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Figure 3-11: Comparisons between the calculated and measured velocities. 
The comparison between the final calculated velocity using the formula (vfc) (one 
absolute calculated value, SD=0) and the final velocity (Mean ± SD, n=5) which 
was experimentally measured (vfm) by using the high-speed camera (HSC). The 
measured velocity of case 1 was very close to the mean value therefore, it may not 
be clearly seen in this image. The p > 0.05 was obtained by statistical analysis 
using the “single Student t-test” for comparisons between the single value 
(calculated) and the mean value (measured) indicating that there is no significant 
difference between these two methods.  
 
Impact velocity validation for reproducibility and accuracy 
The relative error between final velocities derived from analytical 
calculation using the formula (vfc) and experimental measurements (vfm) 
utilising a high-speed camera is defined as: 
 Relative error (%)=|vfc - vfm |/|vfc|⨯100 (3-5) 
 
The numerator represents the absolute error (the absolute differences 
between the calculated and measured velocities). The relative error obtained 
from Equation 3-5 was as small as 3.5% and indicated that the final measured 
velocity (vfm) produced by the HSC is very close to the final calculated velocity 
(vfc) obtained from equation 3-2. Also, for the measured velocities (vfm) obtained 
from experiments (n=5) using the HSC, a small coefficient of variation (CV% = 
SD/Mean×100) of 2.8% was found. These results indicated that theoretical 
velocity is an accurate method to predict the velocity pattern of the drop weight 
in reality and therefore, it is reliable for creating a consistent injury.  
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The final theoretical velocity was used for calculating the energy of the 
impact to create the CSTT.  
 
3.3.2 Impact weight characterisation  
As discussed, the height of the impact device used in this research (1.66 m) 
was shorter than the one utilised by Claes and colleagues (Claes et al. 2006). 
Therefore, to achieve an equal impact energy the weight of the drop weight had 
to be increased to 180g. As the original weight of the drop weight was 130g, 
additional plasticine (50g) was added to the drop weight to obtain the weight of 
180g. However, the drop weight of 180g, created a muscle injury of Grade 2 
(n=5). Therefore, to achieve a CSTT of Grade 4, the weight of the drop weight 
was increased. The tested weights were 230g (n=7), 300g (n=4) and 400g (n=6) 
which produced a CSTT and muscle injuries of Grade 3, Grade 3 and Grade 4 
respectively based on the AO classification (Figure 3-12).  
 
 
 
Figure 3-12: Determining the degree of CSTT and muscle injury.  
The results of the muscle injury obtained from four different drop weights are shown. 
Various drop weights including 180g (n=5), 230g (n=7), 300g (n=4) and 400g (n=6) were 
applied to impact the biceps femoris muscle on the lateral side of the rat’s hindlimb and 
also the gracillis muscle on the medial side. Here the results of the lateral side of the 
hindlimb are shown. These weights produced CSTTs of Grade 2, Grade 3, Grade 3 and 
Grade 4 respectively based on the AO classification. A severe CSTT with serious muscle 
injury (Grade 4) and defect (on the biceps femoris) was achieved using the drop weight of 
400g.  
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By using a drop weight of 400g, a severe CSTT including extensive 
haematoma, inflammation and bleeding could be observed on the superficial 
muscles (biceps femoris and gracillis) of both lateral and medial sides of the 
rat’s hindlimbs along with a muscle defect on the biceps femoris. These 
symptoms of the CSTT were defined as Grade 4 based on the AO classification 
(Figure 3-12). In addition, the skin evaluation showed no obvious haematoma or 
defect on the skin surface of the rat’s hindlimbs utilising the drop weight of 
400g, (Figure 3-13). Further investigation utilising an X-ray image (Faxitron DX 
V1, Faxitron Bioptics LLC, USA) revealed that there was no broken bone on the 
injured hindlimb where the drop weight of 400g was applied (Figure 3-14).  
 
 
Figure 3-13: The evaluation of the skin surface of the rat’s hindlimbs.  
The skin surface of the rat’s hindlimbs from both lateral and medial sides is shown. No 
obvious haematoma or perforation could be seen on the skin surface of the injured 
hindlimb where CSTT was applied using the drop weight of 400g.  
 
 
Figure 3-14: Bone fracture inspection following CSTT. 
An X-ray image from the medial view of both injured and non-injured hindlimbs is shown.  
No broken bone could be observed in the injured hindlimb where the CSTT was induced by 
the drop weight of 400g. 
 60 
 
Therefore, the desirable CSTT of Grade 4 based on the AO classification 
including extensive muscle injury (Figure 3-12) with no skin perforation (Figure 
3-13) and no broken bone (Figure 3-14) was achieved using the drop weight of 
400g. This weight was chosen and kept constant throughout all experiments. 
 
3.3.3 CSTT characterisation 
One day after impact, the CSTT was qualitatively evaluated by taking 
photographs of the skin and muscle injury before and after skin dissection using 
a digital camera (Sony, DSLR-A330) for all animals. The symptoms were 
assessed before dissection of the skin surface (epidermis side) and after 
dissection to observe the injury under the skin (subcutaneous side). A mild to 
moderate swelling and stiffness could be palpated with no obvious haematoma 
on the skin surface where the CSTT was induced. Although the skin surface 
(epidermis side) showed no obvious sign of haematoma, a serious haematoma 
was observed under the skin (subcutaneous side) in the injured region after 
dissection (Figure 3-15). In addition, the CSTT was evaluated on the superficial 
muscles on both lateral (biceps femoris) and medial (gracillis) sides of the rat’s 
hindlimb. To find whether CSTT had affected the deeper muscles, the biceps 
femoris on the lateral side of the rat’s hindlimb, where a serious muscle defect 
could be observed, was dissected. The same symptoms as described for the 
superficial muscles could be observed on the deeper muscles as well (e.g. 
semimembranosus) (Figure 3-16).  
The severity of the CSTT using the drop weight of 400g was also confirmed 
through histological analysis and observation of extensive muscle fibre 
destruction as well as the presence of inflammatory cells in the injured region 
(Figures 3-17). Furthermore, the reproducibility of the CSTT model was 
quantitatively verified to ensure that the model produced consistent muscle 
injuries with the same degree. This quantification was conducted by measuring 
the inflamed areas of the haematoma (n=6) of the hindlimbs where the CSTT 
was induced by the drop weight of 400g.  
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The Mean ± SD of 5.2±0.6 cm2 was obtained from the results although an 
outlier value of 2.2 cm2 was quantitatively detected (Figure 3-18).  
 
 
Figure 3-15: Skin evaluation after CSTT.  
Skin inspection of both external and internal sides is shown after a CSTT created by the 
impact device using a 400g drop weight. A: The evaluation of the skin’s surface showed no 
obvious haematoma on either lateral or medial sides of the injured hindlimb. B: This 
image exhibits that after skin dissection of the injured hindlimb, a severe haematoma 
could be observed under the skin (subcutaneous side) where it was attached to the biceps 
femoris muscle (BF) in the region that the CSTT was induced (green lines). 
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Figure 3-16: The CSTT and muscle injury evaluation following an impact. 
The CSTT and muscle injury inspection following CSTT using a drop weight of 400g is 
exhibited. The first row depicts the muscle injury and defect (Grade 4 based on the AO 
classification) on the superficial muscles of both lateral (biceps femoris) and medial 
(gracillis) views while the second row exhibits the deeper muscle injury of the lateral side 
(semimembranosus) after dissecting the biceps femoris. A severe muscle injury, 
haematoma, inflammation and bleeding resulted from the drop weight of 400g which 
could be observed in both superficial and deep muscles. This confirms the severity of the 
injury as well as the depth of the CSTT affecting several muscle compartments. These 
findings were consistent over all animals (n=6). 
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Figure 3-17: The histological analysis following CSTT.  
The histological analysis (haematoxylin and eosin staining) of the injured and non-injured 
regions of the rat’s hindlimbs (biceps femoris) is illustrated. The severity of the CSTT 
produced by a 400g drop weight was confirmed by observing extensive necrotic areas 
including destructed muscle fibres (yellow arrows) and the presence of inflammatory cells 
(green arrows) where the impact was induced. These findings were consistent over all 
animals (n=6). 
 
 
 
Figure 3-18: The quantitative analysis of inflamed areas due to CSTT. 
The quantified inflamed areas of the CSTT (n=6) one day after impact where the injury 
was induced using a 400g drop weight. Regardless of the presence of an outlier value, 
which was excluded, the evaluation of the individual measurements with a Mean ± SD of 
5.2±0.6cm2 showed a small variation indicating the reproducibility of the CSTT model for 
producing the CSTT with the same degree of injury (Grade 4).   
 
After exclusion of the outlier value based on the defined criteria (3.2.6), 
the variability reduced in data with a CV of 11.5% in the inflamed areas. This CV 
value was very close to the acceptable CV range (CV ≦ 10%) suggesting that the 
model was relatively reproducible for creating a consistent CSTT with the same 
degree (Grade 4).  
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The investigation regarding the characterisation of the impact device and 
the CSTT was finalised for this research by determining the standard operating 
procedures (SOP) for developing a severe and consistent injury using the impact 
device. These protocols can be used to create a CSTT with defined impact 
parameters including the weight (e.g. 400g) and velocity (e.g. 5.7 m/s) of the 
drop weight to produce a desirable injury within the ROI (e.g. Grade 4 based on 
the AO classification) (SOPs for the impact device, Appendix C).   
 
3.4 DISCUSSION 
3.4.1 The impact device characterisation 
The goal of this study was to create a CSTT with serious muscle and 
vascular injury with no skin perforation and no broken bone. Such an injury has 
been described by the AO classification as Grade 4. The severity of the injury is 
primarily influenced by the energy of the impact, which was characterised 
based on two affecting parameters: the impact velocity and the weight of the 
drop weight. 
To create a standardised and reproducible CSTT, a well-characterised 
impact device was required with a validated impact velocity as well as an 
appropriate weight for the drop weight at the impact surface. The impact 
velocity was characterised by analytical calculations and verified with respect to 
the reproducibility and accuracy using a high-speed camera. The small relative 
error of the measured velocity (vfm) produced by the HSC was very close to the 
calculated velocity (vfc) obtained from analytical calculations suggesting the 
accuracy of the HSC technique. In addition, a small coefficient of variation 
indicated that the impact device was a reliable system to produce precise and 
reproducible impacts with the same velocity thereby creating a consistent 
injury. One explanation for the small difference between the calculated and 
measured velocity can be the friction effect between the rod and the impactor.  
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A systematic characterisation of the impact velocity was not found in 
publications by other authors who also used an impact device to produce a 
defined CSTT, and only basic information such as the impact velocity was 
provided (Claes et al. 2006, Melnyk et al. 2008). Claes et al. reported that a CSTT 
of Grade 2 was created in their experiments, based on the Tscherne 
classification. However, a detailed description or images of the muscle injuries 
resulting from the CSTT to support this classification have not been provided in 
any of their research articles. In our experiments, even though the fundamental 
basis of the impact device, and initially also the impact energy for creating a 
CSTT was similar to the one applied by Claes et al., we did not achieve the 
desired severity of muscle injury. It is unlikely that the difference in injury 
severity was caused by different animals in the experiments (we used male rats 
at 12 weeks of age, while Claes et al. used rats of unspecified gender at 11 weeks 
of age. But while we have no definitive explanation for the differences between 
Claes et al.’s and our findings, the discrepancy between reported injury severity 
may highlight the problems associated with the subjective injury classification 
systems of Tscherne and AO. Particularly for the injury assessment in rats, 
which do not exhibit any observable superficial bruising after CSTT (e.g. Figure 
3-15) it is difficult to assess the degree of the muscle injury precisely from a 
superficial visual observation alone. Consequently, for the injury classification 
during the model development phase, we removed the skin and based our 
assessment on visual observation of the superficial muscles (Figure 3-12 and 
Figure 3-16). We then incrementally increased the weight of the drop weight to 
eventually achieve an injury that was classified as of Grade 4 based on the AO 
classification using the drop weight of 400g. This weight subsequently used 
throughout all experiments.  
 
3.4.2 Characterisation of the CSTT model  
A severe CSTT model (Grade 4 based on the AO classification) including 
extensive acute muscle injury, haematoma, inflammation with no skin 
perforation and no broken bone was achieved using the characterised impact 
device.  
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Based on the injury description given by the AO classification and the 
quantification of the inflamed areas, the established CSTT model for this 
research was consistently graded 4 using a drop weight of 400g with a velocity 
of 5.7m/s.  
The muscle injury following CSTT was also verified by histological 
evaluations where serious muscle fibre destruction along with the presence of 
inflammatory cells were observed in the region that CSTT was induced. In the 
histological analysis, the CSTT region containing damaged muscle fibres and 
inflammatory cells potentially indicate necrosis as described in the literature 
(Radley et al. 2008). The skin observations indicated that while no obvious 
haematoma could be observed on the skin surface (epidermis side), there was 
substantial injury to the deeper layers (subcutaneous side). A reason why no 
obvious haematoma could be seen on the skin surface (epidermis side) may be 
explained by the nonvascular structure of the rat’s skin.  
In general, the structure of the skin’s surface (epidermis side) is 
nonvascular with thick cellular layers that act as a barrier against mechanical 
loads (Sanders et al. 1995). Rats are loose-skinned animals and the skin is 
highly elastic with no strong structure to attach it to the underlying tissue 
(Dorsett-Martin 2004, Dorsett-Martin et al. 2008). This suggests that after a 
high-energy impact, the surface of the skin can slide on the deeper structures 
(subcutaneous facia) and transfer this energy to the underlying tissue where the 
injury could be obviously seen.  
However, the human skin is attached to the tissue (Dorsett-Martin 2004) 
and therefore, the CSTT can be obviously seen on the skin’s surface since the 
energy of the impact can easily be passed on to the underlying soft tissue which 
is firmly attached to the skin. Although the skin results obtained from the CSTT 
model can be used for other loose-skinned animal models, these results may not 
be appropriate for humans.  
In conclusion, the qualitative characterisation of the CSTT and muscle 
injury from the CSTT model developed for this research has confirmed and 
expanded on the previous efforts of other studies (Schaser et al. 1999, Claes et 
al. 2006).  
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The experimental model inflicted injuries that correspond with the 
description of qualitative CSTT symptoms in clinical classifications of CSTT (AO 
and Tscherne) (Table 2-1).  
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Chapter 4: Development of perfusion 
and micro-CT evaluation protocols for 
characterisation of the vascular injury 
following CSTT 
4.1 INTRODUCTION 
 
        As discussed in Chapter 2, from CSTT models reported using a rat’s 
hindlimb, evidence was found suggesting a reduction in blood flow during the 
first 24 hours after trauma (Claes et al. 2006). Also by using an ischemia model 
of mouse hindlimbs, changes to vascular morphology such as a decrease in the 
vessel volume, connectivity, number and diameter have been shown one day 
after injury (Duvall et al. 2004). Based on these findings, it was hypothesised 
that the vascular morphology changes after CSTT and this leads to a reduction 
of these parameters within the injured hindlimbs at day 1. To test this 
hypothesis, it was essential to visualise and then quantify the vascular 
morphometric parameters. These morphological parameters are vessel volume 
(VV), vessel connectivity density (VConn.D), vascular degree of anisotropy (DA), 
vessel number (VN), vessel diameter (thickness) (VD) and vessel spacing or 
separation (VSp). Briefly, VV is calculated based on the number of segmented 
voxels and the voxel size in the 3D micro-CT image after applying the 
thresholding technique (Jing et al. 2012). The parameter of vascular 
connectivity (VConn) which is defined per total volume (TV) (normalised by TV 
as 1/mm3) (Scanco Medical SCANCO Medical microCT systems: 3D analysis) is 
“the maximal number of branches that can be broken within a structure before it 
is divided into two separate parts” (Duvall et al. 2004). The vascular network 
orientation is analysed by the geometrical degree of anisotropy (DA) (1) and is 
quantified as the ratio between the maximum and the minimum radius of the 
‘mean intercept length’ (MIL) ellipsoid. The DA varies from 1 for isotropy and 
greater than 1 for anisotropy (Bouxsein et al. 2010, Scanco Medical SCANCO 
Medical microCT systems: 3D analysis).  
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The VN, VD and VSp are determined based on a model-independent 
technique suggested for computing the thickness in 3D images (Hildebrand et al. 
1997, Zagorchev et al. 2010). The inverse of the mean distance between the 
mid-lines of vessels (1/mm) gives the VN (Jing et al. 2012). The average of the 
local voxel (a volumetric pixel) thicknesses within the structure is calculated as 
the VD, and a similar calculation on the surrounding space of the voxels is 
computed as the VSp (Duvall et al. 2004).  
Through the literature review performed in Chapter 2, it was found that 
the microfil contrast agent (Cheung et al. , Savai et al. 2009, Jia et al. 2010, Yeung 
2011) and histomorphometry analysis (Boerckel et al. 2011, Tomlinson et al. 
2013, Ehling et al. 2014) are accurate approaches for evaluating and quantifying 
vascular morphometric parameters. In addition, it was appeared that ImageJ 
software has been successfully used by other authors for quantifying 
morphological parameters of the vascular network (Zhuang et al. 2006, 
Tomlinson et al. 2013). 
In a comprehensive systematic analysis, Nebuloni et al (2014) have 
validated the accuracy of the vessel number produced by contrast-enhanced 
micro-CT using 2D histomorphometry and ImageJ software (Nebuloni et al. 
2014).  
Ehling and colleagues (2014) have correlated the microfil-enhanced 
micro-CT results with histology evaluation using ImageJ for the vessel number 
and diameter in tumour angiogenesis models (Ehling et al. 2014). They reported 
an excellent correlation and agreement between contrast-enhanced micro-CT 
utilising microfil, and histomorphometry for producing the vessel number and 
diameter in 2D correlated sections. Also, by using histomorphometrical 
evaluations, Jia and colleagues (2010) found significant positive correlations 
between 2D histology and 3D contrast-enhanced micro-CT for quantitative 
assessments of the vascular volume ratio and vessel number (Jia et al. 2010).  
Therefore, in this research, a systematic characterisation method was 
established for a 3D vascular network through the development of protocols for 
perfusing and evaluating the vascular network of rat hindlimbs enabling us to 
visualise and quantify the vasculature using microfil enhanced micro-CT 
imaging.  
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The efficiency of the perfusion protocols developed for the vascular injury 
model to fill the vasculature and capillaries with contrast agent was verified 
using histomorphometrical analysis. Furthermore, ImageJ software was applied 
to compare micro-CT and histology images for possible vascular morphology 
changes as well as for testing the efficiency of the developed perfusion 
protocols.  
The sensitivity of this characterised vascular model was tested for 
detecting the changes to the vascular morphometric parameter following injury. 
In addition, the reproducibility and accuracy of the vascular injury model 
obtained from micro-CT evaluation was confirmed using statistical and 
histomorphometrical analysis. 
 
4.2 MATERIAL AND METHODS 
4.2.1 Rat hindlimb injury model 
In the previous chapter, a defined and reproducible experimental CSTT 
model including muscle injuries using rat’s hindlimbs was developed and 
characterised. Here, a vascular injury, as a key element of a CSTT model, is 
characterised based on the standardised protocols for perfusion, visualisation 
and quantification of the vascular network. 
 
4.2.2 Vascular perfusion protocol 
To visualise the vascular network using micro-CT imaging in 3D, standard 
operating protocols (SOP, Appendix D) were developed to perfuse the blood 
vessels effectively with the microfil contrast agent. To achieve this, rats were 
anaesthetised and impacted on the left hindlimb (ROI) to create a standardized 
and reproducible vascular and muscle injury using an impact device (3.2.3). One 
day following trauma, animals were euthanised and prepared for perfusion with 
a contrast agent. Immediately after euthanasia, rats were laid in the supine 
position and the thoracic cavity was exposed.  
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A 22-gauge angio-catheter was inserted into the left ventricle and the 
vasculature was flushed with heparinised-saline (0.9% normal saline and 
heparin sodium (100 U/ml), Pfizer Ltd, NSW, Australia) through this catheter 
using a peristaltic infusion pump (Pump 1: Cole-Parmer, 6-600 RPM, Extech 
Equipment Pty Ltd, VIC, Australia). A vasodilating agent (Papaverine 
hydrochloride, 120mg/10ml, Hospira, VIC, Australia) was used to dilate the 
blood vessels and improve the subsequent contrast agent perfusion. The right 
atrium was punctured to facilitate the drainage of blood.  
Once the flushing of the vasculature was completed and the fluid draining 
through the punctured right atrium appeared clear, the vascular perfusion was 
switched to microfil, a radio-opaque contrast agent (explained in 2.5.1). A 
compound-diluent ratio of 1:2 was used mixed with 10% curing agent by 
employing a second peristaltic pump (Pump 2: 505 U, 220 RPM, Watson Marlow 
Ltd, NSW, Australia) (Figures 4-1 and 4-2).  
The microfil preparation protocols were carried out based on the 
manufacturer’s instructions (Flow Tech Inc 1999). The pump flow rate was set 
to 20 ml/minutes to keep the perfusion pressure low enough to prevent any 
vasculature breakage or leakage. The perfusion continued for 15 minutes until 
the rat’s organs, hindlimbs, feet and tail turned yellow (the colour of microfil) 
indicating a satisfactory perfusion (Figure 4-2). After perfusion, animals were 
stored at 4° Celsius overnight to facilitate the polymerization of the contrast 
agent. The next day, the hindlimbs were dissected and transferred to a 10% 
neutral buffered formalin fixative solution. 
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Figure 4-1: Two schematic views representing set ups for the perfusion protocol.  
Peristaltic pump 1 was used to flush the blood vessels by perfusing the heparinised saline 
(A) and peristaltic pump 2 was utilised for refilling the vasculature with the microfil 
contrast agent (B). 
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Figure 4-2: The designed set ups for perfusing the vascular network. 
These images show the perfusion set-ups for flushing (A) and perfusing the blood vessels 
with the microfil contrast agent (B) using two peristaltic pumps. The organs in their 
natural state after euthanasia appear darker in colour due to the presence of blood within 
the vasculature (C). The perfused organs turned pale during cleansing since blood was 
flushed from the vasculature (D) and then yellow (the colour of microfil) (E) after microfil 
perfusion indicating that the microfil has filled the vasculature. The opened thoracic 
cavity and the microfil contrast agent perfused through the left ventricle and lungs are 
also shown (F).  
 
4.2.3 Vascular visualisation and quantification using micro-CT  
In order to evaluate the vascular network qualitatively and quantitatively, 
the analysis was divided into two steps. Firstly, the whole hindlimbs were 
scanned to observe the 3D vascular network particularly in the area where the 
injury was applied within the region of interest (ROI), which was defined as the 
tissue between the knee joint and the tibia-fibula conjunction. This was used for 
the visualisation of the macroscopic changes to the perfused vascular 
architecture, as well as for confirming the efficiency of the perfusion protocols 
for filling the major blood vessels.  
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Secondly, to visualise the vascular structural changes in more detail and 
for a quantitative assessment of the micro-vascular morphometric parameters, 
corresponding biopsy samples were taken (See 3.2.5) and scanned using micro-
CT from the impacted region in the centre of the ROI. 
 
Micro-CT imaging protocols for the hindlimb scan (ROI) 
For a 3D visualisation of the entire vascular network within the ROI, the 
rat’s injured and non-injured hindlimbs were scanned using a micro-CT imaging 
system (µCT 40, Scanco Medical, Switzerland). Samples were scanned in a 
micro-CT sample tube (Figure 4-3) with an inner diameter of 37 mm at an 
energy of 55 kVp, intensity of 145 µA, integration time of 250 milliseconds and 
at a maximum resolution (isotropic voxels1 size) of 18 µm. The energy and 
intensity values used for the scanning parameters were adapted from the 
literature (Duvall et al. 2004). 
 
 
 
Figure 4-3: A scout view image of the rat’s hindlimb inside the micro-CT tube. 
The position of the rat’s hindlimb including the femur, tibia and fibula as well as the ROI is 
shown within the micro-CT tube.  
 
                                                        
 
 
1 A voxel is a volumetric pixel, a basic element of 3D image. 
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For visualisation and quantification, the 3D image of the vascular network 
was segmented from the surrounding tissue using a threshold of 2072 
Hounsfield units (HU: a standardised computed tomography attenuation 
coefficient) where a value of -1000 HU corresponds to air, 0 HU is assigned to 
water, and 2072 HU is for bone and microfil. In order to reduce noise, a low-
pass Gaussian filter (σ=0.8, support=1) was utilised. The reconstructed images 
were evaluated using Scanco software (Scanco Medical AG, Version 4.05, 
Brüttisellen, Switzerland). In addition, the length of the ROI volume was 
assessed by multiplying the voxel size (isotropic, 18 µm) to the average number 
of micro-CT slices between the tibia notch and tibia-fibula conjunction and 
presented.  
 
Vascular segmentation for the ROI evaluation 
The scanned images contained the vascular network, as well as bone 
including the tibia and fibula. Since the x-ray attenuation of microfil is very 
similar to bone, it was not possible to distinguish the two structures using basic 
thresholding procedures alone. Therefore, for the 3D quantification of the ROIs, 
the entire hindlimb volume including bone and vasculature was scanned and 
evaluated (Figure 4-4). This volume within the ROI was defined as the “total 
segmented volume” (TSV) and is the summation of all segmented elements 
including bone volume (BV) and vessel volume (VV). The BV includes the 
summation of the reconstructed tibia and fibula volumes in the ROI micro-CT 
image. The VV is the total volume of blood vessels surrounding the tibia and 
fibula also segmented in the ROI micro-CT image. The TSV parameter was 
evaluated based on the assumption that the BV maintains a constant volume 
with negligible variations. The hypothesis was that if the BV variation is small 
between the injured and non-injured hindlimbs and also among the  animals, 
then the TSV changes result from variations in the VV. To assess the BV 
variation between animals, the reconstructed bone was digitally extracted from 
the micro-CT image obtained from four rats. This was achieved by manually 
contouring the bone’s outer surface on some sections distributed along the 
length of the bone and then applying a ‘morphing’ tool available in the Scanco 
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evaluation software to interpolate the entire bone surface between two 
manually contoured sections. The vasculature was then eliminated using this 
contouring technique, leaving a 3D segment of bone.  
 
 
Figure 4-4: Micro-CT images of the rat’s hindlimb (ROI). 
A: A greyscale cross-section image of the rat’s hindlimb (ROI) including vascularised 
muscle tissue, tibia and  fibula (green arrows) and microfil-filled blood vessels (red 
arrows) obtained from micro-CT in 2D (x-y plane, voxel size: 18 µm). Since the grey-levels 
of microfil are very similar to bone, during thresholding, bone and vasculature were 
segmented as solids together (B). 
 
The BV values were recorded and presented as Mean ± SD for the non-
injured and injured hindlimbs. This was to ensure that there would not be a 
significant difference between the non-injured and injured hindlimbs and 
consequently, the TSV differences between the injured and non-injured 
hindlimbs are due to the VV differences.  
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The vascular network of the injured hindlimbs within the total ROI volume 
(TV) was quantified for the total vessel volume (TSV) which was compared to 
the non-injured contralateral hindlimbs. The TV parameter was selected as a 
cylinder comprising of the internal diameter of the micro-CT tube cross section 
(37 mm) where the hindlimb was located and also the length which was 
between two anatomical landmarks; the tibia-notch and tibia fibula conjunction. 
Since for each hindlimb, the diameter of the micro-CT tube and the distance 
between these two anatomical markers were constant, the TSV remained 
constant within this volume. Therefore, in this research, the ratio of the TSV/TV 
was not used.  
 
Micro-CT quantification of vascular morphometric parameters (biopsies)  
Since the resolution (voxel size) used for the whole hindlimb (ROI) 
imaging was limited to 18 µm, any capillaries smaller than 18 µm diameter were 
not visualised. Therefore, for a detailed analysis of the microvasculature 
architecture, corresponding smaller biopsy samples were taken from both 
injured and non-injured hindlimbs using a biopsy punch (8 mm diameter) (See 
3.2.5). These smaller biopsy samples could be scanned with the smallest micro-
CT tube providing the highest available resolution (the smallest isotropic voxel 
size) of 6 µm. This method facilitated the visualisation and quantification of 
small micro-vessels and capillaries down to 6 µm diameter. The scanning 
parameters (energy, intensity and the integration time) for the biopsy samples 
were kept the same as the ROI scans, with the exception of the threshold, which 
was adjusted to 1434 HU for better visualisation of capillaries and ultra-small 
blood vessels. To quantify the vascular morphometric parameters, 250 sections 
(1.5 mm) from the biceps femoris region, which was the most affected muscle 
by the injury, were processed using the morphometric evaluation scripts in the 
Scanco software. In the “Scanco evaluation window”, the 250 sections were 
selected from where the vascularised muscle tissue within the cross section of 
the full circular biopsy began (x-y plane where ‘z’ direction indicates the length 
of biopsy sample) (Figure 4-5).  
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Figure 4-5: Selection of a biopsy stack for micro-CT imaging. 
An example showing the selection of the 250 slices from the top section of a biopsy sample 
including the vascular network for quantifying the vascular morphometric parameters 
using micro-CT (voxel size: 6 µm). A: A cross-section of a biopsy stack in 2D showing the 
first selected slice where the vascularised muscle tissue (red arrows) can be seen within 
the x-y plane. B: The cross section of the 250 slices are exhibited in 3D (x-y plane where ‘z’ 
direction indicates the length of biopsy stack) with corresponding vascularised regions 
(red arrows) derived from Image A. C: A 3D image of the 250 slices in the ‘z’ direction (the 
length of the biopsy sample) with corresponding blood vessels (red arrows) derived from 
image A is illustrated.  
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4.2.4 Validation of the vascular injury model following CSTT 
Selecting random histology views 
The histology sections obtained from biopsy samples were prepared and 
H&E stained according to 3.2.5. The H&E histology images were then visualised 
and a grid was superimposed on the image using the Leica Biosystem software 
(Leica Biosystem, NSW, Australia). Each grid was divided into smaller 300µm × 
300µm fields of view and numbered along the ‘x’ and ‘y’ axis. Six randomly 
generated numbered pairs were selected by using Microsoft Excel software 
(2013, Microsoft Corporation, USA) (Figure 4-6). The first number of each pair 
was plotted on the ‘x’ axis of the grid and the second number was plotted on the 
‘y’ axis (Figure 4-6). These six randomly selected fields of view were used for 
histological analysis.  
 
 
Figure 4-6: A gridded histology image and a randomly generated section. 
 A gridded histology image (25×24) captured from an injured hindlimb at day 1 is shown. 
A randomly selected field of view (300µm × 300µm) was chosen by using the ‘random 
number generator function’ within the Microsoft Excel software (x=15, y=2) and is 
exhibited by a black arrow in the image. This method was used throughout this research 
to randomly select each section for histological analysis.  
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It should be pointed out that only the fields of view fully filled with tissue 
were quantified and therefore, the randomised fields of view with no tissue or 
partially filled with tissue were not taken into account.  
 
Determination of the perfusion limit for small blood vessels using VD 
The efficiency of the developed perfusion protocols was tested by 
measuring the smallest diameter capillaries that were filled with microfil. In a 
given histology section, the diameter of the smallest detected capillary per field 
of view was directly measured using ImageJ software (freehand line tool) and 
then the results were presented as Mean ± SD per square millimetre of tissue 
area.  
 
Verification of the perfusion efficiency using VN 
In the micro-CT scans, it is only possible to observe the vessels perfused 
with contrast agent (microfil) and not the total number of blood vessels. 
Therefore, the quantified VN within the micro-CT slices is actually the perfused 
vessel number (PVN). In a histology section, both perfused (filled) and non-
perfused (non-filled) vessels can be identified, making up the total number of 
blood vessels (TVN).  
In this study, the PVN parameter per area of tissue was used for two 
purposes. Firstly, to determine the correlation between the micro-CT and 
histology-derived values. Secondly, to test the efficiency of the developed 
perfusion protocols as a better perfusion means more blood vessels are 
perfused with the contrast agent. Besides the PVN, an additional parameter was 
defined for testing the efficacy of the vascular perfusion protocols. This 
parameter was named the “relative vascular perfusion” (RVP) and was defined 
as a percentage of the PVN over the total number of blood vessels (TVN) 
(summation of filled and non-filled vessels) counted per square millimetre of 
tissue area (RVP=PVN/TVN⨯100).  
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In a histology section, the PVN can be measured manually by directly 
counting the filled vessels, or automatically using tools available for contrast-
enhanced images within the ImageJ software. The automatic measurement of 
the PVN per area of tissue in a randomised histology view is explained in the 
following section. 
 
Automatic PVN measurement using ImageJ 
After transferring the image (JPEG format) into ImageJ, the threshold was 
adjusted (87) to separate the perfused blood vessels from the background. The 
background noise was reduced using the ‘analyse particles’ tool by selecting the 
smallest pixel size to be removed and by applying the ‘de-speckle’ tool.  
The image was then converted to a binary image to facilitate other image 
processing such as filling the partially filled vessels. The reason for this was to 
ensure that during de-speckling, partially filled small vessels were not removed 
from the image. If two or more blood vessels were attached to each other, they 
were separated using the ‘watershed’ tool for precise counting. The image was 
then converted to ‘mask’ and then the PVN counted using the ‘analyse particles’ 
tool (Figure 4-7).  
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Figure 4-7: Counting the perfused vessel number using ImageJ. 
The image processing techniques for counting the perfused blood vessels (orange arrows) 
are illustrated in the images A-C. A: H&E image shown using ImageJ which includes tissue 
structures, perfused blood vessels (red arrows) and non-perfused vessels (green arrows). 
Although the non-filled vessels are called here ‘non-perfused vessels’ for simplicity, there is 
a possibility that they may have been perfused earlier and the microfil has been washed 
away from the vessels due to extensive rinsing. As the microfil contrast agent within the 
blood vessels (black spots) has a higher intensity compared to the surrounding tissue, the 
blood vessels can be separated from the tissue structure. This was carried out by applying 
a threshold to the image to separate the perfused vessels from the background. The image 
was then converted to a binary image to show the blood vessels as black against a white 
background (B). The image processing continued for de-speckling to reduce the level of 
noise, filling the vessels that are partially filled and then separating those that are 
attached to each other. The image was then converted to ‘mask’ to facilitate 
quantification of the vessel number counted per total area using the ‘analyse particle’ tool 
(C). Although a general microfil shrinkage can be observed within the blood vessels, this 
may not affect the blood vessel count as even a small spot is taken into account.  
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Collecting correlated sections between micro-CT and histology 
Correlated sections between micro-CT and histology results were needed 
for validating the PVN parameter. To confirm that correlated sections from 
biopsy samples were collected from the same regions, the first step was to find 
the variability in the biopsy length by averaging the height of the biopsy 
samples (biopsy length) between injured and non-injured hindlimbs. This was 
then followed by collecting the correlated sections from biopsy samples used for 
micro-CT and histological analysis (Figure 4-8).  
 
 
 
Figure 4-8: Correlating the micro-CT and histological slices. 
Image (A) exhibits three main muscle compartments of a biopsy including biceps femoris 
on top, semimembranosus in the middle and gracillis at the bottom (See Figures 2-3 and 
2-4). Image (B) depicts the starting point where the correlated sections have been taken 
from biopsy samples for both histology and micro-CT evaluations. The length of 0.25mm 
(250 µm) was discarded from the top of each sample to ensure the tissue sample filled the 
entire cross section of the image. This length was equivalent to 42 slices with a thickness 
of 6 µm (250µm/6µm=42 slices) for the micro-CT samples and 50 sections with a 
thickness of 5 µm for the histology biopsy samples. In this research, for the micro-CT 
quantification, 250 sequential digital slices were taken from the starting point where the 
biceps femoris was located.  
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Validation of the micro-CT using histology for producing the PVN  
The PVN parameter determined by micro-CT was validated using 
histological assessments by calculating the PVN using ImageJ software between 
two correlated sections obtained from these two modalities (Figure 4-9).  
 
 
 
 
Figure 4-9: The correlated cross sections of a biopsy sample captured from micro-CT and 
histological analysis (H&E).  
The correlated blood vessels (histology: black arrows and micro-CT: red arrows) (A) as 
well as the correlated locations of the muscle compartment which have been identified by 
numbers (B) are illustrated. In the H&E sections (B), the stars indicate a few blood vessels 
that were filled with microfil previously as they could be seen in the micro-CT slice (red 
circles). The microfil in these few vessels may have been washed away during the 
histological process. 
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4.2.5 Statistical analysis for the reproducibility and validity of the vascular 
injury model 
As well as the general statistical analysis explained in 3-2-6, statistical 
approaches were applied for the quantitative validation of the vascular injury 
model following CSTT. These analyses were undertaken to verify the 
reproducibility of the characterised vascular injury model. The sensitivity of the 
vascular injury model to detect vascular morphometric changes was assessed 
based on the significant differences (p < 0.05) between the non-injured and 
injured hindlimbs where the mean values were compared using the two tailed 
Student’s paired t-test for means. However, there are influencing parameters 
that may affect the p value such as sample size and variability in the data.  
Therefore, in these situations, utilising the effect size (ES) within the evaluated 
population can be useful. The ES is defined as the degree of a phenomenon 
occurrence within the evaluated population in which the null hypothesis can be 
rejected. The ES is a non-zero value in which a greater ES value will indicate a 
higher effect of a phenomenon within a population (Cohen 2013). The ES is 
calculated as the difference between two independent mean values of a 
parameter (e.g. the mean values of the injured and non-injured hindlimbs for 
vessel volume) divided by the average of the standard deviations given for two 
independent mean values. The ES is classified into three categories: small, 
medium, and large with given values of .20, .50, and .80 respectively 
representing the degree of effectiveness of a phenomenon or a method (Cohen 
1992). For example, the effect size of 0.8 represents that a method or a 
phenomenon has been highly effective and the effect size of 0.2 shows a small 
effect.  
In this research, the level of correlation and agreement between vascular 
morphometric parameters determined by micro-CT and histological techniques 
was validated according to the approaches described by Lee (Lee et al. 1989) 
and Bland-Altman (Bland et al. 1990) using ICC and the Bland-Altman plot. The 
coefficient of variation was also calculated to determine the reproducibility of 
the vascular injury model following CSTT.  
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The accuracy of the micro-CT based vascular injury model was also 
validated using histomorphometry to determine the correlation and agreement 
between the results obtained from these two independent modalities for 
producing the PVN parameter.  
 
4.3 RESULTS 
In the presentation of the results, the following colour coding has been 
used consistently in bar charts throughout this chapter: 
 
Table 4-1: The colour coding and symbols used for presenting the results.  
 
Colour coding Translation 
Red  The values for the injured hindlimbs 
Blue  The values for the non-injured hindlimbs 
Symbols Translation 
* P values between injured and non-injured pairs (p < 0.05) 
** P values between injured and non-injured pairs (p < 0.01) 
*** P values between injured and non-injured pairs (p < 0.001) 
 
4.3.1 Characterisation of the vascular injury model  
Using micro-CT analysis, the visualisation and characterisation of the 
vascular morphology changes following trauma are presented for the injured 
and non-injured hindlimbs (n=6) one day after trauma. 
 
Visualisation of the total vascular architecture (ROI) 
The 3D vascular anatomy was scanned at a resolution of 18 µm to visualise 
the perfused blood vessels located within the ROI of the hindlimbs where the 
length of the ROI was measured as 23.6 ± 0.9 mm based on the method 
described in 4.2.3. Well-perfused hindlimbs within micro-CT images were 
identified by observing the tree of vascular network including the major blood 
vessels. Perfused hindlimbs with only a few individual perfused vessels with 
microfil indicated a poor perfusion, which caused variability within the data. 
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The vascular network including the main arteries (e.g. arteria poplitea) 
could be visualised in the rat’s hindlimb suggesting that the vascular perfusion 
protocols developed for perfusing the blood vessels with microfil contrast agent 
were optimally performed (Figure 4-10).  
 
 
Figure 4-10: Micro-CT visualisation of the vascular network. 
The 3D micro-CT reconstruction of the vascular network is shown for non-injured 
hindlimbs (medial view, voxel size: 18 µm). Three main arteries including the arteria 
femoralis, arteria poplitea, and arteria caudalis femoris distalis are highlighted. 
 
The 3D reconstructed results of the ROI (Figure 4-11) obtained from six 
rats exhibited a satisfactory perfusion in most cases. However, there were a few 
cases (e.g. Figure 4-11-I) that showed a lower number of perfused vessels that 
may be due to a delay in perfusion. In the ROI evaluation, less perfused cases 
(e.g. Figures 4-11, I, J, K and L) caused a variation within the data and this effect 
could be observed in the non-injured hindlimb of one of these cases (Figure 4-
11-I).  
For this research, the values that caused variability within the data due to 
a known reason (e.g. experimental obstacles) were excluded after a quantitative 
assessment confirmed that their values were defined to be outliers. The data 
was then presented with and without these outlier values to investigate the 
effect of the excluded values on the final results.  
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Figure 4-11: A 3D micro-CT visualisation of the vascular architecture. 
A 3D micro-CT visualisation of the vascular network is shown for the paired hindlimbs 
(ROIs) one day after CSTT (voxel size: 18 µm). A few identified major vessels including 
‘arteria poplitea’ (red arrows) and ‘arteria caudalis femoris distalis’ (yellow arrows) are 
highlighted. Images I and K suggest there are less perfused vessels compared to the others. 
The results obtained from the injured hindlimbs appear to show more blood vessels 
compared to those from the non-injured hindlimbs. 
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The evaluation of Figure 4-11-I suggests that except for a few individual 
large vessels including ‘arteria poplitea’ and ‘arteria caudalis femoris distalis’, a 
connected vascular network can hardly be observed. In addition, while more 
blood vessels and the connected vascular network could be seen in Figure 4-11-
K, the ‘arteria caudalis femoris distalis’ was barely visible. Although the injured 
hindlimbs of these cases indicated more blood vessels (e.g. Figure 4-11-L), 
during the exclusion process of these inconsistent cases, both non-injured and 
injured hindlimbs had to be removed since they were assessed as paired 
hindlimbs.  
Overall, the 3D segmented results of the total vascular network within the 
ROI suggested that more blood vessels could be observed in the injured 
hindlimbs compared to the non-injured hindlimbs one day post trauma (Figure 
4-11).  
 
Quantification of total vessel volume obtained from ROI’s 
As explained, the total segmented volume (TSV) parameter was defined as 
the summation of bone volume (BV) and vessel volume (VV). By assuming that 
BV does not change over time as a result of injury or during healing, it was 
hypothesised that if the BV variation would be small enough among the 
samples, then the TSV may represent the VV changes. The comparisons between 
the extracted BV values obtained from injured and non-injured hindlimbs (using 
methods described in 4.2.3: Vascular segmentation for the ROI evaluation) 
showed no significant differences between these two groups with very small 
values for the coefficient of variation (Table 4-2). This indicates that the TSV 
variations represent the total vessel volume changes within the ROI model, as 
the BV variations are very small. Therefore, the mean value of the BV was 
calculated between the injured and non-injured hindlimbs and presented as one 
value BV=297.6±10 (mm3) for comparisons with the TSV parameter (Figure 4-
12). The absolute and normalised results are presented (scattered and Mean ± 
SD) for the TSV captured from the ROIs of the injured and non-injured 
hindlimbs (Figure 4-13 and Appendix A-2).  
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In this research, six animals was used for the TSV analysis and four 
animals were utilised for the extracted BV values. 
 
 
Figure 4-12: Bone volume evaluation. 
The comparisons between the extracted BV values (n=4) obtained from injured and non-
injured hindlimbs (ROI region) (showed no significant differences (Student paired t-test). 
 
The averaged results obtained from original data indicated significantly 
higher TSV values for the injured hindlimbs compared to the non-injured 
hindlimbs (Figure 4-13-A). To investigate the changes between individual 
paired hindlimbs, the results are also exhibited as scattered data (Figure 4-13-
B). A variability could be observed within the absolute TSV values as 
particularly two cases (5 and 6) (Figure 4-13-B) corresponded to Figures 4-11-I, 
J, K and L indicating lower values compared to the other hindlimbs. One possible 
way to reduce this variability was to present the data as normalised values 
(injured/non-injured⨯100) (Figure 4-13-C). The data obtained from the 
absolute values of the TSV indicated some variation for both non-injured and 
injured hindlimbs. After normalising the TSV data, the coefficient of variation 
reduced to an acceptable level suggesting that the normalised model is 
reproducible (Table 4-2). The data of the non-injured hindlimb of case 5 that 
was less perfused compared to other hindlimbs was assessed to detect whether 
this case met the quantitative criteria of an outlier value explained in 3.2.6. The 
investigation indicated that the TSV value of the non-injured hindlimb of case 5 
(304.1 mm3) was outside the defined band (317-486.1 mm3). Therefore, this 
case was excluded and the results of the five cases were evaluated.  
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Figure 4-13: The quantitative analysis of the TSV. 
The comparisons of the total segmented volume (TSV) results obtained from the ROIs at 
day 1 following CSTT are shown. The TSV results are presented (n=6) as absolute values 
(scattered data and Mean ± SD) between the non-injured and injured hindlimbs (A) and 
(B) and normalised values (injured/non-inured × 100) (C). The bone volume (BV, n=4) is 
illustrated as an average between the non-injured and injured hindlimbs. The TSV results 
suggest significantly higher values in the injured hindlimbs compared to the non-injured 
hindlimbs (p < 0.01, Student paired t-test) (A). Image C indicates that by normalising the 
injured data over non-injured values, the variability in the data has been reduced.  
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The normalised and absolute mean values of the TSV increased after the 
exclusion of the outlier values for the non-injured and injured hindlimbs 
respectively. In addition, after excluding the outlier value, lower CV values 
indicated that the variability within the data reduced (Table 4-2). This suggests 
that this method has reduced the error value since the non-injured hindlimbs 
represented an acceptable level of reproducibility after exclusion. The BV 
parameter with very small CV values indicated a good level of reproducibility. 
The TSV and VV showed to be reliable with acceptable CV values after 
normalising the data. The TSV were also exhibited acceptable CV values after 
exclusion of an outlier value (Table 4-2).   
 
Table 4-2: The evaluation of the coefficient of variation (CV). 
A comparison between the coefficient of variation (CV) obtained from the ROI is presented 
for the original and normalised data as well as the results with outlier excluded values 
collected from the BV, TSV and VV parameters.   
 
CV (%) for the ROI BV TSV VV 
Original data 
Non-injured 2.7 13.9 53.73 
Injured 4.1 20.7 51.7 
Outlier excluded 
Non-injured N/A 9.1 16.6 
Injured N/A 31.0 38.3 
Normalised with no outliers 
(Injured/ Non-injured)100 1.5 7.4 8.5 
 
The differences between the mean values and CVs obtained from the 
normalised data with and without an outlier value were not significant 
suggesting that normalising the data is a robust method for reducing the 
variability of the data. Overall, the TSV results suggest that CSTT has 
significantly induced a higher perfused volume in the ROI of the injured 
hindlimbs compared to the non-injured hindlimbs. As the BV variation was 
small, another alternative to this particular study was to subtract the mean BV 
from each TSV and present the remaining value as VV by assuming that the BV 
does not change over time (after one day).  
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The VV values indicated significantly higher values in the injured 
hindlimbs compared to the non-injured hindlimbs including the outlier value. 
After excluding the outlier value, the results showed less variability for the 
injured hindlimbs compared to the non-injured hindlimbs. The normalised VV 
results were 285.0 ± 236.5% and 179.4 ± 15.3% before and after the outlier 
value was excluded. The CV values also reduced after exclusion of the outlier 
value (Table 4-1). The normalised mean value results presented for the VV 
indicated significantly higher values compared to the normalised TSV mean 
values after omitting the outlier data (Figure 4-14).   
     
 
 
Figure 4-14: The comparisons between the total segmented volume (TSV) and vessel 
volume (VV). 
The comparisons of results between the normalised values (Mean ± SD) of the TSV and VV 
obtained from the ROIs at day 1 following CSTT are shown with (A, n=6) and without (B, 
n=5) the outlier value. The bone volume (BV, n=4) is illustrated as an average between the 
non-injured and injured hindlimbs. The VV results suggest significantly higher values 
compared to the TSV after excluding the outlier value (B, p < 0.001, Student t-test).  
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4.3.2 Microvascular injury visualisation (biopsies) using micro-CT 
The 3D vascular network that was analysed at a high resolution of 6 µm 
obtained from biopsy samples indicated a highly detailed structure including 
capillaries (Figure 4-15) compared to the images obtained from the ROI with 
resolution 18 µm (Figure 4-11). 
 
 
Figure 4-15: The microvascular visualisation obtained from biopsy samples. 
The visualisation of the microvascular structure obtained from 3D cylindrical biopsy 
samples (longitudinal view) using the micro-CT imaging system one day after trauma 
(n=6, voxel size: 6 µm). The left (A, B, C, D, E and F) and right (G, H, I, J, K and L) panels 
indicate paired hindlimbs of three cases which the left column of each panel (A, C, E and G, 
I, K) shows the non-injured hindlimbs and the right columns (B, D, F and H, J, L) exhibit the 
injured hindlimbs. Overall, the qualitative assessments suggested there were more blood 
vessels in the injured hindlimbs compared to the non-injured hindlimbs. However, Image I 
obtained from a non-injured biopsy indicates a lower number of captured blood vessels 
compared to other non-injured biopsy images.  
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4.3.3 Optimising the quantification by defining a cut-off diameter  
In a few micro-CT images obtained from biopsy samples, a small number 
of large blood vessels were noticed that appeared to overshadow the results of 
these samples particularly for the VV and the VD parameters. Although the 
biopsy samples were collected in a defined manner, these large vessels 
randomly appeared in the micro-CT images. Large blood vessels observed in the 
biopsy images could also be identified in the corresponding 2D micro-CT slices 
(Figure 4-16). To reduce this effect, a method was developed as a possible way 
to remove the effect of the large blood vessels on the VV and VD results. To 
achieve this, a vessel diameter “cut-off point” was determined, whereby vessels 
with a diameter larger than this point were removed from the calculations.  
 
 
 
Figure 4-16: Identifying the largest blood vessels in the micro-CT images. 
This example shows a large blood vessel (red arrow) identified in a 3D biopsy image (A) 
and the corresponding vessel detected in a 2D micro-CT slice (voxel size: 6 µm) (B). The 
diameter of this vessel was 204 µm (C). 
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To find a suitable cut-off diameter, two criteria were addressed. One 
criterion was to determine an appropriate cut-off diameter where the 
vasculature below this point would indicate an acceptable coefficient of 
variation for the VD and VV parameters. Another criterion was to determine the 
techniques for recalculating the VD and VV after applying the cut-off method 
and removing the large vessels. The first stage to find a suitable cut-off diameter 
was to identify the diameter range of the large blood vessels. To determine this, 
histograms of the vessel diameter distributions versus their relative populations 
(blood vessels with given diameter as a percentage of entire blood vessel 
population) were plotted for the non-injured hindlimbs (Figures 4-18).  
It should be pointed out that only the non-injured hindlimbs were taken 
into account for this evaluation, since the diameter of the blood vessels in the 
injured hindlimbs may have been affected by the injury (e.g. possible 
vasodilation). 
For simplicity in analysis and comparisons, the vessel diameters of this 
particular histogram were divided into various categories: small, medium, large 
and very large vessels (Figure 4-17). For example, vessels with diameters 
ranging between 6-72 µm that accounted for more than half of the 
microvasculature population (54.5%) were categorised as “small” blood vessels. 
The diameter of 72 µm that was approximately in the middle of the frequency 
distribution was chosen as the midpoint diameter. The next group ranging 
between 72-144 µm (72 µm × 2 = 144 µm) which accounted for 16.5% of the 
vascular population was categorised as medium sized blood vessels. The “large” 
vessels ranging between 144-216 µm (72 µm × 3 = 216 µm) had a population of 
13.8% and the “very large” vessels ranging between 216-294 µm had a 
population of 15.2%. This showed that the small and medium groups together 
contributed towards the majority of vasculature within the biopsy samples 
(71% of the vascular population) while the “large” and “very large” vessels 
together accounted for 29% of the population. The graph shows that the vessel 
population is skewed towards the small microvasculature.  
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Figure 4-17: The vessel diameter distribution versus their population. 
The vessel diameter distribution plotted versus their population is shown for the non-
injured hindlimbs (n=6) at day 1 post trauma (12 week old rats). The categories of the 
vessel diameters along with their populations are also exhibited. 
 
 
 
Figure 4-18: Identifying the largest blood vessels in the micro-CT images. 
An example of a biopsy stack (250 slices) exhibiting two 3D views of the vascular network 
in ‘z’ direction (A), x-y plane (B) and the corresponding histograms of the vessel diameter 
distributions versus their populations (C) (voxel size: 6 µm). The major segment of the 
largest blood vessel (red arrow) ranged between 240-294 µm that indicates that this 
vessel belongs to the category of very large blood vessels (216-294 µm). The images and 
the histogram show that this vessel has a small concentration within the biopsy stack 
compared to other vessel diameters.  
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After applying the cut-off technique and removal the values of the large 
blood vessels from the VV and VD, these parameters were required to be 
recalculated again to obtain their new values without large blood vessels. The 
recalculated VD distributions were obtained through the ‘weighted mean value’ 
of the VD distributions and given as:  
 
where X, is the weighted mean, xi is each individual VD (bin diameter) in 
the distribution range and wi is the non-negative weight. Here the ‘weight’ 
means a constant value representing the quantity of xi within the distributed 
range. The VV parameter was also recalculated as the summation of the 
distributed voxel volumes above the cut-off diameter (Table 4-3).  
 
Table 4-3: The recalculation methods for the VV and VD parameters. 
 The micro-CT quantitative results obtained from a non-inured hindlimb one day after 
CSTT are shown.  
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In Table 4-3, the ‘bin’ means vessel and ‘bin diameter’ shows the 
distribution of the vascular diameter ranges within the biopsy sample. The ‘bin 
count’ represents the frequency distribution of vessels within each diameter 
range and the ‘bin volume’ indicates the volume of the vessels in a diameter 
range within the biopsy sample. Based on these definitions, Table 4-3 shows the 
distribution of the vessel diameter (VD) ranges versus their corresponding 
count, volume, and population (%). This example shows the techniques for 
recalculating the total vessel volume (VV) and VD after applying the cut-off 
technique. The techniques for recalculating the VV (Table 4-3-A) and VD (Table 
4-4-B) after applying the cut-off method are also explained. 
Here, a suitable cut-off diameter was determined to be the largest vessel 
diameter (bin diameter) which was within an acceptable CV level (CV<10%) for 
the recalculated VD and VV parameters. Diameters larger than the cut-off 
diameter had a CV>10%.  
In the example shown in Figure 4-17, various diameters were chosen from 
the defined categories. Since the category of small vessels had the highest 
population, more diameters were selected from this group. These diameters 
were 72 µm (the midpoint diameter and the diameter between the small and 
medium groups), 144 µm (the diameter between the medium and large groups), 
216 µm (the diameter between the large and very large groups) and 294 µm 
(the largest diameter in the frequency distribution). Also, the two diameters of 
50 µm and 100 µm were found from the literature (Bemelmans et al. 2009) to 
be within the microvascular range (the small category). In the frequency 
distribution (Figure 4-17), the closest diameters to 50 µm and 100 µm were 48 
µm and 102 µm so these were selected. The diameter of 78 µm (the midpoint 
between 48 and 102 µm) was also used. The results of the recalculated VD and 
VV parameters obtained from six biopsy samples were compared at cut-off 
diameters 48 µm, 72 µm, 78 µm, 102 µm, 144 µm, 216 µm and 294 µm (Figures 
4-19 and 4-20).  
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Figure 4-19: Determining the cut-off diameter for the vessel diameter (VD). 
The recalculated values for the vessel diameter (VD) parameter are illustrated with (A) 
and without (B) the outlier value at various cut-off diameters (Mean ± SD) at day 1. The 
data suggests that the VD values less than 78 µm indicate considerably lower variations 
compared to the larger cut-off diameters and the exclusion of the outlier value has no 
significant effect on the reduction of the VD variations. 
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Figure 4-20: Determining the cut-off diameter for the vessel volume (VV). 
The recalculated values for the vessel volume (VV) parameter are shown for the original 
(A) and outlier excluded (B) data at various cut-off diameters (Mean ± SD). The 
variability within the data has notably reduced after removal of the outlier value (B) 
particularly for the VV values less than 78 µm.  
 
The results indicate that the VD parameter was not affected by the outlier 
value regarding the VV. Therefore, exclusion of this value did not have a 
significant effect on the VD. The cut-off point of 78 µm showed an acceptable 
level of variability before and after excluding the outlier value compared to 
other cut-off points and the cut-off diameters higher than 78 µm increased the 
CV values. While the mean values for the cut-off points at 144 µm and 216 µm 
showed very close values, the error was smaller at 144 µm (Figures 4-19 and 4-
20, Table 4-4). As the cut-off results suggested that the diameter of 78 µm 
includes most vasculature with an acceptable CV for both VV and VD parameters 
(Figures 4-19 and 4-20, Table 4-4), this cut-off diameter was chosen to be used 
throughout this research. By selecting this cut-off diameter, the evaluations for 
the VV and VD were within the range of microvasculature with a population of 
56%.  
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Table 4-4: Reproducibility of the VD and VV at various cut-off diameters. 
A comparison between the coefficients of variation is presented comparing the original 
data to the results that exclude the outlier values at various cut-off diameters one day 
post trauma. Except for the original VV (real data), the cut-off points of 78 µm and under, 
showed an acceptable level of variability before and after excluding the outlier value.     
 
CV for 
vascular 
parameters 
(%) 
VV 
(Original) 
VV 
(Outlier excluded ) 
VD 
(Original) 
VD 
(Outlier excluded) 
Cut-off 
diameter (µm) 
    
48 0.40 0.06 5.24 3.57 
72 41.14 8.67 6.67 6.58 
78 41.42 9.78 8.18 8.42 
102 41.56 10.71 12.15 13.23 
144 42.06 12.21 17.01 18.65 
216 42.50 13.15 28.66 21.05 
294 44.17 16.81 35.01 37.20 
 
Also, the results indicated that except for the VV values presented for the 
microvasculature smaller than 48 µm with a small CV of 0.4%, the VV values 
obtained from other cut-off diameters indicated a high variability (CV > 10%). It 
appeared that the existence of an outlier value as well as the presence of large 
blood vessels have significantly influenced the variation of the VV data which 
resulted in high CV values. Although applying either the cut-off technique or 
excluding the outlier value reduced the CV for all vascular diameter ranges, the 
CV was still higher than 10%. Using the cut-off point of 78 µm along with 
excluding the outlier value reduced the CV to an acceptable level (CV < 10%) 
compared to other cut-off points. After this point, the CV showed higher values 
(CV > 10%). While the cut-off point of 144 µm and 216 µm reduced the 
variability within the data, the CV values were not within an acceptable level 
(CV < 10%). Although the VV mean values at the cut-off points 144 µm, 216 µm 
and 294 µm showed very close values, the error was smaller at 144 µm. 
The suggested cut-off technique was applied to reduce the variations of 
the VV and VD results. These results were then compared to the VV and VD 
values given by the original data.  
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Since the VV and VD parameters were calculated independently from 
other vascular morphometric parameters (e.g. the VN), applying the cut-off 
point may not significantly affect the analysis of the other vascular 
morphometric parameters. The data showed that the effect of the outlier value 
was more notable on the VV compared to the VD. This may be due to the 
existence of various diameter ranges (bin sizes) distributed within the vascular 
network which has been taken into account for the calculation of the VD 
parameter. However, the VV is calculated as the summation of the voxels 
allocated to the to the diameter distribution (bins). Therefore, the count 
(weight) of these voxels is important as it allocates more volume of voxels 
within these bins. 
Here, the cut-off diameter of 78 µm was obtained from the non-injured 
hindlimbs of 12-week-old rats at day 1 post trauma. To confirm whether the CV 
values obtained for the VV and VD remains in an acceptable range for other 
independent experimental groups after applying the cut-off point of 78 µm, the 
results attained from day 1 were compared with another independent group; 
the non-injured hindlimbs of 16 week old rats 28 days post injury (Figure 4-21). 
The results collected from the rats at day 28 verified an acceptable CV range for 
both VV and VD parameters using the cut-off diameter of 78 µm. 
 
 
 
Figure 4-21: The frequency distribution of the vessel diameter at day 28. 
The vessel diameter distribution plotted versus their population is exhibited for the non-
injured hindlimbs (n=4) at day 28 post trauma (16 week old rats). The graph shows that 
the vessels are skewed towards the small and medium size vessels (e.g. microvasculature 
less than 150 µm) with a higher population compared to the larger vessels.  
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The cut-off evaluation using this group of rats (16 week old at day 28) 
with no outlier value indicated that the maximum cut-off diameter could be 
increased to 120 µm for the VV and to 150 µm for the VD diameter (Figures 4-22 
and 4-23, Table 4-5). Consistent with the cut-off diameter of 78 µm proposed for 
12 week old rats at day 1, the results for the cut-off diameter of 78 µm obtained 
from the 28 day group exhibited an acceptable CV for the VV and the VD 
parameters (Table 4-5). 
 
 
 
Figure 4-22: The recalculated vessel diameter (VD) at various cut-off diameters. 
The recalculated VD values are shown for the non-injured hindlimbs of 16-week-old rats 
at various cut-off diameters (Mean ± SD) 28 days post trauma. The data suggests that the 
VD values less than 150 µm indicate considerably lower variation compared to the larger 
diameters (288 µm). 
 
 
 
Figure 4-23: The recalculated vessel volume (VV) at various cut-off diameters. 
The recalculated values for the VV parameter are presented for the non-injured hindlimbs 
of 16 week old rats 28 days post trauma at various cut-off diameters (Mean ± SD). The 
variability within the data increased for the cut-off diameters larger than 120 µm. 
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Table 4-5: Comparisons of coefficient of variations at various cut-off diameters. 
The values for the coefficient of variation are presented as a percentage for the original 
values of the vessel volume (VV) and vessel diameter (VD) parameters at various cut-off 
diameters at day 28 post trauma. The CV values were within an acceptable range (CV < 
10%) for the cut-off diameter less than 120 µm for the VV and less than 150 µm for the 
VD.  
 
CV for 
vascular 
parameters (%) 
VV 
(original data) 
VD 
(original data) 
Cut-off diameter (µm)   
78 7.30 5.83 
120 9.53 7.25 
150 12.80 9.70 
288 24.06 24.14 
 
4.3.4 Quantification of microvascular morphometric parameters (biopsy) 
The quantitative results for vascular morphometric parameters obtained 
from the biopsy samples including the vessel volume (VV), diameter (VD), 
number (VN), vessel space (VSp), connectivity density (VConn) and degree of 
anisotropy (DA) are presented (Figures 4-24 to 4-29 and Appendix A-3).  
The vascular morphometric results obtained from biopsy evaluations 
suggest that CSTT induces notably higher values for the VV, VD and VConn in the 
injured hindlimbs compared to the non-injured hindlimbs one day after trauma. 
The CSTT effect was not significant for the VSp, VN and DA parameters although 
the VN was lower and the VSp was higher in the injured hindlimbs at day 1 post 
injury. 
It appeared that case 5 of the non-injured hindlimbs was not well perfused 
compared to other hindlimbs and created outlier values for a few parameters 
including the VV, VN and VSp. For example, the VV variability was due to the 
presence of an outlier value that was quantitatively identified as being 0.05 mm3 
that was outside the qualifying band of 0.11-0.63 mm3 based on the defined 
criteria (3.2.6) so was excluded. However, the variability of the VD parameter 
was due to the presence of large blood vessels.  
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Figure 4-24: Comparisons for the vessel volume (VV) parameter.  
The quantitative VV collected from biopsy samples (n=6) are presented for non-injured 
and injured hindlimbs one day after trauma. The original absolute values (Mean ± SD) (A) 
as well as the corresponding scattered data (B) suggested significantly higher values for 
the injured hindlimbs compared to the non-injured hindlimbs (p < 0.05, paired Student t-
test). The variability in the data that can be observed is due to an outlier value (case 5). 
The absolute VV values are also presented after applying the cut-off technique (Mean ± 
SD) (C) and the corresponding scattered data is showing (D). This indicates that the VV 
values obtained from the vessel less than 78 µm exhibit significantly higher values for the 
injured hindlimbs compared to the non-injured hindlimbs (p < 0.01). After the exclusion of 
the outlier value from both the original (E) and the cut-off data (F), the variability 
notably reduced particularly for the non-injured hindlimbs. The results show that the 
variability of the VV reduced by removing the outlier value from the data while the 
injured hindlimbs still indicated significantly higher values compared to the non-injured 
hindlimbs. 
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Figure 4-25: Comparisons for the vessel diameter (VD) parameter.  
The quantitative VD obtained from biopsy samples (n=6) are shown for non-injured and 
injured hindlimbs one day after trauma. The absolute values for the VD collected from the 
original data (Mean ± SD) (A) as well as the corresponding scattered data (B) suggested 
no significant differences between the non-injured and injured hindlimbs. The variability 
in the data can be observed particularly in the non-injured hindlimbs. The absolute VD 
values are also presented after applying the cut-off technique as (Mean ± SD) (C) and the 
corresponding scattered data is showing (D). This indicates that the VD values obtained 
from the vessels less than 78 µm illustrate significantly higher values for the injured 
hindlimbs compared to the non-injured hindlimbs (p < 0.01, paired Student t-test). The 
data variability reduced considerably after applying the cut-off technique.  
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Figure 4-26: Comparisons for the vessel number (VN) parameter.  
The quantitative VN obtained from biopsy samples (n=6) is exhibited for non-injured and 
injured hindlimbs one day after trauma. The absolute values for the VN obtained from the 
original data (Mean ± SD) (A) as well as the corresponding scattered data (C) showed 
lower values for the injured hindlimbs compared to the non-injured hindlimbs. The 
variability in the data reduced notably after excluding the outlier value (non-injured 
hindlimbs of case 5) from the original data (p = 0.1, ES > 0.8) (B).  
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Figure 4-27: Comparisons for the vessel spacing (VSp) parameter.  
The quantitative VSp captured from biopsy samples (n=6) is illustrated for non-injured 
and injured hindlimbs one day after trauma. The absolute values (n=6) for the VSp 
obtained from the original data (Mean ± SD) (A) as well as the corresponding scattered 
data (C) indicated no significant differences between the non-injured and injured 
hindlimbs (p = 0.27). The variability reduced notably after excluding the outlier value (the 
non-injured hindlimb of case 5) from the original data (B). The injured hindlimbs 
displayed higher VSp values compared to the non-injured hindlimbs after excluding the 
outlier value (p = 0.098). 
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Figure 4-28: Comparisons for the vessel connectivity (VConn) parameter.  
The quantitative VConn collected from biopsy samples (n=6) is shown for non-injured and 
injured hindlimbs one day after trauma. The absolute values (n=6) for the VConn obtained 
from the original data (Mean ± SD) (A) as well as the corresponding scattered data (C) 
suggested notably higher values for the injured hindlimbs compared to the non-injured 
hindlimbs (p =0.058,  effect size of 1.2) although this was not statistically significant. A 
high variability could be observed within the data obtained from both non-injured and 
injured hindlimbs. Here, the outlier value was a very well perfused hindlimb (case 3) 
rather than case 5 and by removing this value, the variability within the data reduced 
although this was not significant (p = 0.062) (B).  
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Figure 4-29: Comparisons for the vascular degree of anisotropy (DA) parameter.  
The quantitative DA captured from biopsy samples (n=6) is displayed for the non-injured 
and injured hindlimbs one day after trauma. The absolute values (n=6) for the DA 
obtained from the original data (Mean ± SD) (A) as well as the corresponding scattered 
data (B) showed no significant differences (p = 0.33) between the non-injured and injured 
hindlimbs. The variability in the data was minimal for both non-injured and injured 
hindlimbs.  
 
4.4 VERIFICATION AND VALIDATION  
4.4.1 The reproducibility of the vascular injury model (biopsy) 
In general, some variability was observed in the actual values of the 
vascular morphometric parameters obtained from the biopsy evaluation. After, 
data processing including the exclusion of outlier values and by using the cut-off 
technique, the variability was reduced. The CV values obtained from the original 
and processed data were computed for each vascular morphometric parameter 
and presented in Table 4-6.  
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For example, after data processing, the VV and VD indicated an acceptable 
level of reproducibility (defined in the terminology and applications section) 
with a CV of 9.7% and 8% respectively (Table 4-6). Removing outliers reduced 
the CV for parameters such as VN and VSp to 12% and 11.5% respectively. 
Normalising the data did not significantly reduce the variability of the results.   
 
Table 4-6: The CV values for all vascular morphometric parameters.  
The acceptable values of the CV (red) as well as the values with small variation (blue) are 
shown. 
 
 
 
4.4.2 Perfusion of the smallest capillaries  
One way to test the degree to which the vascular perfusion was successful, 
was to determine the smallest capillary diameter that could be filled with the 
contrast agent (microfil) (4.2.4). The smallest filled capillary that could be 
detected from the histology sections (n=10) had a diameter of approximately 2 
µm, while the average diameter of the ten smallest filled vessels in each 
histological section was 2.96±0.57 µm (Figure 4-30). Considering that the 
smallest capillary diameter in a rat’s hindlimb was reported to be in the order of 
2 µm (Kano et al. 2000), this finding suggested that there is no minimum limit to 
the vessel diameter for a capillary to be filled by contrast agent.  
 
 
CV (%) 
 
Absolute 
values  
Absolute  
values 
after 
outlier 
exclusion 
Normalised 
values 
Normalised 
values after 
outlier 
exclusion 
Absolute 
values after 
cut-off 
  Absolute  
values after 
cut-off and 
exclusion 
Parameter       
VV 46 24 71 58 41 9.7 
VD 38 41 50 52 8 8 
VN 18 12 21 17 N/A N/A 
VSp 20 11.5 22 19 N/A N/A 
VConn 110 92 144 169 N/A N/A 
DA 13 13 20 17 N/A N/A 
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Therefore, capillaries much smaller than the micro-CT resolution (6 µm) 
could be perfused using these methods. 
 
 
 
Figure 4-30: The smallest capillary filled with microfil contrast agent. 
The assessment of finding the smallest capillary filled with microfil contrast agent to test 
the perfusability of the perfusion protocols. The capillary bed filled with microfil contrast 
agent (dark brown stain) captured from histological sections (haematoxylin and eosin 
staining) is shown with yellow arrows (A) within the random histology fields of view of 
the non-injured hindlimb tissue one day after CSTT. The individual diameter values of the 
smallest perfused capillaries with microfil contrast agent as well as the average value 
(Mean ± SD) are presented per area of tissue (B). To determine the smallest capillary 
filled with microfil, the scattered data was sorted from smallest to largest. 
 
Qualitative verification for the efficiency of the perfusion protocols 
As well as being identified in the micro-CT images, the microfil-perfused 
blood vessels could also be identified in histology sections captured from 
biopsies (Figure 4-31).  
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Figure 4-31: Perfused vessels with microfil in a histology image. 
An example of a histology image (haematoxylin and eosin) exhibiting the perfused vessels 
with microfil is presented from a non-injured hindlimb tissue one day after CSTT. This 
image indicates the perfused blood vessels (blue arrows) with the microfil contrast agent 
(dark brown/black spots) and non-perfused vessels (green arrows). The observation of 
perfused vessels qualitatively confirmed that the perfusion protocols were able to fill a 
large number of the blood vessels and the microfil could still be observed within the blood 
vessels after the histological process. However, a general shrinkage of the microfil 
contrast agent could be seen within all perfused blood vessels.  
 
4.4.3 Validation of the micro-CT analysis using histology (biopsies) 
Collecting correlated sections between micro-CT and histology 
Correlated sections between micro-CT and histology modalities were 
needed for validating the PVN parameter. To ensure that correlated sections 
from biopsy samples were collected from the same regions, the average depths 
of the biopsy samples (biopsy length) between injured and non-injured 
hindlimbs was measured (Mean ± SD) and compared (n=18). The calculated 
average depths of the biopsy samples were derived from the non-injured and 
injured hindlimbs and these were calculated as 10.92 ± 1.3 mm and 10.88 ± 1.3 
mm respectively that were not significantly different (Figure 4-32).  
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Figure 4-32: Evaluation of the length (depth) of the biopsy samples. 
The length comparisons between the mean values (Mean ± SD) of biopsy samples (n=18) 
of the non-injured and injured hindlimbs has shown no significant difference between 
these two groups (Paired student t-test). 
 
Quantitative validation between the micro-CT and histology 
To ensure that the results of the perfused vessel number (PVN) per tissue 
area (mm2) obtained from biopsy samples using the micro-CT technique is 
correct, the PVN values were validated using histomorphometrical analysis by 
comparing  the PVN results obtained from two modalities (Figure 4-33). The 
correlation and agreement between the micro-CT and histology for producing 
PVN were analysed using the Intra-class correlation coefficient (ICC) (Table 4-7) 
and the Bland-Altman plot (Figure 4-34).  
 
  
 
Figure 4-33: Validations between micro-CT and histomorphometry for the PVN. 
The comparisons between the individual values of the perfused vessel number per tissue 
area (PVN/mm2) as determined by the micro-CT imaging system and histomorphometry 
for six fields of view showed no significant difference between these two modalities (p > 
0.05) (Student t-test). 
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Table 4-7: Validations between micro-CT and histomorphometry for the PVN. 
The validation factors for the perfused vessel number (PVN/mm2) determined by micro-
CT and histology (H&E). The two modalities have shown significant correlation (p<10E-5) 
with a 95% confidence interval and an ICC value of 0.988 indicating the accuracy of these 
two modalities for the PVN parameter. 
 
Modalities Micro-CT and IHC 
Parameter N Mean ± SD 
(Micro-CT) 
Mean ± SD 
(Histology) 
ICC CI95% ICC P 
PVN /mm2 6 31.8±17 31±16 0.998 0.988-1.0 <10E-5 
Descriptions 
N Sample size 
  
ICC Intra-class correlation coefficient 
CI  Confidence Interval 
P Significance level of correlation coefficient 
 
 
Figure 4-34: Validations between micro-CT and histomorphometry. 
The Bland-Altman plot of differences between micro-CT measurements versus histology 
(H&E) for the perfused vessel number per tissue area (PVN/mm2) obtained from MedCalc 
software. The vertical axis shows the difference between the PVN values produced by 
micro-CT and histology. The horizontal axis exhibits the mean (0.8) of the individual 
measurements for the PVN produced by the two modalities. The blue solid line indicates 
the mean difference, and the red dashed lines show the 95% confidence intervals that 
have been defined as 1.96×SD confirming the level of agreement between the two 
techniques. All measurements have fallen between the two lines of agreement indicating a 
good level of agreement between these two modalities for producing the PVN. 
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4.4.4 Verification of the PVN and RVP using histomorphometry 
To verify the VN results obtained from micro-CT using histomorphometry, 
the blood vessels perfused with microfil contrast agent were quantified in the 
histological sections obtained from biopsy samples. More blood vessels could be 
observed per tissue area in the injured regions at day 1 (Figure 4-35). The 
variation within the data points suggests that the distribution of the PVN was 
not uniform across the histology section.  
 
 
  
 
Figure 4-35: The perfused vessel number (PVN) from histological analysis. 
The individual PVN per tissue area (PVN/mm2) of two biopsy samples obtained from a 
rat’s non-injured and injured hindlimb (six random histological fields of view for each 
biopsy sample). The results indicated higher PVN values for the injured hindlimbs 
compared to the non-injured hindlimbs one day after trauma.  
 
In order to determine the efficiency of the developed perfusion protocols to fill 
the vasculature, we determined the “relative vascular perfusion” (RVP). This 
parameter was calculated as the percentage of the total number of blood vessels 
filled with contrast agent divided by the total number of blood vessels (filled 
and non-filled) counted per tissue area (mm2). The average RVP obtained from 
the analysis of six random views of one histological section revealed that 72 ± 
11% (Mean ± SD) of the vasculature within the non-injured hindlimbs could be 
perfused where the values were within a range of 55.6-89% (Figure 4-36). This 
suggests that the perfusion technique developed for this research successfully 
filled a majority of the blood vessels (72%) within the six field of views that 
 118 
 
were perfused with the microfil contrast agent. In addition, the data suggests 
that the RVP distribution within one biopsy section is not uniform and there 
may be regions that are highly perfused (89%) compared to areas with a 33.4% 
reduction in the RVP (55.6%).  
 
   
Figure 4-36: The relative vascular perfusion (RVP) parameter per tissue area (mm2).  
The RVP parameter was defined for testing the efficiency of the developed perfusion 
protocols for filling the vasculature obtained from the non-injured hindlimbs. The RVP 
parameter was calculated as the percentage of the total number of blood vessels filled 
with contrast agent divided by the total number of blood vessels (filled and non-filled) 
counted within random field of views (n=6) of a histological biopsy section. The results 
suggest that the perfusion technique developed for this research was successful as the 
majority of the blood vessels with an average RVP of 72 ± 11% (Mean ± SD) were perfused 
with the microfil contrast agent within the field of views where the values were within a 
range of 55.6-89%. 
 
Verification of vasodilation using histomorphometry and the VD 
The micro-CT results have suggested a significantly higher VD in the 
injured hindlimbs compared to the non-injured hindlimbs one day after trauma 
(Figures 4-24). The micro-CT results raised the hypothesis that at day 1, the 
higher VD in the injured hindlimbs may be due to vasodilation.  
To verify this hypothesis, 10 micro-vessels with the largest diameters 
were measured within the histological sections (n=6 per group) of the non-
injured and injured hindlimbs at day 1 (Figure 4-37, Appendix A-4).  
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The reason for choosing the largest vessels was because vasodilation is a 
mechanism that mainly occurs within the large blood vessels (Dodd et al. 1993, 
Williamson et al. 2004). 
 
 
 
Figure 4-37: Vasodilation one day after trauma using histomorphometry.  
The diameter of the 10 largest blood vessels (VD) captured from random views of 
histological sections (n=6) obtained from biopsy samples of the non-injured and injured 
hindlimbs of rats are presented (Mean ± SD). These results suggest significantly higher VD 
values for the injured hindlimbs (2.6 times) compared to the non-injured hindlimbs 
(p<10E-6) (Student t-test) that may be due to the effect of vasodilation. 
 
4.4.5 Evaluation of the microfil shrinkage 
During evaluation of the histological sections, a general shrinkage of the 
microfil contrast agent could be observed in all blood vessels (Figure 4-30). To 
quantify this shrinkage in the histology images, the microfil diameter (MD) 
filling the blood vessels was measured as well as the actual diameter of the 
corresponding perfused blood vessels (VD). The shrinkage percentage of the 
microfil was then calculated as 100-MD/VD⨯100 and presented versus the 
actual vessel diameter (Figure 4-38). The results indicated that regardless of the 
diameter of the blood vessel, shrinkage has occurred in all blood vessel 
diameter ranges and that the amount of shrinkage is not dependent on vessel 
diameter. This was confirmed through a comparison of different correlations, 
whereas all resulted in small R2 values (linear correlation: R2 = 0.0202; 
logarithmic: R2 = 0.0652; power: R2 = 0.0493; 2nd and 3rd order polynomials:  R2 
= 0.0618 and R2 = 0.2813,  respectively). 
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Figure 4-38: The microfil shrinkage. 
The microfil shrinkage values (%) versus the actual vessel diameter (VD) for the non-
injured hindlimbs is shown. Regression analysis has shown a small R2 indicating no 
relationship between the VD and the microfil shrinkage.  
 
4.5 DISCUSSION 
Characterisation of the vascular morphology changes following CSTT 
The characterisation of the vascular injury following CSTT was performed 
at two levels. One evaluation was taken from the ROIs that was defined to 
visualise the 3D vascular anatomy of the perfused blood vessels in the whole 
hindlimb where the CSTT was located. Another assessment was made from 
biopsies that were taken from the central areas of the CSTT and scanned with a 
higher resolution for a more detailed analysis of the vascular structure 
particularly at the capillary level.  
In general, the 3D images of the vascular network captured from the ROI 
exhibited a satisfactory perfusion in most cases. The qualitative evaluation of 
the vascular architecture in both the ROI (Figure 4-11) and biopsy images 
(Figure 4-15) revealed notable changes in the vascular network suggesting 
more perfused blood vessels in the injured hindlimbs compared to the non-
injured hindlimbs one day post trauma. The general vascular network including 
the main arteries (e.g. arteria poplitea) obtained from the ROI images were 
comparable with the anatomy of the blood vessels of a rat’s hindlimb as 
presented in the literature (Duvall et al. 2004, Zhuang et al. 2006, Oses et al. 
2009).  
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The 3D quantitative results for total segmented volume (TSV) obtained 
from the ROI has illustrated higher values in the injured hindlimbs compared to 
the non-injured hindlimbs one day following trauma. The TSV parameter is 
mainly comprised of the BV and only a small portion of VV. Therefore, since the 
BV variation was small, to highlight the volume changes of the vasculature, the 
VV was also analysed by subtracting the BV from the TSV. This was 
demonstrated by the small CV where it was assumed that the BV does not 
change over time (after one day).  
Another, physical method to remove the bone from the samples, by 
decalcifying the bone using a mixture of formic acid and formalin has been 
reported previously (Nyangoga et al. 2011). However, due to the susceptibility 
of microfil to exposure of ethanol and solvents (resulting in shrinkage) we did 
not think this was a suitable option for our purposes.  
The VV results also demonstrated significantly higher values for the 
injured hindlimbs compared to the non-injured hindlimbs. These results 
contradicted with the findings from a mouse ischemic model where the authors 
have indicated a reduction in the vessel volume of the injured hindlimbs one 
day after injury (Marks et al. 2013). The reason for differences between the 
findings of this research with those of Marks et al. 2013 may be explained 
through the fundamental differences between the CSTT and ischemia models. In 
ischemia models, the main vessel (arterial femoralis) which is responsible for 
the main VV is completely disconnected and is therefore no longer able to 
provide blood supply to regions more distally from the point of ligation. 
Therefore, until alternative vasculature has been developed that can 
compensate for the loss of perfusion capacity, a lower VV is expected after one 
day. In contrast, in a CSTT model, our results have shown that this vessel 
remains mostly intact and functional, therefore no immediate loss in perfusion 
capacity is expected.  
In this research, the exclusion of an outlier value for the ROI evaluation 
was based on the quantitative assessment of the ROIs.  
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Potentially, poorly perfused hindlimbs including those with major blood 
vessels that have not been filed with microfil (e.g. arteria popliteal and arteria 
caudalis femoris distalis) can be suggested as another possible criterion for 
qualitative exclusion along with quantitative assessments.  
In agreement with the ROI results, the biopsies have also shown a 
significantly higher VV in the injured hindlimbs compared to the non-injured 
hindlimbs one day after CSTT. This may be interpreted that the response of the 
vasculature to trauma was to increase the perfused vessel volume in the injured 
hindlimbs.  
In general, the quantitative assessments of the biopsies suggest that the 
vascular morphology changes one day following CSTT. CSTT caused significantly 
higher values for the VV, VD and VConn in the injured hindlimbs compared to 
the non-injured hindlimbs one day after trauma. Although the CSTT effect was 
not statistically significant for the VSp, VN and DA parameters, the effect size 
was large for both VN and VSp after exclusion of the outlier value. The VN was 
lower and the VSp was higher in the injured hindlimbs at day 1 post injury as 
expected since the VSp is directly correlated to the inverse of the VN.  
In agreement with the VN results, lower capillary density has been 
reported in the injured hindlimbs of a mouse ischemia model one day after 
injury (Couffinhal et al. 1998). 
The changes to the VD derived from micro-CT images may be attributed to 
the effect of vasodilation one day after CSTT (Williamson et al. 2004). The 
vasodilation effect was confirmed at day 1 post injury by further 
histomorphological evaluation suggesting a statically significant increase in the 
VD values of the injured hindlimbs compared to the non-injured hindlimbs. This 
suggests that the vasodilation effect in the injured hindlimbs may have allowed 
a higher perfused volume (VV) through the vasculature of the injured hindlimbs.  
Within a one day difference, a significant increase in the VD along with a 
notable decrease in the VSp have also been shown in the injured hindlimbs of a 
mouse ischemia model 2 days after injury (Nebuloni et al. 2014).  
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These findings aligned with the VD results and contradicted the VSp values 
presented for this research one day after CSTT. 
The developed cut-off technique was found to be an effective method for 
reducing the variability caused by large blood vessels within the evaluation 
volume. Similar patterns of vascular diameter distributions shown in this study 
have been reported in the literature before, confirming a large proportion of 
blood vessels with diameters below 100µm (Boerckel et al. 2011, Uhrig et al. 
2013).  
It should be pointed out that there are other techniques available in the 
literature such as vascular corrosion casting for visualising the 3D of blood 
vessels. In this method, after replacing the vascular network with a 
polyurethane-based casting resin (e.g. PU4ii), the surrounding tissue is removed 
to reconstruct the vascular morphology (Krucker et al. 2006). However, since 
one of the goal of this project was to investigate the muscle injury, none of these 
technique could be used in this research as for the histological analysis, the 
muscle tissue was required to remain intact. 
 
The reproducibility of the injured vascular model 
The capability of the microfil enhanced micro-CT imaging system to 
characterise the vascular network morphology accurately and consistently has 
been demonstrated previously (Duvall et al. 2004, Bolland et al. 2008, Savai et 
al. 2009, Ehling et al. 2014). The reproducibility of the vascular injury model 
with two evaluation methods (ROI and biopsy) was tested. In general, both 
models indicated some degree of variability. 
The CVs obtained from the mean absolute values presented for the TSV 
and VV indicated variability for both non-injured and injured hindlimbs. 
Normalising the data along with excluding the outlier value appeared to 
increase the level of reproducibility to an acceptable level for both TSV and VV 
within the ROI.  
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The vascular injury model obtained from the ROI evaluation was found to 
be reliable and presenting the results as normalised without outlier values was 
shown to be an effective measure to reduce inter-individual variability.  
In addition, the evaluation of the vascular morphometric parameters 
captured from biopsies indicated a high reproducibility of the results after data 
processing including normalising, exclusion of outlier values and application of 
a cut-off technique, particularly for the parameters VV and VD, which had an 
acceptable coefficient of variation. While VN, VSp and DA indicated a small 
variation after data processing, the VConn parameter was highly variable even 
after data processing and therefore, may not be a reliable parameter for the 
characterisation of the vascular injury model.  
 
Validation of the micro-CT accuracy using histomorphometry  
The accuracy of the vascular injury model (biopsies) derived from micro-
CT scans was validated based on the perfused vessel number (PVN) through 
qualitative and quantitative histology in the correlated regions. This was aligned 
with the literature where micro-CT has been acknowledged for producing 
accurate vessel number parameter through correlation with histomorphometric 
results (Savai et al. 2009, Boerckel et al. 2011, Ehling et al. 2014, Nebuloni et al. 
2014). In this research, the PVN was validated as a common key parameter 
between micro-CT and histology because both modalities have independently 
showed higher PVN for the injured hindlimbs. The accuracy of the vascular 
injury model captured from biopsy samples was validated by demonstrating a 
significant correlation between micro-CT and histomorphometry for producing 
the PVN.  
This validation was also confirmed by Bland–Altman’s limits of agreement 
indicating that the measurements have not been affected by systemic bias since 
there were no significant differences between the mean values obtained from 
micro-CT and histology for the PVN parameter, as it had been shown previously 
(Savai et al. 2009, Ehling et al. 2014, Nebuloni et al. 2014). 
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Verification of the perfusion protocols’ efficiency 
Qualitatively, the functionality of the perfusion protocols was verified for 
the vascular injury model (ROI and biopsy) through the identification of the 
vascular network in the micro-CT images.  
The anatomy of the connected vascular network including the main 
arteries (e.g. arteria popliteal) could be also confirmed by comparison with 
corresponding reports in the literature (Duvall et al. 2004, Zhuang et al. 2006). 
The established perfusion protocols were able to fill the vascular network 
successfully so the changes between the injured and non-injured hindlimbs 
could be visually detected one day after trauma.  
Quantitatively, the efficiency of the perfusion methods was confirmed 
using histological biopsy sections through two approaches. In the first approach, 
the “relative vascular perfusion” (RVP) was calculated to determine the 
perfusability of the microfil through the vascular network. The analysis of the 
RVP obtained from histomorphometrical assessments confirmed that the 
perfusion protocols developed for this research were successful to fill a majority 
of the blood vessels (72%) within the non-injured hindlimbs with the microfil 
contrast agent.  
The second approach was to test the efficiency of the perfusion protocols 
by finding the smallest capillaries that could be filled with the contrast agent. In 
this research, the smallest capillary that could be detected as being filled with 
microfil contrast agent in the histology sections was approximately2 µm in 
diameter. This was in agreement with the smallest capillary diameter of 2 µm 
from a range of 2-10 µm previously reported in rat’s hindlimbs (Kano et al. 
2000).  
 
4.5.1 Limitation of the vascular injury model 
In the development and characterisation of the vascular injury model 
following CSTT, limitations were found in both ROI and biopsy evaluations. In 
the ROI evaluation, extracting the bone from the surrounding vascular network 
appeared to be very time consuming and computationally extensive in practice.  
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Due to the large micro-CT file size (25-27 GB for each hindlimb) and lack 
of memory space within the micro-CT system, this technique was not found to 
be logistically feasible for this project. 
Although 3D micro-CT images indicated a satisfactory perfusion for most 
of the blood vessels, there were a few cases that showed a lower number of 
perfused vessels compared to others. A reason for this was a delay in perfusion 
after euthanasia that may be due to blood sampling taken from the left ventricle 
that was conducted prior to starting the perfusion in some of the experiments. 
This experience showed that the time between euthanasia and perfusion is 
crucial and any delay in perfusion can cause a poor perfusion due to the 
blockage of blood vessels with blood clots. 
In general, some variability could be observed in both ROI and biopsy 
assessments. One reason for this was the existence of an outlier value due to a 
delay in perfusion. However, by excluding the outlier value, the results 
improved particularly for the VV.  While normalising the results appeared to be 
useful for reducing the variability, there were cases (e.g. VConn) which were 
irresponsive to this technique and consequently could not be represented as 
reproducible values. A small sample size can be another reason that makes the 
model sensitive to any variation. While collecting the biopsy samples was 
conducted in a defined and reproducible manner, large blood vessels within the 
biopsy samples were randomly captured.  
For a better evaluation of the microvasculature, the assessment of either 
more slices, whole biopsy samples or the completely affected muscle 
component (e.g. biceps femoris muscle) is required. However, this was 
technically not possible due to limitations in memory size and computing power 
of our micro-CT system, which prevented the quantitative analysis of larger 
volumes. Furthermore, the vascular injury model developed was restricted due 
to a general shrinkage of the microfil contrast agent that was observed in all 
blood vessels during microscopic evaluation of histological sections. The 
investigation for the comparisons between the diameter of the correlated blood 
vessels obtained from the micro-CT (microfil diameter) and histology sections 
(actual vessel diameter) showed a considerable shrinkage of the microfil.  
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Therefore, the vessel diameter parameter may not be accurately 
represented in the micro-CT scans, and consequently other parameters related 
to the VD will be affected (e.g. absolute values of the VV). However, there are 
vascular morphometric parameters such as PVN, RVP, VConn and DA that are 
independent from the VD and therefore, are not being influenced by the microfil 
shrinkage. In addition, the VSp parameter obtained from the non-injured 
hindlimbs at day 1 indicated that this parameter is 10.9 times larger than the 
VD. Consequently, the VSp parameter may not be significantly affected by the 
VD variations that are too small compared to the VSp and therefore, the 
shrinkage effect on the VSp is negligible.  
Finally, further analysis revealed that the microfil shrinkage has occurred 
in all diameter ranges of the blood vessels independent of the vessel size. 
Therefore, the comparison results of this research were presented as 
normalised values to reduce the effect of the microfil shrinkage on the findings.  
 
4.5.2 Concluding remarks 
Overall, by establishing the perfusion and micro-CT protocols, the vascular 
injury model following CSTT was developed and characterised to fulfil one of 
the aims of this research. The developed vascular injury model showed the 
ability to detect the changes to the vascular morphometric parameters following 
CSTT one day after trauma. This was confirmed through sensitivity tests to 
identify the differences between the injured and non-injured hindlimbs post 
trauma. Through histomorphometrical analysis and data processing, the 
reproducibility of this model was confirmed.  
As discussed in 4.1, based on the literature (Duvall et al. 2004), it was 
hypothesised that the vascular morphology changes following CSTT and this 
leads to a reduction of these parameters within the injured hindlimbs one day 
after injury. The results of this research confirmed the changes to the 
morphology of the vascular network one day after CSTT.  
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However, the findings of this research suggests that the values of a few 
parameters such as VV, VD and VConn increased following CSTT which 
contradicted the results of similar vascular morphometric parameters reported 
for an ischemia model (Duvall et al. 2004).  
It was expected that this model would be able to distinguish the vascular 
morphometric changes over a longer period of time following CSTT and during 
treatments. Therefore, the next step was to apply the developed methods and 
the results of the vascular injury model to a therapeutic modality (e.g. 
cryotherapy). This was conducted to test the sensitivity of the model for 
identifying the changes to the anatomy of the vascular network in response to 
treatment at various time points that are explained in Chapter 5.  
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Chapter 5: The effect of cryotherapy on 
CSTT and injured vasculature 
5.1 INTRODUCTION 
In the previous chapter, it was demonstrated that contrast-enhanced 
micro-CT imaging is capable of detecting differences in the vascular network 
architecture one day following CSTT. The findings from the literature review 
performed in Chapter 2 (Duvall et al. 2004, Oses et al. 2009) and also results 
presented in Chapter 4 raised a question whether the changes to the vascular 
morphology shown one day after CSTT will continue during the healing period, 
and whether a treatment will affect these changes? 
Therefore, it was hypothesised that the vascular morphology changes after 
CSTT during the healing period and during treatment. To confirm this 
hypothesis and to determine whether the developed methods for the vascular 
injury model would be sensitive enough to detect differences in the effect of 
treatment modalities, the model was tested using cryotherapy for two reasons. 
Firstly, this technique has been acknowledged in the literature (2.6.1) as the 
most commonly used therapy for CSTT treatment (Smith et al. 1993, Smith et al. 
1994, Deal et al. 2002, Schaser et al. 2006, Swenson et al. 2007). Secondly, 
controversies exist regarding the effect of cryotherapy on CSTT healing (Takagi 
et al. 2011) (2.6.2).  
Therefore, the aim was to investigate the effect of CSTT and cryotherapy 
on the vascular morphology over time in rats using contrast-enhanced micro-CT 
imaging. 
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5.2 METHODOLOGY AND STUDY DESIGN 
5.2.1 Sample size analysis  
The sample size was calculated for this research based on the equation 
below where ‘n’ is the sample size, Za is a constant based on the α error (e.g. for 
error of 5%, Za is 1.65), Z1-β is also a constant depending on the power of the 
study (e.g. for a power of 95%, Z1-β is 1.64), σ is the estimated standard 
deviation and μ0-μ is the mean difference (effect size) between the known mean 
value (μ0) and the estimated mean value (Kadam et al. 2010, Rosner 2010). 
 
 
n =
2(𝑧𝛼 + 𝑧1−𝛽)
2
⨯ 𝜎2
(𝜇0 − 𝜇)2
 
 
(5-1) 
 
For example, the sample size for the ratio of the TSV/TV (%) parameter 
with the known mean value of 1.2 from the literature (Oses et al. 2009) and the 
estimated mean value of 1.9 ± 0.3 (non-injured hindlimb in the ROI) gives a 
sample size of 4.  
n =
2(1.65 + 1.64)2 ⨯ (0.3)2
(1.2 − 1.9)2
= 3.9 ≈ 4 
 
Consequently, for micro-CT quantifications including the ROI and biopsy 
evaluations the sample size of n=4 was chosen. Also, the sample size of n=2 was 
determined for verification purposes of the micro-CT results using histological 
analysis. Therefore, in this study, the sample size of n=6 was applied per group 
at each time point (Moding et al. , Melnyk et al. 2008). 
 
5.2.2 Animal preparation and treatment groups  
For this research, 54 male Wistar rats (12 weeks) from the Animal 
Resources Centre, Canning Vale, WA, Australia were used. The experimental 
groups contained a pre-injury group (control group: n=6, day 0) and two post-
injury groups which were randomly divided into sham and icing groups (n=6 
per time point, time points 1, 3, 7 and 28 days).  
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Except for the control group, all rats were anaesthetised and impacted to 
induce a standardized and reproducible CSTT and vascular injury on the left 
hindlimbs within the ROI (e.g. biceps femoris) using an impact device (3.2.3).  
In the icing group, cryotherapy was applied onto the CSTT region based on 
the methodologies described in the literature (Zemke et al. 1998, Jutte et al. 
2001, Takagi et al. 2011). Cryotherapy was carried out five minutes after the 
impact injury was induced while the rats were still anaesthetised. A cylindrical 
ice block (5-cm diameter) was created, by freezing water in a paper cup, and 
was gently applied without compression where the only pressure was the 
weight of the ice block. The ice block was applied for one session to the skin’s 
surface surrounding the CSTT for 20 minutes in a circular motion to ensure that 
ice block covered the entire injured region.  
In the sham group, a 50-ml flat-bottomed beaker comparable with the ice 
block was gently applied to the injury area without compression where the only 
pressure was the weight of the beaker. The beaker was applied at room 
temperature for 20 minutes in the same manner as the ice block to simulate the 
icing method with no cooling. The control group and also the non-injured 
hindlimbs of both sham and icing groups received no injury or treatment.  
Animals were euthanized at days 0 (n=6, uninjured control group), 1, 3, 7, 
and 28 (n=6 for each time point and treatment). For a three-dimensional 
vascular morphological assessment, the blood vessels of euthanised rats were 
flushed with heparinised saline and then perfused with the microfil contrast 
agent using two peristaltic pumps (4.2.2).  
After perfusion, both hindlimbs were dissected, and then the injured and 
non-injured hindlimbs were imaged using a micro-CT scanner for quantifying 
the vascular morphometric parameters including TSV, VV, VD, VSp, VN, VConn 
and DA (4.2.3). The biopsies were then analysed histologically to confirm the 
results derived from contrast-enhanced micro-CT imaging (4.2.4). For this 
study, the histological processes including the section preparation and H&E 
staining were carried out based on the methods described in 3.2.5.  
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Since the developed vascular injury model indicated vasodilation in the 
injured hindlimbs one day after trauma, the effect of icing on the diameter of the 
blood vessels following CSTT was also investigated. The VD was measured one 
day after trauma in both sham and icing groups and then compared according to 
the histomorphometrical analysis. The PVN parameter was also measured 
within the histological sections using the histomorphometrical technique (4.2.4) 
as an indication of angiogenesis and presented as the Mean ± SD for both sham 
and icing groups at different time points. 
 
Qualitative CSTT assessments  
The CSTT was qualitatively evaluated by taking photographs of the skin 
before and after dissection using a digital camera (Sony, DSLR-A330). The 
epidermis and subcutaneous sides of the skin as well as muscles including the 
biceps femoris and gracillis surfaces were assessed for signs of injury and 
presented for all time points.  
 
5.2.3 Statistical analysis  
The statistical approaches applied for this study have already been 
explained in 3.2.6 and 4.3.5.  In addition to these statistical techniques, one-way 
analysis of variance (ANOVA) was used for comparisons of each vascular 
morphometric parameter across the time points. ANOVA analysis was followed 
by a post-hoc test called the Fisher's Least Significant Difference (LSD) to 
identify the significant differences across the five time points for each 
parameter within the different groups.  
The differences between the two treatment groups (sham and icing) were 
analysed using a two-tailed Student T-test assuming equal variances. The 
sensitivity of the vascular injury model to detect vascular morphometric 
changes was assessed based on the significant differences (p < 0.05) between 
the sham and icing groups over time. 
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5.3 RESULTS  
The table below shows the colour coding that was used for presenting the 
quantitative results of this research. 
 
Table 5-1: The colour coding and symbols used for presenting the results. 
 
Colour coding Translation 
Pink  The values for the sham group 
Blue  The values for the icing group 
Green  The values for the control group 
Symbols Translation 
* P values between the sham and icing groups (p < 0.05) 
** P values between the sham and icing groups (p < 0.01) 
*** P values between the sham and icing groups (p < 0.001) 
+ P values between the sham and icing groups (p < 0.0001) 
 
5.3.1 CSTT qualitative and quantitative assessment 
 
Observation of the epidermis and subcutaneous sides of the skin 
The observations of the skin surface (epidermis side) showed no obvious 
haematoma in either sham or icing groups for all time points. Since the 
appearance of the skin’s surface for all hindlimbs was similar, only one example 
is exhibited here (Figure 5-1).  
 
 
 
Figure 5-1: Skin evaluation. 
The observation of the skin (epidermis) from the lateral and medial views exhibited no 
obvious haematoma. The presented images are from day 1 of the sham group. 
 
Lateral View Medial View 
  
 
Injured Non-Injured Injured Non-Injured 
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A mild to moderate swelling and stiffness was palpated in the region that 
the CSTT was induced at day 1 in all groups. Following skin dissection, it was 
observed that unlike the skin surface, the subcutaneous side of the skin 
exhibited extensive haematoma, inflammation and bleeding in all animals at day 
1 post injury. These symptoms reduced in size progressively towards day 3, 7 
and 28 in all groups (Figure 5-2). 
 
Muscle observation after dissection of the skin 
 Observations of the traumatised muscle tissue revealed an extensive 
haematoma, bleeding and inflammation, located in the region where the CSTT 
was induced compared to the non-injured hindlimbs. The CSTT was observed 
on the lateral side of the hindlimb on the biceps femoris muscle (BF) and on the 
medial side of the hindlimb on the Gracilis muscle (GC).  
The injury was severe particularly at day 1 (Grade 4 based on the AO 
classification) in the lateral and medial sides of all hindlimbs for both sham and 
icing groups. Contusions and swelling symptoms decreased in size from day 3 to 
day 28 post trauma in the lateral and medial sides of all hindlimbs for both 
sham and icing groups (Figure 5-2). 
 
 
A 
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B 
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C 
Figure 5-2: Muscle injury evaluation. 
The muscle injury (red arrow) is qualitatively exhibited for the sham (B) and icing (C) 
groups compared to the non-injured (control) group (A). The images of the sham and 
icing groups show the skin (subcutaneous tissue (SC)) and the traumatised muscles 
including biceps femoris (BF, lateral side) and Gracilis (GC, medial side). Extensive 
haematoma and inflammation could be observed at day 1 post injury (grade 4 based on 
the AO classification) which then reduced in size towards day 3, 7 and 28. The yellow 
colour indicates the presence of the microfil in the vasculature.  
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The CSTT was qualitatively graded 4, 3, 2 and 1 at day 1, 3, 7 and 28 
respectively based on the symptoms described in the AO classification (Table 5-
2).  
 
Table 5-2: CSTT and muscle injury descriptions. 
This table represents a comparison between the observed CSTT symptoms at different 
time points and the graded symptoms of the soft tissue injury described by the AO 
classification. CSTT observations confirmed the information given by the AO classification 
and also provided additional information regarding the CSTT syptoms. 
 
The AO description of the muscle 
and vascular injury 
 
Additional CSTT symptoms 
observed in this research 
Grade Symptoms 
 
Time 
points 
Symptoms 
 
 
 
4 
Muscle defect, tendon 
laceration, extensive 
muscle contusion, 
extensive segmental 
vascular injury 
 
 
 
Day 1 
Extensive haematoma in muscle 
tissue and subcutaneous side of the 
skin, muscle laceration, 
inflammation, bleeding, swelling, 
stiffness 
 
 
3 
Considerable muscle 
injury, two compartments, 
localized vascular injury 
 
 
Day 3 
Localised haematoma and 
inflammation in muscle tissue and  
subcutaneous side of the skin, 
possible muscle laceration 
 
 
2 
Circumscribed muscle 
injury, one compartment 
only, isolated nerve injury 
 
 
Day 7 
Small haematoma located mostly 
on one muscle and subcutaneous 
side of the skin 
1 No muscle injury, no 
neurovascular injury 
Day 28 The injury was healed, no obvious 
haematoma or symptoms 
 
The quantitative analysis of the CSTT area 
A quantitative assessment was carried out to determine the changes in the 
inflamed area of the haematoma during the natural healing period and during 
ice treatment over time. The quantitative data obtained from measurements of 
the area of the inflamed regions illustrated a healing trend from day 1 to day 7 
through a reduction in size of the inflamed areas (Figure 5-3, Appendix A-5). In 
addition, the results suggest that icing has significantly reduced the inflamed 
area at day 1. By day 7, the sham group indicated a smaller inflamed area 
compared to the icing group.  
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Figure 5-3: Quantitative evaluation of the CSTT area.  
The quantified changes to the size of the CSTT and muscle injury (inflamed regions) over 
time for both sham and icing groups are shown (Mean ± SD, n=6). A: The evaluation of the 
inflamed regions obtained from the original data (Mean ± SD, n=6) suggested that icing 
has significantly decreased the inflammation at day 1 compared to the sham group (p < 
0.05) (Student t-test). The size of the inflamed areas significantly reduced from day 1 to 
day 7 in both sham and icing  groups. B: The variability within the data reduced after 
excluding the outliers from both sham and icing groups. While the size of haematoma 
significantly reduced in the sham group from day 3 to day 7 (p < 0.05), the icing group 
indicated an increase in the size of the haematoma at day 3 (p < 0.05) and day 7 (ES > 0.8) 
compared to the sham group (B). Since the haematoma was healed at day 28, the 
quantification of the inflamed areas was conducted up to day 7. 
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Several outlier values could be quantitatively detected causing a 
variability within the data at days 1, 3 and 7 in the sham group as well as day 1 
in the icing group.  
After exclusion of the outlier values i.e. from the sham group at days 1 (2.2 
cm2 which was outside the qualified band of 2.8 – 6.5 cm2) based on the defined 
criteria explained in 3.2.6 and equation 3-4, the data variability reduced (e.g. CV 
reduced from 27% to 12%).  
 
5.3.2 CSTT and muscle injury verification using histology 
Haematoxylin and eosin (H&E) stained sections were utilised to evaluate 
the level of muscle damage and regeneration, as well as the degree and location 
of the inflammatory cell influx. The infiltration of inflammatory cells appeared 
in the injured regions (Figure 5-4), possibly indicating macrophages (large 
mononuclear cells) and neutrophils (cells with a complex, lobulated shape 
nucleus) (Tsivitse et al. 2003, Shireman et al. 2006). The degenerated muscle 
fibres were distinguished by a faded staining of the sarcoplasm and reduction of 
nuclei, presence of inflammatory cells in the site of the injury, broken 
sarcoplasm which in some cases was hardly visible, irregular shape and 
disorientation (Grounds et al. 2004, Rüegg et al. 2011). Also, the non-injured 
myofibres were identified by their regular and orientated shape (polygonal 
shape in cross-sections), peripheral nuclei, intact sarcolemma and sarcoplasm. 
 
 
 
Figure 5-4: Inflammatory cell influx in a histology image (H&E). 
A configuration of the inflammatory cell influx (green arrows) within the haematoma is 
shown for the injured hindlimb of the sham group at day 1.   
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Extensive injury of muscle fibres along with the inflammatory cells was 
observed at day 1 post trauma in both the sham and icing groups (Figures 5-5).  
 
 
Figure 5-5: Histological evaluation of the CSTT at day 1. 
Histological cross-sectional images (H&E) of the rat’s muscle following CSTT are shown at 
day 1. The sham group is shown in the left column of the table while the icing group is 
located in the right column. The first row (A, B) shows the non-injured hindlimbs. The 
second row (C, D) shows comparisons between the muscle injury area (left hand side of 
each section) and the benign region (right hand side of each section). The third row (E, F) 
shows magnified images of the second row’s highlighted areas (yellow boxes). Serious 
muscle fibre damage (yellow arrows) in the injured regions was observed at day 1 (E, F) 
compared to the regular and oriented muscle fibres in the benign areas and the control 
hindlimbs of both sham and icing groups. Arrows: (orange: blood vessels, green: 
inflammatory cells, yellow: destructed muscle fibre). The scale bars of the first and second 
rows of each table are 100 µm and those in the third row of each table are 10 µm. 
 
The presence of the inflammatory cells in the site of the injury increased 
particularly at day 3 in the sham group and at day 7 in the icing group (Figures 
5-6 and Figures 5-7). The regenerated muscle fibres could be observed at day 7 
in the sham group while this was delayed in the icing group (Figure 5-7).  
 
Sham group Icing group 
  
Day 1 (Control) 
  
  
Day 1 (Injured) 
Injured Injured 
Injured 
Benign Benign
Injured 
A B 
C D 
E F 
  
The effect of cryotherapy on CSTT and injured vasculature 141 
The tissue was healed in both sham and icing groups at day 28 as a large 
number of matured muscle fibres could be observed with peripheral nuclei 
(Figures 5-8). A few newly regenerated muscle fibres were also detected at this 
time with a centrally located nuclei within the myofibres (Myburgh et al. 2012) 
immigrating to the peripheral sides of the myofibres during maturation.  
 
 
Figure 5-6: Histological evaluation of the CSTT at day 3. 
Histological cross-sectional images (H&E) of the rat’s muscle following CSTT are shown at 
day 3. The sham group is shown in the left column of the table while the icing group is 
located in the right column. The first row (A, B) shows the non-injured hindlimbs. The 
second row (C, D) shows comparisons between the muscle injury area (left hand side of 
each section) and the benign region (right hand side of each section). The third row (E, F) 
shows magnified images of the second row’s highlighted areas (yellow boxes). At day 3, 
the injured muscle fibres had almost cleared in the sham group (C, E) but these could still 
be observed in the icing group (D, F). Also, at day 3, more inflammatory cells could be seen 
in the injured regions of the sham group (C, E) compared to the icing group (D, F). 
Arrows: (orange: blood vessels, green: inflammatory cells, yellow: destructed muscle 
fibre). The scale bars of the first and second rows of each table are 100 µm and those in 
the third row of each table are 10 µm. 
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Figure 5-7: Histological evaluation of the CSTT at day 7. 
Histological cross-sectional images (H&E) of the rat’s muscle following CSTT are shown at 
day 7. The sham group is shown in the left column of the table while the icing group is 
located in the right column. The first row (A, B) shows the non-injured hindlimbs. The 
second and fourth rows (C, D, and G, H) show comparisons between the muscle injury 
area (left hand side of each section) and the benign region (right hand side of each 
section). The third and fifth rows (E, F and I, J) show magnified images of the second and 
fourth row’s highlighted areas (yellow boxes). In general, at day 7, a decrease in 
inflammatory cells (green arrows) and an increase in the blood vessels (orange arrows) 
(G, I) were exhibited in the injured areas of the sham group. Here, the regenerated muscle 
fibres with central nuclei were mostly observed in the boundary region between the 
injured and benign areas (yellow arrow) (C, E). However, the icing group showed a large 
number of inflammatory cells and less blood vessels (H, J) within the necrotic areas at day 
7 where hardly any regenerated muscle fibres could be seen (D, F) within either the 
necrotic region or the boundary between the injured and benign areas. The scale bars of 
the first, second and fourth rows are 100 µm and those in the third and fifth rows are 10 
µm. 
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Figure 5-8: Histological evaluation of the CSTT at day 28. 
Histological cross-sectional images (H&E) of the rat’s muscle following CSTT are shown at 
day 28. The sham group is shown in the left column of the table while the icing group is 
located in the right column. The first row (A, B) shows the non-injured hindlimbs. The 
second row (C, D) shows comparisons between the muscle injury area (left hand side of 
each section) and the benign region (right hand side of each section). The third row (E, F) 
shows magnified images of the second row’s highlighted areas (yellow boxes). At day 28, a 
large number of matured muscle fibres with many peripheral nuclei could be observed in 
the injured regions along with a very few regenerated muscle fibres in both sham and 
icing groups indicating tissue has healed at this time point (C, D, E, F). Arrows: (orange: 
blood vessels, yellow: regenerated muscle fibre, light blue: matured muscle fibre). The 
scale bars of the first and second rows of each table are 100 µm and those in the third row 
of each table are 10 µm. 
 
5.3.3 Vascular injury following CSTT and cryotherapy  
Visualisation of the total vascular architecture (ROI) 
The qualitative observation of 3D images obtained from the ROI suggested 
more blood vessels in the injured hindlimbs compared to the non-injured 
hindlimbs in both sham and icing groups at various time points post trauma 
(Figure 5-9). 
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Figure 5-9: 3D visualisation of the vascular network using micro-CT. 
3D micro-CT visualisation of the vascular architecture is shown for the ROI of the control, 
sham and icing groups at different time points (voxel size: 18 µm). The images of the 
injured hindlimbs appear to have more blood vessels compared to those from the non-
injured hindlimbs. Also, more blood vessels could be observed in the injured hindlimbs of 
the sham group at days 1 and 7 post injury compared to the injured hindlimbs in the icing 
group.  
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Quantification of the total vessel volume ratio obtained from the ROI’s 
The TSV normalised results (Mean ± SD) obtained from the ROI evaluation 
suggest notably higher values for the sham group compared to the icing and 
control groups at days 1, 3 and 7 although these were not statistically significant 
(Figure 5-10, Appendix A-6). The mean values of the TSV for both sham and 
icing groups fell from day 1 towards day 3 and were at the same level at day 28. 
A significant difference between the TSV mean values of the control group and 
both sham and icing groups at day 28 suggested the TSV did not return to pre-
injury values within this time frame. Although the difference in TSV values for 
the injured hindlimbs of the sham group compared to the icing group were not 
statistically significant, the large effect sizes were measured at days 1 (ES > 0.8) 
and 3 (ES > 0.8) as well as a medium effect size at day 7 (ES > 0.5). Also, while 
the TSV values in the sham group reduced from day 1 to day 3 (ES > 0.8) and 
remained steady towards day 28, these values decreased from day 1 to day 7 
followed by an increasing trend towards day 28 (ES > 0.5) in the icing group.  
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Figure 5-10: Total segmented volume (TSV) results obtained from the ROI. 
Normalised values of the TSV obtained from the ROI are presented (n=4) for comparisons 
between both sham and icing groups (TSV%=injured/non-injured×100) at various time 
points. The results suggest that icing has significantly reduced the TSV values at days 1, 3 
and 7 compared to the sham group (Paired Student t-test). Both sham and icing groups 
indicated significantly (p < 0.01) higher TSV values at day 1 compared to the control 
group followed by a notable decrease at day 3 where this was significant for the icing 
group (p < 0.05). Both sham and icing groups showed considerably higher values (p < 
0.01) compared to the control group at day 28 suggesting these did not return to the 
original values prior to injury (ANOVA).  
 
5.3.4 The reproducibility of the micro-CT results obtained from the ROI 
evaluation 
The CV values presented for the TSV parameter obtained from the micro-
CT based ROI evaluation indicated that nearly 89% of all results (100% for the 
sham group and 75% for the icing group) exhibited either a good or acceptable 
level of reproducibility for both sham and icing groups at days 1, 3, 7 and 28 
(Table 5-3).  
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Table 5-3: The CV results for the TSV parameter. 
The CV values are presented for the TSV parameter obtained from the ROI evaluation. The 
acceptable values of the CV (red) as well as the values with a small variation (black) are 
shown.  
 
 
 
5.3.5 Microvascular injury visualisation (biopsies) using micro-CT 
The 3D vascular network which was studied at a high resolution of 6 µm 
for the biopsy samples displayed a highly detailed structure capturing more 
capillaries compared to those obtained from the ROI with a resolution of 18 µm 
(Figure 5-11). 
 
 
CV (%) 
ROI (Real data) 
Day 0 Day 1 Day 3 Day 7 Day 28 
Control 3.0     
Sham  8.5 8.0 3.0 7.0 
Icing  7.7 1.7 13.0 3.8 
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Figure 5-11: Micro-CT visualisation of the microvascular morphology. 
The microvascular structure of 3D biopsy stacks (transversal view) was visualised using 
the micro-CT imaging system and is shown for three groups (control, sham and icing) at 
different time points (n=4, voxel size: 6 µm). Overall, the qualitative assessments 
suggested more blood vessels in the injured hindlimbs compared to the non-injured 
hindlimbs. Also more blood vessels could be observed at day 1, 3 and 7 in the sham group 
and surprisingly in the icing group at day 28. The colour coding shows that most of these 
vessels have a dark blue to black colour suggesting that these vessels are within the range 
of very small blood vessels and capillaries.  
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5.3.6 Quantifications of microvascular morphometric parameters (biopsy) 
The micro-CT results for the quantified vascular morphometric 
parameters obtained from biopsy samples are presented (Mean ± SD, n=4) as 
normalised values (non-injured/injured×100) (Figure 5-12 to 5-17 and 
Appendix A-8). It should be pointed out that although both sham and icing 
groups at various time points indicated a satisfactory perfusion, there were a 
few cases from days 1, 3 and 7 that appeared to be poorly perfused due to a 
delay in perfusion. These cases were excluded from data after they were 
quantitatively identified to be outliers. The data was then presented with and 
without the outlier values to assess the effect of these values on the results.  
 
 
Vessel volume (VV) 
The original normalised values of the VV indicated some variability due to 
the presence of outlier values and large blood vessels. The results improved 
after the data processing and notable effect sizes could be seen between the 
groups at various time points even though the differences between mean values 
were not statistically significant. After exclusion of the outlier values, not only 
did the data variability reduce but also the differences between the sham and 
icing groups exhibited a notable effect size (e.g. ES > 0.8 at day 1, sham group). 
For instance, after excluding the outlier value of 2278.9% which was outside the 
qualified band of -605.8-2073.1%, based on the defined criteria (3.2.6, equation 
3-4) from day 7 of the sham group, the CV reduced from 121% to 20%. Although 
the differences between and within the sham and icing groups were not 
statistically significant, the effect size was large. For example, while the sham 
group showed a large effect size (ES > 0.8) compared to the icing group at day 7, 
this reversed at day 28 (ES > 0.8). Both sham and icing groups showed notably 
higher VV values at day 1 compared to the control group (ES > 0.5 and ES > 0.8 
respectively). The VV values reduced from day 1 towards day 3 (ES > 0.8) which 
was followed by an increasing trend from day 3 to day 7 (ES > 0.8) and then 
again towards day 28 (ES > 0.5).  
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Figure 5-12: The results for the vessel volume (VV) parameter.  
The normalised values for the VV parameter captured from biopsy samples are presented 
(n=4) for the sham, icing and control groups at various time points. A: The normalised 
values of the VV obtained from the original data (Mean ± SD) indicated significantly (p < 
0.001) higher VV values for the sham group compared to the icing group at day 3 (A). The 
VV values reduced from day 1 towards day 3 which was followed by an increasing trend 
from day 3 to day 7 and then again towards day 28. After exclusion of the outlier values 
(e.g. day 7 of the sham group) the data variability reduced (B). Also, a reduction in the VV 
from day 3 to day 7 could be observed in the sham group. The variability due to the 
presence of the large blood vessels within the biopsy samples was also reduced by 
applying the cut-off technique to the data with the excluded outliers (C). Overall, the 
results suggest an increasing trend from day 1 to day 7 for the VV values followed by a 
decreasing pattern towards day 28 in the sham group (C). However, the icing group 
indicated an increasing trend from day 1 to day 28. After data processing, while the icing 
group indicated lower VV values compared to the control group at day 1, this was 
considerably higher in the sham group (C) (Student t-test and ANOVA). 
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However, the VV increase at day 1 remained steady in the sham group 
until day 7 which was followed by a decrease towards day 28 (ES > 0.8). In 
addition, by applying the cut-off technique to the data with the excluded 
outliers, the variability due to the presence of large blood vessels within the 
biopsy samples was also reduced (e.g. CV reduced from 65% to 20% at day 28).  
 
Vessel diameter (VD) 
 
   The original normalised values for the VD parameter indicated some 
variability due to the presence of large blood vessels within the biopsy sample 
affecting the VD results. This variability was reduced considerably after 
applying the cut-off technique (e.g. CV reduced from 45% to 8.5% at day 28) 
where different results could be observed between the original and cut-off data. 
For example, the VD results showed slightly higher values for the icing group 
compared to the sham group at day 1 (ES > 0.2), however, after applying the 
cut-off technique this outcome was reversed. The original data illustrated higher 
VD values in the sham group at days 3 (ES > 0.8) and 7 (ES > 0.5) compared to 
the icing group. Compared to the control group, the original data showed that 
the VD values of the sham group reduced at day 1 (ES > 0.5) followed by an 
increase towards day 7 (ES > 0.5) where again the VD decreased to the values 
below the control group at day 28 (ES > 0.8). In addition, in the icing group, the 
VD reduced from day 1 to day 3 (ES > 0.8) followed by an increase towards day 
7 (ES > 0.8) and again a decrease in the values below the control group at day 28 
(ES > 0.5).  
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Figure 5-13: The results for the vessel diameter (VD) parameter. 
The normalised values for the VD parameter from biopsy samples are illustrated (n=4) for 
the sham, icing and control groups at various time points. While the normalised data of 
the VD captured from the original data (Mean ± SD) indicated slightly higher values for 
the icing group compared to the sham group at day 1 (ES > 0.2), this was higher in the 
sham group at days 3 (ES > 0.8) and 7 (ES > 0.5) (A). However, a variability within the 
data was reduced after applying the cut-off technique (e.g. at day 7 in the sham group) 
(B). B: The cut-off results suggest higher VD values for the sham group at days 1 (ES > 0.2) 
and 7 (ES > 0.5) compared to the icing group where no significant differences could be 
detected at days 3 and 28. Both sham (ES > 0.8) and icing (P < 0.05) groups indicated 
significantly higher VD values compared to the control group at day 1. The VD values of 
the sham (ES > 0.8) and icing (P < 0.05) groups notably decreased from day 1 to day 3 
followed by an increase from day 3 towards day 7 (ES > 0.2). The VD values of both sham 
(ES > 0.8) and icing (ES > 0.5) groups reduced from day 7 towards day 28 where these 
values were lower than the control group (Student t-test and ANOVA). 
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Vessel number (VN)  
The normalised results of the VN collected from the original data  
indicated higher values for the sham group at days 1 and 3 (ES > 0.8) and for the 
icing group at day 28 (ES > 0.8). The comparisons with the control group 
revealed that the VN values in the icing group notably reduced at days 1 (ES > 
0.8) and 3 (ES > 0.5) followed by an increasing trend towards day 7 (ES > 0.8) 
and then to higher values than the control group at day 28 (ES > 0.5). In the 
sham group, the VN values increased to higher values than the control group at 
day 28 (ES > 0.8). 
 
 
 
 
Figure 5-14: The results for the vessel number (VN) parameter. 
The normalised original values (Mean ± SD) for the VN parameter from biopsy samples 
are shown (n=4) for the sham, icing and control groups at various time points (Student t-
test and ANOVA). 
 
  
 154 
 
Vessel spacing (VSp)  
The normalised results of the VSp obtained from the original data 
indicated higher values for the icing group compared to the sham group at days 
1 and 3 (ES > 0.8). The comparisons with the control group exhibited that the 
VSp values notably increased for the icing group at days 1 and then 3 (ES > 0.5) 
followed by a decreasing trend towards day 7 (ES > 0.8) and then to lower 
values than the control group at day 28 (ES > 0.5). In the sham group, the VSp 
values did not show significant changes compared to the control group at earlier 
time points until day 7 where the VSp reduced to lower values than the control 
group at day 28 (ES > 0.8). 
 
 
 
Figure 5-15: The results for the vessel spacing (VSp) parameter. 
The normalised original values (Mean ± SD) for the VSp parameter from biopsy samples 
are displayed (n=4) for the sham, icing and control groups at various time points (Student 
t-test and ANOVA). 
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Vessel connectivity (VConn)  
The normalised original values of the VConn indicated a high variability 
due to the presence of three outliers that could be observed within the data 
particularly in the sham group at days 1, 3 and 7 (e.g. 22154.7% which was 
outside the qualifying band of -4796.7 - 20867.0 % at day 1) based on the 
defined criteria (3.2.6, equation 3-4).  
 
 
 
Figure 5-16: The results for the vessel connectivity (VConn) parameter. 
The normalised original values for the VConn parameter captured from biopsy samples 
are presented (n=4) for the sham, icing and control groups at various time points (A). 
After exclusion of the outlier values, the normalised  values of the VConn (Mean ± SD) 
indicated higher values for the sham group compared to the icing group at days 1 (ES > 
0.8), 3 (ES > 0.8) and 7 (ES > 0.2) (B). The increased VConn values at day 1 reduced over 
time towards day 7 and then gradually increased towards day 28 for both sham and icing 
groups (Student t-test and ANOVA). 
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Degree of anisotropy (DA)  
The normalised values of the DA collected from the original data  
suggested significantly higher values for the sham group compared to the icing 
group at days 1 (ES > 0.8) and 3 (p < 0.05) post trauma. However, the icing 
group indicated higher DA values compared to the sham group at day 28 (ES > 
0.8). While the icing group indicated a decrease in the DA values from day 1 to 
day 3 (ES > 0.8), this increased towards day 7 (ES > 0.8) but then reduced again 
at day 28 (ES > 0.8). In the sham group, the DA values indicated a dramatic 
increase compared to the control group at day 1 (ES > 0.8) followed by a 
decrease towards day 3 (ES > 0.5). The DA values increased again at day 7 in the 
sham group and then significantly reduced at day 28 (p < 0.001). Although a 
small variation could be observed with the data particularly at day 1, no outlier 
value could be detected. 
 
 
 
Figure 5-17: The results for the vascular degree of anisotropy (DA) parameter. 
The normalised values (Mean ± SD) for the DA parameter obtained from biopsy samples 
are illustrated (n=4) for the sham, icing and control groups at various time points 
(Student t-test and ANOVA). 
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5.3.7 The reproducibility of the results obtained from the biopsy 
evaluation 
The data showed that the DA, VN and VSp were robust parameters compared to 
the other vascular morphometric parameters as their variations were small and 
no outlier value could be detected within the data. In addition, it was confirmed 
that the DA parameter was the most reliable parameter since the CV results 
indicated that 60% of the measurements were in an acceptable range (CV < 
10%) and 20% of the results exhibited a low level of variability (CV = 11.5%). 
The VD after applying the cut-off technique and excluding the outlier value 
showed an acceptable range of reproducibility in most cases (60%). However, 
the VV and VConn were more sensitive than the other vascular morphometric 
parameters particularly the VConn that illustrated a high level of variability 
even after excluding the outliers. Overall, the CV results suggest a significant 
improvement towards day 28 (Table 5-4).  
 
Table 5-4: The CV results for the vascular morphometric parameters. 
The CV values are presented for the vascular morphometric parameters obtained from the 
normalised processed results of the biopsy evaluation after excluding the outliers and 
large blood vessels in the sham group at various time points. The acceptable values of the 
CV (red) as well as the values with small variation (blue) are shown.  
 
 
 
CV (%) 
 
Day 0 Day 1 Day 3 Day 7 Day 28 
Parameter      
VV 42.2 37.5 30.9 19.0 19.7 
VD 7.8 15.2 9.9 16.2 8.5 
VN 22.0 16.0 18.7 18.0 7.0 
VSp 26.0 16.4 22.8 31.3 6.6 
VConn 103.3 89.9 104.2 62.0 113.0 
DA 11.5 18.7 9.6 4.7 6.4 
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5.4 VERIFICATIONS 
Verification of vasodilation using the VD 
The micro-CT results have suggested a higher VD in the injured hindlimbs 
of the sham group compared to the icing group (Figures 5-14). Through the 
developed vascular injury model, the effect of vasodilation was confirmed one 
day after trauma after comparisons between the injured and non-injured 
hindlimbs.  
To investigate whether the vasodilation effect is influenced by 
cryotherapy, the VD was measured in the non-injured and injured hindlimbs of 
the sham and icing groups and at day 1 using histology images (n=10) according 
to the methodologies described in 4.5.4. The VD values were then normalised to 
the non-injured limb and presented (Mean ±SD) (Figure 5-18 and Appendix A-
7). 
 
 
Figure 5-18: Indications of vasodilation using the VD. 
 The effect of icing on the diameter of the large blood vessels (VD) captured from random 
histology sections (n=10) of the biopsy samples is presented (Mean ± SD). These 
normalised VD results represent the comparisons between the sham and icing groups at 
day 1. This image suggests that cryotherapy following CSTT has significantly decreased 
the vasodilation effect through the reduction in VD values (1.7 times) in the icing group 
compared to the sham group (p < 10E-9) (Student t-test). 
 
The comparisons between the sham and icing groups for the VD indicated 
that icing has significantly reduced the vasodilation effect following CSTT.  
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5.4.1 Angiogenesis indication using the PVN over time 
The blood vessels perfused with the microfil contrast agent were 
identified and quantified in histological sections obtained from biopsy samples 
of both sham and icing groups. More blood vessels could be observed per tissue 
area in the injured regions of the sham group compared to the icing group at 
each time point (Figure 5-19 and Appendix A-9).  
 
 
 
Figure 5-19: The perfused vessel number (PVN) per tissue area (mm2).  
The PVN captured from 2D histological sections of the biopsy samples (n=6) (Mean ± SD) 
for the non-injured (control) and injured hindlimbs of both sham and icing groups. The 
results indicated higher values for the injured hindlimbs of the sham group compared to 
those in the icing group that was significant at days 1, 3 and 7 (p < 0.05). Since the 
differences between the mean values of the control hindlimbs were not significant (p > 
0.05), only an average of these mean values is presented (Student t-test and ANOVA). 
 
Another angiogenesis indication using vWF 
In addition to this research, the von Willebrand Factor (vWF) which is a 
commonly used angiogenesis marker (Starke et al. 2011) was investigated 
through immunohistochemistry (IHC) analysis. vWF is an endothelial cell 
marker synthesized by endothelial cells of both pre-existing and newly formed 
blood vessels and is used for studying angiogenesis/neovascularisation (Starke 
et al. 2011). The methodologies for vWF staining are given in Appendix B.  
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The initial results of the vWF expression are presented in Figure 5-20 
suggesting more blood vessel (capillaries) at day 3 and 7 in the sham group 
compared to the icing group.. While initial results for vWF expression were 
promising, further optimisation is required to suppress the non-specific 
background staining. Even though the vWF staining was accompanied with 
background artefacts, the initial results have shown more blood vessels stained 
with the vWF at day 3 and 7 following CSTT, which seemed to support the 
occurrence of angiogenesis.  
 
 
Figure 5-20: The positively stained blood vasculature with the vWF antibody 
The positively stained blood vessels and capillaries with the vWF antibody (red arrows) 
using immunohistochemistry staining are presented for the negative control and injured 
hindlimbs. Images are from muscle samples collected from the sham (left column) and 
icing (right column) groups at 1, 3 and 7 days post injury. More blood vessel (capillaries) 
could be detected at day 3 and 7 in the sham group compared to the icing group. The scale 
bar for all images is 10 µm. 
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5.5 DISCUSSION 
5.5.1 The effect of cryotherapy on muscle injury following CSTT  
While icing may reduce the swelling (Deal et al. 2002) and haematoma 
(Swenson et al. 2007), the results of this research suggest that this therapeutic 
modality may delay healing of the injured tissue at earlier time points. 
Regarding muscle injury, the delay in tissue healing following cryotherapy is 
supported by another study on the effect of icing on CSTT reported by Takagi 
and colleagues (Takagi et al. 2011). The authors have concluded that as muscle 
temperature was reduced by more than 15°C due to cryotherapy, there was a 
delay in the degeneration of the necrotic muscle fibers for 12 hours following 
injury. The authors also concluded that early cooling of the tissue delayed the 
macrophage influx into the skeletal muscles, causing the impairment of both 
muscle degeneration and regeneration in the injured region of the icing group 
compared to the sham group.  
Contrary to their results indicating the initiation of muscle fibre 
regeneration in rats at days 3 and 4 (sham group), this research could hardly 
find any regenerated muscle fibres at day 3, but they were present at day 7. 
Furthermore, in a rat’s trauma induced hindlimb, the temperature difference 
between the cooling object and the skin has been shown to be small (2oC) 
(Schaser et al. 2006). For example, the rat’s skin temperature was reported to 
be 10oC after superfusing cold saline at 8oC through the skin for 20 minutes 
using a needle probe (Schaser et al. 2006). Also, the results of a recent clinical 
study did not support the application of cryotherapy for muscle recovery after 
damaging exercise since icing was found to be ineffective in reducing the muscle 
soreness (Crystal et al. 2013). 
The time points chosen for this research were based on the critical events 
following CSTT during the healing phases of muscle injury including 
destruction, regeneration and remodelling (Järvinen et al. 2005, Claes et al. 
2006, Smith et al. 2008).  
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For example, the initiation of angiogenesis at day 3 (Orbay et al. 2013) and 
muscle fibre regeneration at day 7 (Desgranges et al. 1999) have been identified 
as important events that occur following ischemic muscle injuries.    
The visual macroscopic observation of the muscle injury suggested that 
the CSTT created extensive acute symptoms such as haematoma and 
inflammation at earlier time points (destruction phase). These symptoms 
decreased in size from day 1 to 28 with no obvious haematoma at day 28 for 
both sham and icing groups (repair and remodelling phase). These results 
aligned with other reports verifying early acute symptoms such as inflammation 
and swelling in the first few days (destructive phase), muscle regeneration at 
day 7 (repair phase), and healing of the necrotic tissue at day 28 (repair and 
remodelling phases), with no more visible swelling (Huard et al. 2002, Winkler 
et al. 2011).  
Quantitative analysis has confirmed the qualitative findings regarding the 
reduction in size of the injury from day 1 to day 7 for the sham and icing groups 
suggesting healing after CSTT. These findings were aligned with the wound 
healing process of the muscle injury and the time course (Huard et al. 2002). In 
addition, the quantitative results suggested that icing had notably reduced the 
haematoma at day 1 compared to the sham group. This finding supported other 
reports in the literature regarding cryotherapy decreasing the inflammatory 
reactions after soft tissue injury and also delays in haematoma formation 
(Swenson et al. 2007). However, at days 3 and 7, the reduction in the size of the 
haematoma was more pronounced in the sham group compared to the icing 
group. Since no obvious haematoma could be observed at day 28, the 
quantitative evaluations were only conducted up to day 7.  
The findings from the CSTT observations were qualitatively verified with 
microscopic assessments using histology (Shireman et al. 2006). This evaluation 
was carried out by the identification of inflammatory cells as well as the level of 
muscle injury and its progressive improvement from day 1 to 28.  
Similar to the descriptions reported for traumatised muscles in a rat crush 
injury model (Winkler et al. 2011), the histological analysis of the muscle injury 
following CSTT has confirmed the underlying serious damage to the muscle 
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fibres in the regions where the haematoma was originally located. The injured 
regions appeared in the histological images displaying extensive muscle damage 
along with the presence of inflammatory cells that potentially indicate necrosis 
as described in the literature (Radley et al. 2008) at day 1 and 3 following CSTT 
in both sham and icing groups. The histological observations suggest that the 
acute CSTT symptoms may be due to extensive muscle injury and tissue 
destruction following trauma. The muscle injury was accompanied by 
inflammatory cell influx that may explain the reason for inflammatory reactions 
and swelling (Järvinen et al. 2005). The damaged muscle fibres had mostly 
disappeared by day 7 and were replaced with regenerated muscle fibres with 
centred nuclei (Winkler et al. 2011) in the sham group whereas this procedure 
was delayed in the icing group. The healing of the muscle injury was identified 
by maturation of the regenerated muscle fibres (central nuclei) (Carlson 1973) 
into the larger muscle fibres with a peripherally located nuclei (Novak et al. 
2014) 28 days post trauma. In the sham group, the mature muscle fibres were 
more organised, larger and closer together (remodelling phase) (Järvinen et al. 
2007) compared to the icing group. 
Overall, the outcomes of the CSTT characterisation over time suggest a 
trend of injury improvement for the sham group while icing appeared to delay 
the healing process.  
 
5.5.2 The effect of CSTT and cryotherapy on the vascular injury 
The evaluation of the vascular injury following CSTT and cryotherapy (at 
two levels) allowed a 3D assessment of the vascular network for the whole 
hindlimb where the CSTT was located (ROI), as well as a detailed analysis at the 
capillary level (biopsy) over time. As it was hypothesised, the qualitative and 
quantitative evaluation of the vascular architecture from both ROI and biopsy 
samples revealed notable changes to the vascular network following CSTT and 
cryotherapy for all time points. These findings supported the results reported 
for ischemia models indicating vascular morphometric changes such as the VV, 
VD, VN, VSp and DA following injury at various time points (Duvall et al. 2004, 
Oses et al. 2009). 
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The 3D quantitative results obtained from the ROI suggested that CSTT 
induces higher TSV values at days 1, 3, 7 and 28 compared to the uninjured 
control group. These findings were also aligned with the higher VV values in the 
injured hindlimbs compared to the control groups at days 3, 7 and 28 described 
for ischemia models (Duvall et al. 2004, Oses et al. 2009). 
This increase was reduced by ice therapy at days 1, 3 and 7 compared to 
the sham group; however, by day 28 after injury, no significant differences could 
be seen between these groups. The TSV results presented for day 28 did not 
suggest a return to the original values prior to CSTT as the values were still 
significantly higher than those for the control group. Since day 28 was the latest 
time point in these conducted experiments, it is unknown whether after 28 days 
the TSV values would have reduced back towards the original values prior to 
injury.  
In agreement with the ROI results, data for the biopsies also showed that 
CSTT has caused a higher VV in the sham group compared to the control group 
at day 1, 3, and 7 while icing has significantly induced a lower VV on these days. 
On the other hand, the quantified biopsy results suggest that cryotherapy has 
significantly reduced the VD at days 1 and 7. This was also confirmed by 
histomorphometrical analysis that cryotherapy significantly reduced the effect 
of vasodilation at day 1. In humans, it has been shown that brachial artery 
vessel diameter increase leads to a post occlusion blood flow increase after 
whole body resistance exercise training (Rakobowchuk et al. 2005). This finding 
can be further supported by reports in the literature where the capillary 
constriction as well as a reduction in capillary permeability and blood flow due 
to cold-water application has been suggested (Eston et al. 1999, Howatson et al. 
2005).  
The differences between the control group with either sham or icing group 
were not significant for VV values at day 28 suggesting a return to the original 
values prior to CSTT. However, in a CSTT model, authors have shown higher 
values for blood flow (about 20%) compared to a baseline at day 28 (Claes et al. 
2006). 
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In addition, the results suggested that the pattern of vascular 
morphometric changes over time can be varied by the choice of treatment. For 
example, the sham group exhibited an increase in the VV from day 1 to day 7 
followed by a decrease towards day 28 while the icing group showed a constant 
increase in the VV from day 1 towards day 28.  
Similar to the VV results obtained from biopsy samples in the sham group 
(after cut-off) where higher VV values exhibited at days 1, 3 and 7 compared to 
the control group as well as a decrease trend of the VV towards day 28, Claes 
and colleagues reported an increasing trend in blood flow from day 1 to day 7. 
Also, the authors have shown that blood flow increases until the maximum 
values were reached at day 14, then they decreased towards day 28 (Claes et al. 
2006).   
On the other hand, cryotherapy has reduced the Vconn at days 1, 3 and 7 
as well as the VN and DA values at days 1 and 3 post injury compared to the 
sham group. This may be due to a delay in angiogenesis at days 3 and 7 in the 
icing group. These results did not support other reported CSTT assessments 
using fluorescent microscopic regarding cryotherapy for 20 minutes (Schaser et 
al. 2006) and 6 hours (Schaser et al. 2007) following injury significantly 
restores the decreased functional capillary density due to CSTT to the level of 
non-injured hindlimbs and also increases tissue perfusion after injury.   
At earlier time points, a reduction in acute CSTT symptoms such as 
haematoma in the icing group (Swenson et al. 2007) may be explained by a 
decrease in the VD and VN causing a delay of the perfused vessel volume in the 
injured region. TSV 
However, the VN was significantly higher in the icing group compared to 
the sham group at day 28 leading to a considerable lower VSp compared to the 
control group since the VN is correlated with the inverse of the VSp. The 
elevated VN in the icing group at day 28 compared to the sham group may be 
due to delayed angiogenesis. Furthermore, the biopsy results suggest that icing 
has led to a notable decrease in the VN values only at earlier time points (days 1 
and 3) compared to the sham and control groups.  
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The VN increased after day 3 towards day 28 in the icing group where the 
values at day 28 were surprisingly higher than the control group.  
While species and injury model were different, the results of this study 
were consistent with those of previous micro-CT studies for a mouse ischemia 
model  (Duvall et al. 2004). Both studies measured higher values for the VV and 
VConn parameters as well as  lower values for the VSp at day 3 (Duvall et al. 
2004). At day 7, the elevated values of the VV and VConn of the sham group 
supports the results of the same parameters reported by other authors in the 
injured hindlimbs of mice subjected to an ischemia model and compared to the 
control group (non-injured) (Oses et al. 2009).  
 
5.5.3 Verification of vasodilation  
After applying the cut-off technique, the micro-CT results showed higher 
VD values at day 1 for the sham and icing groups compared to the control group. 
However, the VD values were slightly reduced in the icing group. To confirm 
these findings, further histomorphological evaluation of day 1 post injury 
revealed a significant increase in the VD for the injured hindlimbs of both sham 
and icing groups compared to the non-injured hindlimbs. However, the 
histomorphological comparisons between the sham and icing groups indicated 
that cryotherapy has significantly reduced the VD compared to the sham group. 
The vasodilation effect at earlier days following injury has been 
acknowledged in the literature (Stadelmann et al. 1998, Williamson et al. 2004, 
Li et al. 2007), therefore, the increase in the VD at day 1 may be attributed to 
vasodilation mechanism.  
Vasoconstriction has been reported leading to a lower blood flow rate as 
well as a reduction in inflammation and swelling soon after the cooling of the 
traumatised muscles in rats by either cooling the tissue utilising ice pellets for 
20 minutes (Smith et al. 1994), or superfusing cold saline at 3°C for 10 minutes 
(Lee et al. 2005), or superfusing cold saline at 8°C for 20 minutes (Schaser et al. 
2006).  
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The results of this research suggest that vasoconstriction due to icing may 
be a short term effect and is replaced with vasodilation one day after trauma 
although this mechanism was reduced in the icing group compared to the sham 
group. The VD reduced from day 1 to day 3 for both sham and icing groups 
towards values close to the control group suggesting that vasodilation is an 
effect that occurs at very early time points and lasts for a few days. However, an 
increase in the VD at the later time points (e.g. at day 7 in the sham group) may 
be related to another mechanism such as arteriogenesis (Scholz et al. 2002). The 
effect of arteriogenesis has been reported as a dramatic increase in the diameter 
of pre-existing vessels 7 days after arterial occlusion in a rat ischemia model 
(Scholz et al. 2002). Both vasodilation and arteriogenesis mechanisms are 
necessary an adequate perfusion in the injured regions as shown by other 
studies (Hershey et al. 2001, Hoy et al. 2009).  
This was also supported by the results of this research as higher VD values 
at day 1 and 7 post injury were attributed to higher VV values at the same time 
points in the sham group although this effect was delayed in the icing group. 
However, controversies were found regarding changes to the diameter of the 
blood vessels after cooling. While vasoconstriction has been reported following 
cold therapy (Lee et al. 2005), other authors have reported an increase in the 
diameter of veins although the diameter of the arteries remained the same 
(Smith et al. 1993). This may require further histomorphometrical evaluation to 
investigate the response of the veins and arteries to cryotherapy over time. 
 
5.5.4 Indications of Angiogenesis  
Angiogenesis has been demonstrated previously as the measurement of an 
increase in vascular density (the vessel number per tissue area) (Couffinhal et 
al. 1998, Hershey et al. 2001). The vessel number has also been applied to 
validate angiogenesis using micro-CT by histomorphometry (Bolland et al. 2008, 
Raines et al. 2011, Nebuloni et al. 2014). Although the micro-CT results did not 
indicate significant changes to the VN in the sham group compared to the 
control group at early time points (days 1, 3 and 7), the VN notably increased 
from day 7 towards day 28.  
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However, in the H&E images obtained from histological evaluations, more 
perfused blood vessels and capillaries could be qualitatively observed at day 3 
and 7 post trauma in the injured hindlimbs of the sham group compared to the 
non-injured hindlimbs and the icing group. Quantitative histomorphometrical 
analysis has also verified a higher PVN at day 3 and 7 in the injured hindlimbs of 
the sham group compared to the non-injured hindlimbs and the icing group 
(Couffinhal et al. 1998, Hershey et al. 2001).  
In agreement with qualitative and quantitative histological results 
presented for this research, previous studies have also confirmed that 
angiogenesis occurs mostly at the capillary level between days 3-10 after an 
ischemic injury in a rat’s hindlimb (Schaser et al. 1999, Orbay et al. 2013).  
The increase in the capillary density and angiogenesis at day 3 following 
injury has been also demonstrated earlier by in vivo microscopy of rat hindlimbs 
after application of a CSTT (Schaser et al. 1999). Newly formed capillaries need 
time to mature for perfusion functionality (Hershey et al. 2001). In addition, our 
micro-CT’s highest available resolution (6 µm) does not allow capillaries less 
than 6 µm to be visualised. However, in this project, capillaries as small as 2 µm 
could be identified by histomorphometrical analysis. Therefore, based on 
findings from the literature, the increase in the PVN at day 3 and 7 shown in the 
histomorphometrical analysis may be attributed to angiogenesis in response to 
the vascular injury although this could not be detected with our micro-CT at 
earlier time points. As expected the newly formed blood vessels at earlier time 
points combined with the vascular network leading to an increase in the VN as 
shown by the micro-CT at the latest time point (day 28) for both sham and icing 
groups.  
Although vWF was initially investigated outside the scope of this research, 
this maker is known to stain all blood vessels including pre-existing and newly 
formed blood vessels and may not be a specific marker to identify angiogenesis 
(Akagi et al. 2002, Legan 2005). CD105 (endoglin) has been introduced in the 
literature as a specific angiogenesis marker which is mostly expressed on 
endothelial cells of newly formed capillaries and is absent in pre-existing blood 
vessels (Valeria et al. 2008).  
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This immunohistochemistry marker (CD105) has been successfully used 
for demonstrating angiogenesis following a hindlimb ischemia in a rat model 
(Orbay et al. 2013). Using this marker, the authors could confirm that 
angiogenesis activation occurs between day 3 and 10 post injury in rats (Orbay 
et al. 2013). As the PVN results obtained from histomorphometrical analysis 
suggested higher values at days 3 and 7, this can be further investigated using 
CD105 marker in future research.  
 
5.5.5 Alternatives for cryotherapy application 
A variety of cryotherapy techniques using ice have been discussed in the 
literature such as using an ice pack without additional compression (where the 
weight of the ice pack was the only pressure), and with additional compression 
using adhesive tape on the ice pack (Barlas et al. 1996, Oliveira et al. 2007). 
Using a temperature probe inserted into the muscle it was shown that 
application of an ice pack with compression on a dog’s thigh for 1 hour has 
reduced the intramuscular temperature by 2.5oC more than cryotherapy 
without compression (Barlas et al. 1996).  
The effect of cryotherapy combined with compression for reducing the 
intramuscular temperature has also been confirmed in humans which leads to a 
4oC lower temperature compared to cryotherapy alone (Merrick et al. 1993). 
Although cryotherapy with additional compression increases the cooling effect 
(Barlas et al. 1996) as well as restricting swelling of the tissue by locally 
decreasing the blood flow using a mechanical force (Levin et al. 1996), this 
method has its limitations. The overcooling of the tissue may increase the risk of 
damage to the tissue due to freezing, prolonged vasoconstriction and hypoxia 
(Wilke et al. 2003).  Two common cryotherapy techniques have been compared 
by investigating the cooling of deep tissue by using an ice pack containing ice 
cubes and a solid ice block made in a cup (Zemke et al. 1998). This experiment 
was conducted in humans by measuring the muscle temperature using a 
hypodermic needle microprobe inserted through the skin into the medial side of 
the gastrocnemius muscle (n=7) for 15 minutes.  
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It was confirmed that the muscle cooled faster after application of an ice 
block (17.9 ±2.4 minutes) compared to an ice pack (28.2±12.5 minutes). 
Therefore, for this research, the cryotherapy technique was conducted by gently 
applying a block of ice over the injured muscle with no additional compression 
except for the weight of the ice block. Furthermore, since this research focused 
on the vascular morphometric changes following traumatic injury, the goal was 
to avoid any other influencing factors on the vasculature and muscle tissue such 
as compression. In general, cryotherapy using a block of ice was inexpensive 
and simple. The small blocks of ice were made and applied directly onto the 
CSTT region. However, based on the results presented here, cryotherapy using 
an ice block for 20 minutes is not recommended for a fast recovery of the 
injured tissue and vasculature following CSTT in rats.  
While intermittent cryotherapy over a short duration (e.g. 3⨯10 minutes) 
has been suggested to be efficient for relieving the pain of ankle sprains 
(Bleakley et al. 2006) and Achilles tendon disorders in humans (Knobloch et al. 
2007), this treatment regime has been tested in rats over a longer duration of 
3⨯30 minutes for each session.  
Although the results of the extended intermittent cryotherapy in rats has 
been shown to be effective for reducing the size of the injury area (Oliveira et al. 
2007), this may cause more internal damage to the muscles and vasculature due 
to the prolonged exposure to cold temperatures (Wilke et al. 2003, Schaser et al. 
2007). At the other end of the cryotherapy spectrum, the immersion of the rat’s 
impacted hindlimbs in cold water (12-15oC) for 30 minutes has shown to 
restrict swelling after soft tissue trauma (Dolan et al. 1997). 
Finally, another possible treatment regime is the application of alternating 
‘cold and hot’ water, which has been suggested to reduce acute sports injuries in 
humans through alternating vasoconstriction and vasodilation and 
consequently, stimulating the blood flow and decreasing the swelling (Cochrane 
2004).  
More research is still required for an objective conclusion regarding the 
effect of cryotherapy alternatives on the healing of the vascular and muscle 
injury following trauma. 
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5.5.6 Limitations of the icing study 
Although both sham and icing groups at various time points indicated a 
satisfactory perfusion, there were a few cases from days 1, 3 and 7 that 
appeared to be poorly perfused due to a delay in perfusion causing a variability 
within the data of a few vascular morphometric parameters.  
A reason for this delay was that the inserted catheter popped out of the 
left ventricle during perfusion. To perfuse the rats, a catheter was inserted 
through the left ventricle and secured by a liquid adhesive glue (UHU All 
Purpose Glue Adhesive 7 ml). However, a proper adhesion was not achieved by 
using this glue, and this caused the catheter to pop out of the left ventricle 
during perfusion in a few cases. Although this problem improved by replacing 
the adhesive with a superior glue (Loctite Super Glue 5g), the catheter still 
popped out of the left ventricle in a few cases due to the wet tissue surface. This 
issue was finally resolved for the later groups by gently drying the heart’s 
surface using a small paper towel before inserting the catheter and applying the 
super glue. However, the removal of the catheter in the middle of the perfusion 
procedure led to a delay and consequently a reduction of the perfusion in a few 
cases. Since the data was normalised, which reduced the inter-individual 
differences, and as the qualified outliers were removed from the analysis, the 
final results were not significantly affected by this problem. 
A high variability in the biopsy results may also be due to the small sample 
size. The sample size of 4 calculated for this study was based on the TSV/TV 
parameter obtained from the ROI with comparable values found from the 
literature. Throughout this research, it was shown that the ROI evaluations 
exhibited a lower CV compared to the biopsy samples. Therefore, by increasing 
the sample size the high variability within the biopsy samples may be reduced. 
Current methods described for this study have used micro-CT evaluation 
and histological analysis (H&E and vWF) to show an increase in the number of 
blood vessels following CSTT particularly at days 3 and 7 in the injured 
hindlimbs. However, this study was unable to distinguish between pre-existing 
and newly formed blood vessels.  
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More immuno-histological assessments using markers specifically for 
newly formed blood vessels (e.g. CD105) (Orbay et al. 2013)are still required to 
provide further evidence confirming angiogenesis.  Furthermore, for better 
detection and quantification of different inflammatory cells including 
macrophages and neutrophils, immunohistochemistry analysis using specific 
markers such as CD68 to identify macrophages and HIS48 to detect neutrophils 
can be suggested for future studies.  
 
5.5.7 Concluding remarks 
In order to fulfil another aim of this research, the CSTT was characterised 
qualitatively and quantitatively over time and after cryotherapy. A trend of 
healing along with a reduction of haematoma was found from day 1 towards day 
28. While cryotherapy significantly reduced acute CSTT symptoms such as the 
size of the haematoma only one day after trauma, this caused a delay in healing 
over a longer period (days 3 and 7). Histological evaluations also suggested that 
cryotherapy delays the presence of inflammatory cells and regenerated muscle 
fibres in the injured regions at days 3 and 7.  
The developed vascular injury model allowed us to investigate the effect of 
CSTT and cryotherapy on structural elements of the vascular network over time. 
The assessment of the vascular morphometric parameters suggested that 
cryotherapy delays the early mechanisms (e.g. vasodilation and perfused vessel 
volume) which are necessary for healing the injured vasculature and tissue 
particularly at earlier time points from day 1 to 7. The values of the vascular 
morphometric parameters in the sham group did not return to the values prior 
to injury (control group) in most cases suggesting that the healing period may 
not be complete at day 28. This finding supports other studies where the 
authors have shown in a CSTT model that blood flow did not return to the 
control values at day 28 (Claes et al. 2006).  
The effect of vasodilation was also confirmed one day after CSTT while this 
was reduced due to cryotherapy in the icing group.  
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Furthermore, indications of angiogenesis were found in the 
histomorphometrical analysis at days 3 and 7 which was in agreement with 
previous reports (Orbay et al. 2013). 
The normalised results obtained from the ROI over time suggested a good 
level of reproducibility by indicating small CV values at different time points. 
However, the normalised results collected from the biopsy samples exhibited 
degrees of variability for the vascular morphometric parameters. The variability 
within the normalised results was significantly reduced in most cases by 
applying different strategies such as excluding outlier values and by applying 
the cut-off technique.  
In addition, by refining the methods presented in this research for 
perfusing the animals over time, the results improved at the later time points 
particularly at day 28, which exhibited small CV values. The reproducibility 
comparisons confirmed that the DA was the most reproducible parameter and 
the VConn with a high level of variability even after excluding the outliers was 
the most sensitive parameter. Investigation through the literature also 
confirmed that the VConn shows more variability compared to other vascular 
morphometric parameters (Duvall et al. 2004, Oses et al. 2009). This suggests 
that the VConn parameter obtained from the micro-CT software (Scanco) may 
not be suitable for future vascular analysis. 
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Chapter 6: Discussion and conclusions 
6.1 GENERAL DISCUSSION 
The focus of this research was to characterise changes to the vascular 
anatomy following a closed soft tissue trauma (CSTT) and to determine whether 
it is affected by a therapeutic method, such as cryotherapy.   
Therefore, the first aim of this research was to develop a validated CSTT 
model using an impact device. To achieve this, the first step was to characterise 
and validate the impact device to ensure that it created a controlled and 
reproducible CSTT and vascular injury.   
The reproducibility of the CSTT model based on the impact device was 
demonstrated and the optimal weight and velocity of the drop weight for 
producing a reproducible CSTT with the same grade of severity was determined. 
Furthermore, by using a high-speed camera, it was confirmed that the drop 
weight motion and its velocity pattern could be accurately predicted using 
theoretical analysis. This means that the impact energy transferred to the tissue 
to create the injury can also be anticipated accurately using theoretical 
calculations. Using the characterised impact device, a reproducible CSTT model 
including a vascular injury of Grade 4 based on the AO classification was 
developed. This model was characterised quantitatively for changes to the 
vascular morphology following CSTT using contrast-enhanced micro-CT 
imaging. The model was then verified through histological and 
histomorphometrical assessments. This was to confirm the vascular 
morphometric results derived from the micro-CT evaluations, as well as to 
assist in the interpretation of the micro-CT results, indicating physiological 
processes during the healing period, such as vasodilation at day 1 and efficiency 
of the perfusion protocols. Three phases of CSTT healing including destruction, 
repair and remodelling mechanisms have been identified by microscopic 
observations of the injured areas (Järvinen et al. 2005, Hodde et al. 2007, Enoch 
et al. 2008, Smith et al. 2008). 
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These observations showed destructed muscle fibres and blood vessels, 
disoriented muscle fibres and the presence of inflammatory cells at the earlier 
time points particularly at days 1 and 3 (destruction phase). The destructed 
injured regions were eventually replaced with newly regenerated muscle fibres 
at the later time points initiating at day 7 along with the presence of capillary 
clusters in the injury site (regeneration and repair phase).  
Consistent with the literature (Cízková et al. 2009, Myburgh et al. 2012), 
the results of this research confirmed regenerating skeletal muscle fibres which 
were detected as myofibres with a central nuclei in the histological assessments 
along with more blood vessels that appeared in the injured regions at day 7 post 
injury. Muscle observations at the latest time point (day 28) showed a large 
number of matured muscle fibres with migrated nuclei onto the periphery of the 
myofibres in tissue regions where trauma was induced in both sham and icing 
groups.  
The next goal of this research was to investigate the vascular morphology 
changes following CSTT and during icing treatment through a standardised 
vascular injury model in 3D. Using high-resolution contrast-enhanced micro-CT 
images and histological analysis, the developed model enabled us to 
characterise the vascular morphometric changes following CSTT qualitatively 
and quantitatively. A 2-stage evaluation of whole hindlimb and localised sub-
region characterisation of the microvasculature allowed for detection of 
detailed architectural changes of the vascular network.  The evaluation methods 
were shown to be sensitive enough to detect structural changes in the vascular 
network following injury and during the healing period in treated (cryotherapy) 
and untreated animals. The reproducibility of this model was confirmed by 
indicating a small coefficient of variation for the normalised TSV results 
obtained from the ROI evaluation. Furthermore, after data processing biopsy 
samples suggested an acceptable level of reproducibility for a few vascular 
morphometric parameters such as VD and DA at three time points including day 
28. After improvement of the perfusion methods at later time points (day 28), 
the VN and VSp also indicated an acceptable level of reproducibility. 
 176 
 
The accuracy of the model was also verified through validation of the 
micro-CT results by using histomorphometrical analysis, particularly for the 
parameter vessel density (vessel number per area), using an intra-class 
correlation coefficient and Bland-Altman plot. The efficiency of the perfusion 
protocols for filling the blood vessels with contrast agent (microfil) was 
determined through the calculation of an average relative vascular perfusion 
rate of 72%, which was independent of vessel diameter. This suggested that the 
contrast agent also filled vessels below the detection limits of the micro-CT 
scanner. 
The developed CSTT model indicated significant changes in the vascular 
morphometric parameters following trauma in the injured hindlimbs compared 
to the non-injured hindlimbs. The model suggests that CSTT causes a higher TSV 
and VV, VD, VConn, VSp and a lower VN in the injured hindlimbs compared to 
the non-injured hindlimbs one day post trauma. These morphological changes 
at day 1 may be explained through the events that occur during the destructive 
phase. For example, the destruction of the blood vessels due to trauma, which 
causes early blood flow deficiency (Claes et al. 2006) may have resulted in a 
higher demand for more oxygen supply and nutrition for the injured tissue 
(Järvinen et al. 2005). The response by the surviving vasculature surrounding 
the necrotic region to this demand may be to widen the blood vessel diameter 
through vasodilation to increase the blood perfusion rate and vessel volume 
(VV) in the injured regions.  
In addition, the results obtained from the icing study suggested that not 
only CSTT changes the vascular morphometric parameters soon after injury and 
over time but also the recovery of the vascular network may vary by the choice 
of treatment. For example, the results of this research suggested that 
cryotherapy has reduced the vasodilation at day 1 as well as the VV, VN and 
VConn following CSTT and at earlier time points.  
Together, the results suggest the effect of vasodilation at day 1 following 
injury as well as arteriogenesis and indications of angiogenesis at later time 
points may indicate the restoration of the perfused vessel volume (VV) at the 
injury site.  
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Signs of angiogenesis were qualitatively evaluated through histological 
analysis by observing the large number of capillaries in the injured region. This 
was also quantitatively shown by histomorphometrical analysis of the perfused 
vessel number (PVN) indicating higher values in the injured hindlimbs 
compared to the non-injured hindlimbs. Based on the results presented for the 
PVN parameter, it appears that icing treatment significantly delays angiogenesis 
at days 3 and 7.  
Throughout this research, it was demonstrate that by early interference 
with the natural healing process using ice treatment; vasodilation at day 1 may 
be reduced, resulting in a decrease of the perfused volume. This may also cause 
a retardation of arteriogenesis and angiogenesis at later time points. While icing 
reduces acute CSTT symptoms such as swelling and pain post trauma, the 
findings of this research suggest that it may delay the recovery of the injured 
vasculature and tissue at earlier time points. The delay in tissue healing and 
muscle fibre regeneration following cryotherapy is supported by other CSTT 
models reported in the literature (Takagi et al. 2011). However, it was also 
found that the differences of the measured vascular morphometric parameters 
between sham and icing groups were not statistically significant at the latest 
time point (day 28) although the VV and DA were notably higher in the icing 
group. Furthermore, it appeared that healing period of the CSTT and injured 
vasculature may take longer than 28 days since most vascular morphometric 
parameters did not show a return to the original values prior to injury. 
 
6.1.1 What is novel? 
To the best knowledge of the author, this research has for the first time 
provided a systematic characterisation of vascular injury following CSTT and 
during healing, with or without treatment using ice therapy. New strategies and 
methods were developed to answer relevant research questions. The novel 
aspects of this research are: 
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 The systematic characterisation and validation of the weight and velocity 
of the drop weight at the impact surface of an impact device to ensure a 
standardised and reproducible CSTT including vascular injury. 
 To date, all available 3D vascular injury characterisations reported in the 
literature have been based on ischemia injury models, but for the first 
time this was conducted for a CSTT model through this research. 
 The application of ice for CSTT treatment is not new and this therapeutic 
method has been studied qualitatively (Hubbard et al. 2004) and 
quantitatively in 2D (Schaser et al. 2006, Takagi et al. 2011). However, 
this research represents the first 3D characterisation of the effect of icing 
on the recovery of the damaged vascular network. 
 A new method was developed to verify the efficiency of the perfusion 
protocols for filling the vascular network with contrast agent (microfil).  
This method was based on the measurements of the relative vascular 
perfusion parameter (RVP) and the smallest perfused capillary that could 
be detected. This approach can be applied for any contrast-enhanced 
imaging system. 
 A geometrical technique was designed to collect correlated areas in a 
defined, consistent and standardised manner for all biopsy samples 
throughout this research. 
 Although the shrinkage of microfil has been qualitatively reported in the 
literature (Nyangoga et al. 2011), this has been quantified for the first 
time in this research using histological sections. 
 
6.1.2 Limitations and recommendations 
1. One of the major challenges for this research was a general shrinkage of 
the microfil contrast agent that was observed in all blood vessels during 
microscopic evaluation of histological sections. The comparisons 
between the diameter of the correlated blood vessels obtained from the 
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micro-CT (microfil diameter) and histology sections (actual vessel 
diameter) showed a considerable shrinkage of the microfil. Therefore, in 
the micro-CT scans, the absolute values of the vessel diameter may not 
be a precise representation of actual vessel diameter as was observed in 
the histological images. Subsequently, other parameters related to the 
VD such as absolute values of the VV will be affected. Further analysis 
revealed that the microfil shrinkage of about 50% has occurred in all 
diameter ranges of blood vessels and this was independent of vessel size. 
A strategy to overcome the shrinkage problem could be to present the 
results as comparisons between and within the groups as well as 
normalising the quantitative values of the injured hindlimbs over the 
non-injured hindlimbs instead of using absolute values. Therefore, the 
comparison results between the sham and icing groups across the time 
points were presented as normalised values to reduce the effect of the 
microfil shrinkage on the findings in this research. Additionally, there are 
vascular morphometric parameters such as PVN (related to the VN), RVP 
(related to the VN), VConn (related to the vascular connections) and DA 
(related to the vascular orientation) which are independent from VD and 
therefore, are not influenced by the microfil shrinkage. The biopsy 
results of the vascular injury model presented for the VSp parameter 
obtained from the non-injured hindlimbs at day 1 indicated that this 
parameter is 14.4 times larger than the VD (both parameters have the 
same unit (mm)). Therefore, the VSp may not be significantly affected by 
the VD variations because the VSp values are too large compared to the 
very small VD variations and consequently, the shrinkage effect on the 
VSp is negligible. As discussed, previous studies have recommended the 
microfil contrast agent as a superior material for a high quality image in 
vitro. These authors scanned their samples while they were stored in 
formalin with no mention of shrinkage (Bentley et al. 2002, Duvall et al. 
2004, Yeung et al. 2011). In this study, the samples were transferred to 
ethanol after fixation with formalin and scanned while they were stored 
in ethanol. Recently, microfil shrinkage in vascular imaging due to 
ethanol has been discussed in the literature (Nebuloni et al. 2014). 
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Unfortunately, this article was published after the experimental studies 
were finished. The relaxation of the vascular smooth muscle 24 hours 
after death (Ebner et al. 2011) can be another possible cause for an 
increase in the discrepancy between diameters of the microfil and the 
vessels which requires further investigation.  
 
2. While leakage of the microfil contrast agent outside the broken blood 
vessels has also been reported in the literature (Downey et al. 2012), in 
this research, leakage was not observed. Although the presence of a 
haematoma is a sign of vascular breakdown and subsequently internal 
bleeding within the tissue, the vascular tear may have been sealed by 
blood clots soon after the impact. Therefore, after the microfil perfusion 
at 1, 3, 7 and 28 days following trauma, a leakage of microfil was not 
observed within the tissue. Furthermore, this may indicate that the 
perfusion flow rate used for microfil infusion utilising the peristaltic 
pump had been adjusted appropriately and this has facilitated a fluid 
pressure that prevented vascular rupture and microfil leakage.  
 
3. Further limitations were faced during the micro-CT evaluation, due to 
the relatively large file size caused by the high resolution scanning of 
both intact hindlimbs (n=108, around 25-30 GB for each hindlimb) and 
biopsy samples (n=108, around 7-10 GB for each biopsy sample).  
 
4. Due to the limited memory of our micro-CT system, the quantitative 
evaluations of vascular morphology had to be limited to biopsy samples 
only, and within those, to the region of the most affected muscle (biceps 
femoris) which was located in the top 250 image slices sections of the 
biopsy specimens.  
 
5. During the perfusion experiments, a high sensitivity of the perfusion 
protocols with respect to timing of the perfusion was also noticed. After 
euthanasia, a delay in starting the perfusion and flushing the blood 
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vessels appeared to cause blockages in blood vessels that may be due to 
blood clot formation leading to variability of the results. Furthermore, 
although the RVP percentage (72%) indicated a satisfactory perfusion, 
the blockage of the blood vessels due to a delay in perfusion may have 
reduced the perfusability level of the vasculature causing 28% of blood 
vessels not to be filled with microfil. In this research, due to animal 
welfare concerns, blood vessels were flushed using heparinised saline 
immediately after euthanasia, once death was confirmed. It has been 
described (Lu et al. 2010) that perfusion may be initiated on the 
anaesthetised animal, ultimately causing the animals death by excessive 
blood loss during anaesthesia. In this procedure, since the animals are 
still alive, the pumping of the heart assists the drainage of the remaining 
blood. This may reduce the blockage of blood vessels due to blood clots, 
and therefore will increase the number of perfused blood vessels. In 
addition, as the RVP parameter was measured in the histological sections 
(72%), there is a possibility that the microfil was washed away from a 
few vessels due to extensive rinsing during the histological processing. 
This suggests that the effective number of blood vessels filled with 
microfil during micro-CT scanning may have been higher than the RVP 
presented for the histomorphometrical results. In the histological 
sections, microfil had washed away from a few blood vessels that was 
found by comparing corresponding sections from micro-CT. Therefore, to 
prevent this, another histological process that does not require extensive 
washing such as the cryosectioning technique is suggested. This method 
uses frozen tissue for sectioning allowing for less tissue processing 
(Herzog et al. 2002, Brey 2003). On the other hand, the microfil contrast 
agent is a viscous material and therefore, a higher flow rate may allow 
perfusing more blood vessels. However, the concern was that a higher 
flow rate may also increase the chance of rupturing blood vessels due to 
super-physiological pressures. 
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6. Another limitation was that current methods described for this study 
have used micro-CT evaluation and histological analysis (H&E and vWF) 
to show an increase in the number of blood vessels following CSTT in the 
injured hindlimbs. However, this study was unable to distinguish 
between pre-existing and newly formed blood vessels. More immuno-
histological assessments using markers specific to newly formed blood 
vessels (e.g. CD105) are still required to provide further evidence 
confirming angiogenesis. In addition, this research was limited to 
precisely detect and quantify different inflammatory cells including 
macrophages and neutrophils. The immunohistochemical analysis using 
specific markers for identifying the inflammatory cells can be suggested 
for future research. 
 
6.2 RESEARCH IMPLICATIONS AND CONTRIBUTIONS TOWARDS 
KNOWLEDGE 
A standardised CSTT model was developed based on real clinical 
conditions such as sports injuries or accidents that can improve the guidelines 
for current clinical classifications (e.g. Tscherne and AO). For example, the 
quantitative measurements of the inflamed areas (haematoma) can be added to 
qualitative observations by applying the methods established in this research to 
monitor the healing trend over time using a particular treatment (e.g. 
cryotherapy). The CSTT quantification procedure based on the measurements of 
the haematoma area is inexpensive providing valuable information in a non-
invasive manner for clinical applications.  
The methodologies developed for characterising the impact device and 
creating a controlled CSTT can be useful for other experimental orthopaedic 
research including musculoskeletal injuries. The findings of this research based 
on the characterisation of CSTT and the pattern of changes to the vascular 
morphology following CSTT provides a framework that may be applied as a 
fundamental basis for future wound healing and therapeutic modalities to 
monitor the effect of a treatment over time, such as cryotherapy.  
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For example, the results of this experimental study indicated that icing 
may cause secondary tissue damage through a reduction in vasodilation and the 
perfusion volume at earlier time points.  
These findings not only encourage clinical and experimental studies on 
other therapeutic alternatives but also question the efficiency of these 
traditional treatments that have no convincing evidence and should be re-
examined using a scientific basis.  
Furthermore, a cut-off technique was developed throughout this research 
that can be beneficial for the study of microvasculature within various diameter 
ranges or to reduce the variability of results due to the presence of large blood 
vessels for the VV and VD parameters. While the perfusion methods used in the 
literature have been described qualitatively, we have also developed new 
quantitative measures to determine the smallest capillary diameter that was 
filled with contrast agent, and to determine the efficiency of the perfusion 
protocols based on the calculation of the RVP . These methods can be beneficial 
for characterising the perfusability of any contrast agent throughout the 
vascular network. In addition, the quantitative assessment of the microfil 
shrinkage may be useful for future studies using this contrast agent for 
perfusing vasculature. 
The main contribution of this research to knowledge is to provide a 
scientific framework for the quantitative characterisation of changes to the 
vascular architecture in preclinical studies of CSTT. This allows for the objective 
diagnosis and monitoring of CSTT, and for the evaluation of the impact of 
treatment on the progression of healing. Eventually, the methods developed in 
this project may serve as a validation tool during the development of future 
non-invasive clinical assessment modalities for CSTT.  
 
6.3 FUTURE DIRECTIONS 
In this research, the quantitative framework was developed for vascular 
morphometric assessments using contrast enhanced micro-CT imaging.  
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To extend this model, an investigation into the vascular functionality 
following CSTT is suggested. Open questions remain on the long-term effect of 
icing on the healing of injured muscles. Also, practicing different icing protocols 
and using heat for the injury treatment rather than icing are other alternatives 
requiring further research.  
This research investigated the effect of icing on the vascular and muscle 
injuries during 28 days following CSTT where the destructive and repair phases 
as well as the early remodelling phase were discussed. However, our knowledge 
regarding the effect of icing on the healing of vascular and muscle injury during 
the remodelling phase is limited. For example, a few vascular morphometric 
parameters such as the VN showed significantly higher values at day 28 in the 
icing group. In this regard, the unanswered questions are whether the values of 
this parameter will increase further or eventually decrease and if it decreases, 
when does the decline occur? A long-term study may allow for a better 
judgment regarding the outcome of the muscle injury using cryotherapy. 
Different cryotherapy alternatives were also discussed in Chapter 5. 
Although some of these methods such as intermittent cryotherapy with shorter 
duration were reported to be efficient for humans, this still needs to be assessed 
in rats.   
Application of low-level heat wrap therapy has been reported to 
significantly reduce the muscle soreness and lower back pain in humans (Mayer 
et al. 2006). This treatment can be an option for future investigation on the 
effect of low-level heat on the vascular injury following CSTT.  
Using electromyogram (EMG), a clinical study on healthy ankles has 
proposed that icing influences the pain threshold where a 10oC decrease in skin 
temperature has been shown to result in a 33% reduction of nerve conduction 
velocity as well as an increase in pain threshold and pain tolerance (Algafly et al. 
2007). With respect to the vascular morphometric changes, the relationship 
between the injured and non-injured muscle activity following trauma as well as 
between the sham and icing treatments may be worthy of future assessments. 
This research was limited to quantitatively measuring the activity level of the 
muscles following CSTT and cryotherapy. 
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For future research, the examination of other available therapeutic 
methods for CSTT such as hyperbaric oxygen therapy (HBOT) can be explored. 
The benefits of this non-invasive method which uses a high concentration of 
oxygen for wound healing has been discussed in the literature (Babul et al. 
2003, Buettner et al. 2007).  
The literature shows that HBOT has been advocated for increasing tissue 
oxygenation, thereby improving the collagen deposition and angiogenesis (Gill 
et al. 2004, Hopf et al. 2005, Rodriguez et al. 2008).  
However, the direct effect of HBOT on the healing of the vascular injury 
following CSTT has not yet been quantitatively evaluated. 
For better verification of the muscle injury and its regeneration, 
microscopic evaluations can be utilised through immunohistochemistry using 
the nestin antibody (Cízková et al. 2009) which has been recently introduced for 
identifying newly formed myofibres. As mentioned, the vWF marker has been 
commonly used confirming angiogenesis activation (Starke et al. 2011). This 
marker was also applied in the methodology of this research to confirm the 
increase in the number of blood vessels that may be due to angiogenesis. 
However, vWF stains all blood vessels including pre-existing and newly formed 
ones.  
Recently, the CD105 antibody has been suggested as a marker to 
specifically identify newly formed endothelial cells of capillaries indicating 
angiogenesis  (Orbay et al. 2013). Therefore, this research can be continued 
using the CD105 marker to distinguish between pre-existing and newly formed 
capillaries to provide stronger evidence confirming angiogenesis particularly at 
days 3 and 7.  
It has been shown that inflammatory cells such as macrophages 
stimulate angiogenesis (Li et al. 2007), therefore, another future direction can 
be to determine the relationship between the inflammation and angiogenesis 
following CSTT through the evaluation and quantification of the inflammatory 
cells such as macrophages using immunohistochemistry analysis (Tsivitse et al. 
2003).  
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On the other hand, micro-CT software packages were originally developed 
for the morphometric analysis of hard tissue such as trabecular bone structures 
and have been modified for vascular morphological investigation. However, 
there are geometrical parameters that further describe the vascular network, 
such as vessel length, that the standard micro-CT software was not able to 
measure.  
Therefore, combining the vascular parameters derived from a robust 
modality such as the standard micro-CT evaluation software with other 
morphometric parameters provided by other software tools (i.e. AMIRA) may 
allow for an even better interpretation of the micro-CT results.  
Initial evaluations were conducted to assess the vascular morphometric 
parameters more comprehensively through AMIRA software and the 
preliminary results of a pilot study are presented in Figure 6-1.  
 
 
Figure 6-1: 3D of the vascular network using AMIRA software.  
Initial results obtained from a pilot study using AMIRA software are presented for 
the vascular network of a non-injured hindlimb of the sham group. Image (A) 
shows a 3D reconstruction of the vascular network morphology and image (B) 
illustrates a skeletonised image of the same vascular network where the vascular 
connections are exhibited as nodes.  
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6.4 CONCLUSION 
This research was primarily aimed to develop a new, standardised 
trauma model in rats and methods to investigate the changes of the vascular 
morphology following CSTT in 3D at different time points.  
In order to characterise the experimental model, its reproducibility and 
accuracy were verified through comparisons with histomorphometrical 
assessments.  
The sensitivity of this experimental framework was also tested by 
comparing the vascular morphology after trauma and during healing in 
untreated and treated rats using cryotherapy.  The sensitivity of this framework 
was confirmed through the detection of the significant differences between the 
injured and non-injured hindlimbs regarding the muscle injury size and the 
vascular morphometric parameters following trauma, over time (sham group) 
as well as between treatment groups (sham and icing groups).  
The key findings of this characterised experimental model and its 
application to study the effect of cryotherapy on CSTT were: 
 The vascular morphology changed significantly after trauma, and its 
recovery varied between untreated animals and those treated with ice.  
 CSTT increases the perfused vessel volume in the injured region at 
earlier time points while cryotherapy delays this mechanism. 
 One day after trauma, the diameter of the injured blood vessels increased 
significantly compared to the non-injured vessels due to vasodilation, 
which perfused more blood to the injury site during healing. However, 
cryotherapy reduces the effect of vasodilation through decreasing the 
diameter of the blood vessels leading to a reduction in the vessel volume 
perfusion one day after trauma. 
 The early disorientation (degree of anisotropy) in the vascular network 
due to the CSTT reduces significantly at the latest time points (day 28) 
suggesting more organised network in the remodelling phase.  
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 Despite the fact that icing reduces the size of the haematoma in the early 
stages of injury recovery, the evaluation of the vascular injury suggests 
that it also delays the restoration of the vascular network. 
 Practically, normalising the data, excluding the qualified outlier values 
and using the cut-off technique were found to be effective ways for 
reducing the variability within the data obtained from the vascular 
network quantitatively.  
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Appendix A 
NUMERICAL TABLES 
A-1 Impact device characterisation  
Table A-1: The numerical data determined from analytical calculations are given 
for the impactor velocity, kinetic energy and impulse at 18 height points between 
the starting point and the impact surface. 
 
Number of 
calculations 
Impactor 
Mass (Kg) 
Dropped 
Height (m) 
Velocity  
(m/s) 
Kinetic 
Energy (J) 
Impulse 
(Kgm/s) 
1 0.13 1.66 5.70 2.14 0.75 
2 0.13 1.57 5.54 2.02 0.73 
3 0.13 1.47 5.36 1.89 0.70 
4 0.13 1.37 5.17 1.76 0.68 
5 0.13 1.27 4.98 1.63 0.65 
6 0.13 1.17 4.78 1.50 0.63 
7 0.13 1.07 4.57 1.37 0.60 
8 0.13 0.97 4.35 1.24 0.57 
9 0.13 0.87 4.12 1.11 0.54 
10 0.13 0.77 3.87 0.99 0.51 
11 0.13 0.67 3.61 0.86 0.47 
12 0.13 0.57 3.33 0.73 0.44 
13 0.13 0.47 3.02 0.60 0.40 
14 0.13 0.37 2.67 0.47 0.35 
15 0.13 0.27 2.28 0.34 0.30 
16 0.13 0.17 1.80 0.21 0.24 
17 0.13 0.10 1.40 0.13 0.18 
18 0.13 0.07 1.13 0.08 0.15 
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A-2 Total segmented volume obtained from vascular injury model 
(ROI)  
Table A- 2: The quantitative comparisons of the total vessel volume (TSV) 
obtained from the ROIs (n=6) are illustrated as mean values for non-injured and 
injured hindlimbs one day after trauma (Mean ± SD).  
 
Total segmented volume 
(TSV) 
(mm3) 
Bone volume 
 
Non-injured Injured 
 
Mean ± SD 297.6 ± 10.1 401.9 ± 56.0 496 ± 102.8 
 
A-3 Vascular morphometric parameters (biopsies) 
Table A- 3: The original data of the quantified vascular parameters (Mean ± SD) 
obtained from the vascular injury model presented for non-injured and injured 
biopsy samples (n=6) one day after trauma. 
 
Vascular morphometric 
Parameters 
Non-injured 
 
 
Injured 
 
 
VV (mm3) 0.372 ± 0.17 0.729 ± 0.30 
VD (mm) 0.069 ± 0.02 0.069 ± 0.01 
VN (1/mm) 1.348 ± 0.24 1.25 ± 0.16 
VSp (mm) 0.765 ± 0.15 0.817 ± 0.10 
VConn (1/mm3) 1.090 ± 1.20 5.296 ± 5.66 
DA [1] 1.393 ± 0.18 1.452 ± 0.20 
 
A-4 Vasodilation verification for the vascular injury model 
Table A-4: The vessel diameter values (Mean ± SD) of the large vessels (n=10) 
obtained from histology sections are presented as absolute values obtained from 
the non-injured and injured hindlimbs at day 1 for verification of vasodilation. 
 
Vessel diameter (µm) 
Day1 Non-injured Injured 
 17.3 ± 5.8 45.7 ± 12.7 
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Icing study 
A-5 Quantitative analysis of CSTT inflamed areas  
Table A-5: The CSTT and muscle injury quantitative results are presented in this 
table indicating the changes in the haematoma size (inflamed areas) at time 
points of 1, 3 and 7 days post injury after excluding the outlier values. 
 
CSTT area (cm2) Time points Inflamed 
 
Sham 
 
Day 1 5.18 ± 0.63 
Day 3 0.76 ± 0.18 
Day 7 0.36 ± 0.31 
  
 
Icing 
 
Day 1 2.53 ± 0.92 
Day 3 1.06 ± 0.18 
Day 7 1.05 ± 0.90 
 
A-6 The normalised total vessel volume (ROI)  
Table A-6: The normalised mean values are presented for perfused total vessel 
volume (TSV) obtained from sham and icing groups at different time points (Mean 
± SD). 
 
Total segmented volume (TSV)  % 
Time point 
 
Day 0 Day 1 Day 3 Day 7 Day 28 
Control 
 
96.5 ± 3.1     
Sham 
 
 124.1 ± 10.6 112.0 ± 9.0 110.1 ± 5.5 110.2 ± 7.7 
Icing  113.9 ± 8.7 103.1 ± 1.8 105.2 ± 13.9 112.3 ± 4.3 
  
 
A-7 Vasodilation verification (icing study) 
Table A-7: The vessel diameter values (Mean ± SD) of the large vessels (n=10) 
obtained from histology sections are presented as normalised values for the sham 
and icing groups at day 1 indicating higher vasodilation in the sham group. 
 
Vessel diameter% 
Day 1 
Sham 267.8 ± 18.4 
Icing 154.8 ± 26.0 
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A-8 The normalised vascular morphometric parameters (biopsies)  
Table A-8: The normalised (non-injured/injured×100) vascular parameters (Mean ± SD) obtained from biopsy samples presented for all groups. 
 
Normalised original values of the vascular morphometric Parameter (%)  
Groups Time points 
 
VV  VD  VN  VSp  VConn  DA  
Control Day 0 
 
232.3 ± 200.4 172.8 ± 114.7 106.1 ± 23.4 100.2 ± 26.1 246.6 ± 254.9 98.9 ± 11.4 
 
Sham 
Day 1 350.4 ± 233.3 121.5 ± 70.9 105.2 ± 16.8 98.6 ± 16.2 8035.1 ± 8554.5 115.2 ± 21.6 
Day 3 364.0 ± 72.5 168.4 ± 88.6 105.8 ± 19.8 98.4 ± 22.4 4621.5 ± 5142.8 102.8 ± 9.9 
Day 7 733.6 ± 892.9 413.9 ± 594.4 97.5 ± 17.6 108.0 ± 36.9 17398 ± 29581 107.3 ± 5.0 
Day 28 150.3 ± 63.6 116.5 ± 52.6 114.3 ± 8.0 88.1 ± 5.8 598.9 ± 677.3 81.1 ± 5.2 
        
 
Icing 
Day 1 1203.9 ± 1941.9 189.2 ± 119.9 90.9 ± 9.8 98.6 ± 16.2 387.6 ± 401.7 98.9 ± 13.9 
Day 3 115.6 ± 37.0 109.5 ± 38.6 84.9 ± 11.4 98.4 ± 22.4 244.6 ± 228.9 84.6 ± 5.4 
Day 7 183.1 ± 90.7 170.4 ± 67.2  102.2 ± 11.6 108.0 ± 36.9 240.1 ± 160.8 105.4 ± 14.4 
Day 28 241.6 ± 106.6 119.7 ± 23.6 124.5 ± 36.3 88.1 ± 5.8 557.9 ± 531.6 91.9 ± 10.9 
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A-9 The perfused vessel number 
Table A-9: The perfused vessel number (PVN) per area of tissue (Mean ± SD) obtained from histological analysis is presented for the sham and icing 
groups at different time points. 
 
 
 Perfused vessel number (PVN)/mm2 
 Day 0 Day 1 Day 3 Day 7 Day 28 
Control 0.16 ± 0.01     
Sham  0.20 ± 0.06 0.21 ± 0.08 0.28 ± 0.05 0.27 ± 0.14 
Icing  0.13 ± 0.03 0.13 ± 0.03 0.21 ± 0.06 0.26 ± 0.09 
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Appendix B 
IMMUNOHISTOCHEMISTRY TECHNIQUES 
Immunohistochemistry (IHC) uses antibodies as histological tools to 
identify different patterns of antigen distribution within tissues. Antibodies are 
usually pre-made and can bind to a specific protein (antigen) (Ramos-Vara 
2005). These antibodies are then tagged with a fluorescent chemical or an 
enzyme such as fluorescing or rhodamine which converts them to a visible dye. 
The tagged antibodies within the tissue are incubated and after washing the 
unbound antibodies away, the bound antibodies distribution is revealed by 
fluorescence or light microscopy. The assumption is that the antibody 
distribution can show the antigen distribution. In this research, IHC was utilised 
to evaluate the expression level of different antigens associated with 
revascularisation (angiogenesis). The von Willebrand Factor (vWF) is 
commonly used as vascular endothelial cell marker for studying angiogenesis 
and neovascularisation (Starke et al. 2011). 
 
Histological section preparation 
The general section preparation for the immunohistochemistry analysis 
was the same as H&E staining explain in 3.2.5. 
 
Staining methods 
For immunohistochemistry staining, the deparaffinised sections were 
treated by agents to suppress the non-specific background staining. For this 
purpose usually two agents are used including: the hydrogen peroxidase (H2O2 
3%, for 20 min) to suppress the tissue and cells endogenous peroxidase activity, 
and bovine serum albumin (BSA 2% for 60 min) which carries antibodies to 
block reactive sites and sticky proteins.  
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Heat-induced antigen retrieval (unmasking the antigens) was also carried 
out with a tri-sodium citrate buffer (Sigma-Aldrich, NSW, Australia) for 30 
minutes at 70oC in an oven (Cole-Parmer StableTemp oven, NSW, Australia). 
Incubation of the sections was performed overnight at 4oC followed by adding 
the primary antibodies, rabbit polyclonal anti-human vWF (Ready-to-use; 
DAKO, California, USA), to detect the vascular endothelial cells and entire blood 
vessels including pre-existing and newly formed. The sections were then 
incubated for 30 minutes with a goat anti-mouse and anti-rabbit secondary 
antibody conjugated with horseradish peroxidase (DAKO, California, USA). 
Colour (brown) was produced using a 3,3-diaminobenzidine (DAB substrate kit; 
DAKO, California, USA) which is insoluble in alcohol, xylene and also resistance 
to heat along with counter staining with Mayer’s haematoxylin. Negative and 
positive controls were conducted simultaneously to the test the tissue samples. 
Positive control is applied for testing the protocol to ensure it works properly, 
whereas negative control is to test that the involved antibody is specific. The 
exclusion of the primary antibody as well an isotype control (Mouse IgM isotype 
control; BD Pharmingen, San Diego, USA) served as negative controls, whereas 
samples known to have specific cells and tissues were used as positive controls. 
Rat femur scaffold samples were obtained from previous work within the bone 
tissue morphology group, and used as positive controls.  
Other methods including imaging of histological sections were similar to 
H&E imaging (3.2.5). Finally, positively stained blood vessels and capillaries by 
vWF were identified and then all groups were compared.   
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Abbreviations 
 CSTT: Closed soft tissue trauma 
 PPE: Personal protection equipment e.g. gloves, gown, safety 
glasses, suitable shoes 
 PC2: Physical containment level 2 
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Purpose and scope 
This document has been developed to present safe operating procedures 
and standard protocols for utilizing the “impact device” located at MERF, Prince 
Charles Hospital, QUT, Brisbane, Australia. The repair or maintenance of this 
device is not the purpose of this guideline.  
 
Guidelines for the impact device 
 The impact device has been developed to create a controlled reproducible 
closed soft tissue trauma (CSTT) on the hindlimb muscle (biceps femoris) of rats 
using anaesthetised rats or cadavers. This device has been designed to apply an 
impact with variable drop weights at different impact speeds to produce 
different degrees of CSTT.  
 
Responsibilities 
This document covers only basic information regarding the safe operating 
of the impact device. Therefore, as this guideline does not provide specific 
details regarding different experiments, operators will be required to be 
specifically trained for their particular tests. Users are responsible to operate 
the device according to the protocols presented in this guideline. Users are 
expected to be familiar with the terms and conditions described in this 
document and if necessary training must be taken before operating this device. 
 
Precautions 
The device is operated in a PC2 environment, and using PPE equipment is 
essential while operating this instrument especially if the user is working with 
animal specimens and there is a chance of contamination by blood.  
The Safety cabinet door and front lid must be closed while the test is 
running to prevent injuries from the drop weight.  
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Impact device structure 
The following figures illustrate the components of the impact device. 
 
 
Figure C-6-2: The schematic of the impact device’s structure. 
This schematic shows two views of the impact device’s structure including the internal (A) 
and external (B) components. A: The top part of the impact device consists of a guiding 
rod, along which the drop weight slides down. The lower part of the device is comprised of 
a base plate, a support frame, an impact cylinder, and force distributers to transfer the 
force from the drop weight to the impact cylinder and a height-adjustable support anvil. 
Two safety pins were also used in the upper and lower parts of the device to secure the 
drop weight in its location. Since the height of the guiding rod was 1.66 m, here only the 
lower part of the device is shown. The positioning of the specimen (rat leg) between the 
impact cylinder and the support anvil is schematically exhibited. To reduce the risk of any 
injury to the researchers using this device, the entire impact device was encased by a 
frame made from Perspex panels, with lateral holes for locating the safety pins (B). 
 
Procedure 
Before commencing a test, ensure there is appropriate PPE. While not in 
use, the impact device must be kept with the cabinet safety door and front lid 
closed while the calibrated drop weight is held at its lowest position by the 
lower safety pin. 
 
 Open the safety cabinet door gently. 
 Hold the drop weight while removing the lower safety pin. 
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 Slide the drop weight up to the desired height. 
 Hold the drop weight at the desired height and secure it using the upper safety 
pin. The drop height determines the impact velocity as per Table 1. 
 Make sure the lower safety pin is in place. 
 Add more drop weights if necessary using additional plasticine.  
 Close the safety cabinet door gently. 
 Open the front lid gently. 
 Pull the force distributers upwards and place the sample between the anvil and 
impact cylinder. 
 The vertical position of the bottom anvil and sample can be adjusted with the 
two screws located on the base plate. Use the top screw to change the vertical 
position and the bottom screw to lock into position. 
 Close the front lid gently. 
 Remove the lower safety pin. 
 Release the upper pin and the drop weight will slide down the rod and impact 
the sample. 
 Open the safety cabinet door. 
 Pull the force distributors up with one hand and remove the sample using the 
other hand. 
 Hold the drop weight at its lowest position and secure it with the lower safety 
pin. 
 Make sure the safety pins are placed in the right holes to prevent the drop 
weight from falling.  
 When your experiment is finished, clean the device with ethanol. 
 Close the cabinet door. 
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What are the risks? 
 Impact injuries caused by the drop weight. 
 Animal bites. 
 Animal tissue/fluid (i.e. splashing fluids or blood into eyes). 
 Contamination with animal fluid and tissue.  
 Unexpected debris from the sample. 
 Injuries to back and neck muscles due to inappropriate body posture during 
lengthy experimental tests.  
 
What are the controls? 
 The Impact device is designed with shields and guards in place to protect the 
operator. 
 Operators should start with a light weight during calibration of the device, and 
increase the weight as necessary. 
 Only trained operators should use the device. 
 The device should be placed in a secure location away from foot traffic.  
 Appropriate PPE (safety glasses, gloves and lab coat) must be used.  
 Anyone wishing to work with this device must be trained in animal handling. 
 Animals should only be handled briefly to transfer them from a cage into the 
pre-anaesthesia chamber.  
 Follow SOP’s for gas anaesthesia of rats. 
 Users should take a Vaccination against Hepatitis B. 
 Place the device on a stable bench or table at the correct height so users can 
work with the device safely and comfortably. Provide a suitable stand for safe 
access to the top of the drop tower. Sit in an ergonomic position while working. 
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Authority 
Only people who have completed a full laboratory induction including 
animal handling and impact device training are authorised to work with this 
instrument.   
 
Notes 
This SOP has been reviewed and approved by Dr Roland Steck and Dr. 
Lauren Bautler. 
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Abbreviations 
 
 CSTT: closed soft tissue trauma 
 PPE: personal protection equipment e.g. gloves, gown, safety 
glasses, suitable shoes 
 PC2: Physical containment level 2 
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Purpose and scope 
 
This document has been developed to present safe operating procedures 
and standard protocols for perfusing a solution through rat’s vessels for various 
applications at MERF, Prince Charles Hospital, Brisbane, Australia.  
 
Guidelines for rat perfusion 
The rat perfusion protocol has been developed to help investigate 
microvasculature whether it has been injured by closed soft tissue trauma 
(CSTT) or is non-injured, using micro CT on anaesthetised rats or cadavers. 
Depending on the experiment, a variety of solutions can be used to perfuse 
through the microvasculature. This particular SOP is designed for perfusing a 
saline-heparin mixture to flush the blood from the microvasculature and also to 
perfuse a contrast agent (microfil) through the vasculature. 
 
Animal preparation  
The animal housing and welfare are based on the Australian code for the 
care and use of animals for scientific purposes (National Health and Medical 
Research Council 2013). Animals are accommodated in enclosed, safe and clean 
cages where they can freely have access to water and nutritious pellets as well 
as social and physical activity. Prior to the initiation of the impact, the 
anaesthetised animals are injected with analgesic subcutaneously 
(Buprenorphine: 0.2 mg/ml, 0.05 mg/kg) and then transferred to the impact 
device. After impact, animals should be kept warm during recovery while their 
vital signs are monitored. The post-operative pain can be managed by injecting 
one dose of Buprenorphine 12 hours after impact. The rats are euthanized 24 
hours after impact according to the standard operating protocol (SOP) #261 of 
the Medical Engineering Research Facility (MERF) at QUT.  
 
 
 
  
Appendix D XXVII 
Responsibilities 
This document covers only basic information regarding the safe operating 
procedure for rat microvasculature perfusion. Therefore, as this guideline does 
not provide specific details regarding different experiments, operators will be 
required to be specifically trained for their particular tests. Users are 
responsible to perform the perfusion according to the protocols presented in 
this guideline. Users are expected to be familiar with the terms and conditions 
described in this document and if necessary training must be taken before 
initiating the perfusion procedure. 
 
Precautions 
The surgery and perfusion are performed in a PC2 environment as there is 
a chance of contamination by blood or tissue fluid.  Using PPE is essential during 
this procedure.  
 
Procedures 
 Before commencing the test, appropriate PPE must be used.  
 Turn the hood and blower on. 
 Be familiar with the rat’s anaesthesia and euthanasia procedures 
described below. 
 
Rat anaesthesia protocols 
 Connect the oxygen to the tank, then open the oxygen tank valve. If 
the oxygen tank is empty, check with the relevant MERF staff to 
arrange tank replacement. 
 Fill the anaesthetics machine with isofluorane. 
 Obtain the isofluorane key to connect the isofluorane to the 
anaesthetic machine from the relevant MERF staff. 
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 Insert the key into the bottle. 
 Insert the other end of the key into the anaesthetics machine (2 
holes pointing to the right), then secure with a screw. 
 Turn the bottle upside down and open the valve, then fill the 
anaesthetics machine until the maximum line is reached. 
 Close the valve and turn the bottle back on its base, shaking the 
remaining isofluorane back into the bottle. 
 Remove the key from the anaesthetic machine and bottle.  
 Induce anaesthesia. 
 Hold the animal by its tail and carry it from its cage to the 
anaesthesia chamber. 
 Place the animal inside the induction chamber and tighten up the 
chamber lid. 
 Connect the scavenger tube to the carbon tank (or exhaust via fume 
hood). 
 Turn the switch so the anaesthetics flows into the induction 
chamber. 
 Adjust oxygen flow (right valve) to 2-3L Oxygen/minutes and 5% 
isofluorane. 
 Once the animal is unconscious/anaesthetised, stop gas/oxygen 
flow. 
 Maintain anaesthesia. 
 Place the animal on a surgical table with its nose inside the nose 
piece. 
 Reconnect the nose piece to the anaesthetics machine. 
 Reconnect the scavenger hose to the carbon tank (or exhaust via 
fume hood). 
 Switch the gas flow to go through to the nose piece. 
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 Adjust oxygen flow (left valve) to 1-1.5l O2/min at 2-2.5% 
isofluorane. 
 Ensure that the animal is put to sleep properly. 
 
Rat Euthanasia 
 Placed the rat in a plastic container under a laboratory hood.  
 Connected the container to CO2 and seal the lid to prevent the gas 
leaking outside.  
 Verify death of the rat (refer to the NHMRC Guidelines to promote 
the wellbeing of animals used for scientific purposes: the 
assessment and alleviation of pain and distress in research animals. 
2008). 
 
The PC2 preparation room 
 Before commencing the test, ensure the appropriate PPE is used.  
 Prepare the perfusion setup (perfusion pumps, the connectors, 
heparinised saline and microfil contrast agent). 
 Prepare a plastic net over an open plastic container for collecting 
blood and solution. 
 Prepare the surgery setup (bladed scalpel, a pair of scissors, 
tweezers and clamps). 
 Make sure the perfusion pump is working properly then connect 
one tip of the tube to the heparinised saline prepared in a glass 
(250 ml) and the other tip to the three-way connector. 
 Open the rat’s chest using a bladed scalpel and a pair of scissors 
section to expose the heart. 
 Dry the heart with a paper towel. 
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 Insert the 22 G angiocath into the left ventricle and secure it with 
super glue.  
 Transfer the rat onto the plastic net in the supine position and 
attach the angiocath to the three-way connector.  
 Open the right atrium delicately to facilitate the drainage of 
solutions using a needle.   
 Turn on the perfusion pump so the heparinised saline flows 
through the vasculature. 
 When the output has become clear of blood, prepare the microfil 
contrast agent in a disposable glass and connect that to the second 
pump for perfusion. 
 After completing the contrast agent perfusion, transfer the rat into 
the fridge and keep it there at 4°C overnight. 
 The day after dissection put the legs in NBF at 10% concentration 
for future micro-CT imaging. 
 
What are the risks? 
 Contamination with anaesthesia gas (isoflourane).  
 Injuries caused by the blade. 
 Injuries caused by the needle.  
 Animal bites. 
 Animal Tissue/Fluid: Splashing fluids or blood into eyes. 
 Contamination with animal fluid and tissue during surgery. 
 Unexpected debris from the sample. 
 Injuries to back and neck muscles due to inappropriate body 
posture during the procedure.  
 Contamination with chemical materials (i.e. microfil). 
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What are the controls? 
 Be familiar with anaesthesia SOPs.  
 The hood and blower must be on in all times during anaesthesia.  
 The animal chamber must be closed tightly during anaesthesia.  
 The isofloarane lid must be tightened properly after use.  
 Appropriate PPE (mask, safety glasses, gloves, covered shoes, gown 
with long sleeves, and hair net) must be used.  
 If there are any concerns regarding the gloves being torn during the 
surgery, two or even three gloves should be worn. 
 To prevent risks associated with the blade, inserting the blade into 
the scalpel and cutting of the tissue must be carried out by a trained 
person or under expert supervision. Holding the scalpel like a pen 
is the safest position when cutting the tissue. 
 After using scalpel, the blade must be immediately disposed of 
safely.  
 Only trained personnel should perform the surgery. 
 Surgical instruments such as the scalpel should be stored in a 
secure location away from foot traffic.  
 All consumables used for the perfusion should be disposed of 
properly after surgery. 
 All personnel who wish to perform the surgery must be trained in 
animal handling. 
 Users should take a Vaccination against Hepatitis B. 
 Sit in an ergonomic position while working. 
 The safest way to carry the animal from its cage to the anaesthesia 
chamber is by its tail. 
 The scavenger system should be used to prevent chemical 
exposure. 
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Authority 
Only people who have completed a full laboratory induction including 
animal handling and have trained to work with hazardous materials 
are authorised to work using these protocols.   
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